PMID	Sentence_ID	Sentence	Gene1|Gene1_ID	Gene1_Index(start|end)	Gene2|Gene2_ID	Gene2_Index(start|end)	RE_Type
24003223	S1	"A brain-specific Grb2-associated regulator of extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) (GAREM) subtype, GAREM2, contributes to neurite outgrowth of neuroblastoma cells by regulating Erk signaling."	Erk|5594	225|228	GAREM2|150946	147|153	Neutral_Regulation
24003223	S7	"Three GAREM2 tyrosines (Tyr-102, Tyr-429, and Tyr-551) are phosphorylated upon EGF stimulation and are necessary for binding to Grb2."	Grb2|2885	128|132	GAREM2|150946	6|12	Binding
24003223	S7	"Three GAREM2 tyrosines (Tyr-102, Tyr-429, and Tyr-551) are phosphorylated upon EGF stimulation and are necessary for binding to Grb2."	EGF|1950	79|82	GAREM2|150946	6|12	Modification
24003223	S8	"Furthermore, GAREM2 and Shp2 regulate Erk activity in EGF-stimulated cells."	Erk|5594	38|41	GAREM2|150946	13|19	Neutral_Regulation
24003223	S8	"Furthermore, GAREM2 and Shp2 regulate Erk activity in EGF-stimulated cells."	Erk|5594	38|41	Shp2|5781	24|28	Neutral_Regulation
24003223	S10	GAREM2 is expressed in some neuroblastoma cell lines and is also tyrosine-phosphorylated and bound to Grb2 after treatment with EGF.	Grb2|2885	102|106	GAREM2|150946	0|6	Binding
24003223	S11	"Eventually, GAREM2 regulates Erk activation in the presence of EGF or insulin like growth factor 1."	GAREM2|150946	12|18	Erk|5594	29|32	Positive_Regulation
24018422	S3	"Here, we show that the SUMO/Sentrin/Smt3-specific peptidase, SENP7, interacts with the chromatin repressive KRAB-associated protein 1 (KAP1) through heterochromatin protein 1 alpha (HP1a)."	SENP7|57337	61|66	KRAB-associated protein 1 (KAP1)|10155	108|140	Association
24018422	S3	"Here, we show that the SUMO/Sentrin/Smt3-specific peptidase, SENP7, interacts with the chromatin repressive KRAB-associated protein 1 (KAP1) through heterochromatin protein 1 alpha (HP1a)."	heterochromatin protein 1 alpha (HP1a)|23468	149|187	SENP7|57337	61|66	Interaction_Agent
24018422	S4	SENP7 promotes the removal of SUMO2/3 from KAP1 and regulates the interaction of the chromatin remodeler CHD3 with chromatin.	SENP7|57337	0|5	SUMO2|6613	30|35	Translocation
24019069	S3	"Clinical evidence has revealed that p16(INK4A), an allosteric inhibitor of CDK4/6, is inactivated in over half of human melanomas, and numerous animal models have demonstrated that p16(INK4A) deletion promotes melanoma."	p16(INK4A)|1029	36|46	CDK4|1019	75|79	Negative_Agent
24019069	S4	"FBXO4, a specificity factor for the E3 ligase that directs timely cyclin D1 proteolysis, has not been studied in melanoma."	cyclin D1|595	66|75	FBXO4|26272	0|5	Neutral_Regulation
24019069	S6	"Furthermore, we have identified a substrate-binding mutation, FBXO4 I377M, that selectively disrupts cyclin D1 degradation while preserving proteolysis of the other known FBXO4 substrate, TRF1."	TRF1|7013	188|192	FBXO4|26272	171|176	Interaction_Agent
24019069	S6	"Furthermore, we have identified a substrate-binding mutation, FBXO4 I377M, that selectively disrupts cyclin D1 degradation while preserving proteolysis of the other known FBXO4 substrate, TRF1."	FBXO4|26272	62|67	cyclin D1|595	101|110	Positive_Regulation
24019069	S7	"The I377M mutation and Fbxo4 deficiency result in nuclear accumulation of cyclin D1, a key transforming neoplastic event."	Fbxo4|26272	23|28	cyclin D1|595	74|83	Translocation
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	P97|7415	114|117	UFD1|7353	117|121	Complex
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	P97|7415	114|117	NPL4|55666	122|126	Complex
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	UFD1|7353	117|121	NPL4|55666	122|126	Complex
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	NEDD8 ultimate buster-1 long (NUB1L)|51667	0|36	NEDD8|4738	66|71	Translocation
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	NEDD8 ultimate buster-1 long (NUB1L)|51667	0|36	P97|7415	114|117	Interaction_Agent
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	NEDD8 ultimate buster-1 long (NUB1L)|51667	0|36	UFD1|7353	117|121	Interaction_Agent
24019527	S1	NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.	NEDD8 ultimate buster-1 long (NUB1L)|51667	0|36	NPL4|55666	122|126	Interaction_Agent
24019527	S2	"The NEDD8 protein and neddylation levels in cells are modulated by NUB1L or NUB1 through proteasomal degradation, but the underlying molecular mechanism is not well understood."	NUB1L|51667	67|72	NEDD8|4738	4|9	Neutral_Regulation
24019527	S2	"The NEDD8 protein and neddylation levels in cells are modulated by NUB1L or NUB1 through proteasomal degradation, but the underlying molecular mechanism is not well understood."	NUB1|51667	76|80	NEDD8|4738	4|9	Neutral_Regulation
24019527	S3	"Here, we report that NUB1L down-regulated the protein levels of NEDD8 and neddylation through specifically recognizing NEDD8 and P97/VCP."	NUB1L|51667	21|26	NEDD8|4738	64|69	Negative_Regulation
24019527	S3	"Here, we report that NUB1L down-regulated the protein levels of NEDD8 and neddylation through specifically recognizing NEDD8 and P97/VCP."	NEDD8|4738	119|124	NUB1L|51667	21|26	Binding
24019527	S3	"Here, we report that NUB1L down-regulated the protein levels of NEDD8 and neddylation through specifically recognizing NEDD8 and P97/VCP."	P97/VCP|7415	129|136	NUB1L|51667	21|26	Binding
24019527	S4	"NUB1L directly interacted with NEDD8, but not with ubiquitin, on the key residue Asn-51 of NEDD8 and with P97/VCP on its positively charged VCP binding motif."	NUB1L|51667	0|5	NEDD8|4738	31|36	Association
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	P97|7415	25|28	UFD1|7353	29|33	Complex
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	P97|7415	25|28	NPL4|55666	34|38	Complex
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	UFD1|7353	29|33	NPL4|55666	34|38	Complex
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	NUB1L|51667	65|70	NEDD8|4738	92|97	Translocation
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	P97|7415	48|51	UFD1|7353	52|56	Complex
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	P97|7415	48|51	NPL4|55666	57|61	Complex
24019527	S5	"In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation."	UFD1|7353	52|56	NPL4|55666	57|61	Complex
24019527	S6	This mechanism is also exemplified by the canonical neddylation of cullin 1 for SCF (SKP1-cullin1-F-box) ubiquitin E3 ligases that is exquisitely regulated by the turnover of NEDD8.	cullin 1|8454	67|75	NEDD8|4738	175|180	Modification
24035498	S1	Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.	BACH1|571	92|97	NRF2|4780	72|76	Positive_Regulation
24035498	S6	We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.	FBXL17|64839	20|26	HMOX1|3162	73|78	Neutral_Regulation
24035498	S6	We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.	BACH1|571	125|130	FBXL17|64839	20|26	Interaction_Agent
24035498	S6	We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.	HMOX1|3162	73|78	NRF2|4780	61|65	Interaction_Agent
24050775	S6	LGR4 LRR1-14 and ZNRF3 ECD inhibited RSPO2-enhanced Wnt3a signaling.	Wnt3a|89780	52|57	LGR4|55366	0|4	Negative_Regulation
24050775	S6	LGR4 LRR1-14 and ZNRF3 ECD inhibited RSPO2-enhanced Wnt3a signaling.	Wnt3a|89780	52|57	ZNRF3|84133	17|22	Negative_Regulation
24050775	S6	LGR4 LRR1-14 and ZNRF3 ECD inhibited RSPO2-enhanced Wnt3a signaling.	Wnt3a|89780	52|57	RSPO2|340419	37|42	Positive_Regulation
24050775	S7	The RSPOs bound LGR4 LRR1-14 with nanomolar affinities that decreased in the following order in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay: RSPO4 > RSPO2 > RSPO3 > RSPO1.	LGR4|55366	16|20	RSPO4|343637	168|173	Binding
24050775	S7	The RSPOs bound LGR4 LRR1-14 with nanomolar affinities that decreased in the following order in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay: RSPO4 > RSPO2 > RSPO3 > RSPO1.	LGR4|55366	16|20	RSPO2|340419	176|181	Binding
24050775	S7	The RSPOs bound LGR4 LRR1-14 with nanomolar affinities that decreased in the following order in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay: RSPO4 > RSPO2 > RSPO3 > RSPO1.	LGR4|55366	16|20	RSPO3|84870	184|189	Binding
24050775	S7	The RSPOs bound LGR4 LRR1-14 with nanomolar affinities that decreased in the following order in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay: RSPO4 > RSPO2 > RSPO3 > RSPO1.	LGR4|55366	16|20	RSPO1|284654	192|197	Binding
24050775	S8	"RSPO-receptor interactions were further characterized with a native gel electrophoretic mobility shift assay, which corroborated the RSPO-LGR4 TR-FRET results and indicated that RSPOs weakly bound ZNRF3 with affinities that decreased in the following order: RSPO2 > RSPO3 > RSPO1."	ZNRF3|84133	197|202	RSPO2|340419	258|263	Binding
24050775	S8	"RSPO-receptor interactions were further characterized with a native gel electrophoretic mobility shift assay, which corroborated the RSPO-LGR4 TR-FRET results and indicated that RSPOs weakly bound ZNRF3 with affinities that decreased in the following order: RSPO2 > RSPO3 > RSPO1."	ZNRF3|84133	197|202	RSPO3|84870	266|271	Binding
24050775	S8	"RSPO-receptor interactions were further characterized with a native gel electrophoretic mobility shift assay, which corroborated the RSPO-LGR4 TR-FRET results and indicated that RSPOs weakly bound ZNRF3 with affinities that decreased in the following order: RSPO2 > RSPO3 > RSPO1."	ZNRF3|84133	197|202	RSPO1|284654	274|279	Binding
24050775	S9	RSPO4:ZNRF3 complexes were not detected.	RSPO4|343637	0|5	ZNRF3|84133	6|11	Negation_Complex
24050775	S10	"Lastly, ternary RSPO:LGR4:ZNRF3 complexes were detected for RSPO2 and -3."	LGR4|55366	21|25	ZNRF3|84133	26|31	Complex
24050775	S10	"Lastly, ternary RSPO:LGR4:ZNRF3 complexes were detected for RSPO2 and -3."	LGR4|55366	21|25	RSPO2|340419	60|65	Complex
24050775	S10	"Lastly, ternary RSPO:LGR4:ZNRF3 complexes were detected for RSPO2 and -3."	ZNRF3|84133	26|31	RSPO2|340419	60|65	Complex
24056301	S2	"The RAS-like GTPase RALB mediates cellular responses to nutrient availability or viral infection by respectively engaging two components of the exocyst complex, EXO84 and SEC5."	EXO84|149371	161|166	SEC5|55770	171|175	Complex
24056301	S2	"The RAS-like GTPase RALB mediates cellular responses to nutrient availability or viral infection by respectively engaging two components of the exocyst complex, EXO84 and SEC5."	RALB|5899	20|24	EXO84|149371	161|166	Association
24056301	S2	"The RAS-like GTPase RALB mediates cellular responses to nutrient availability or viral infection by respectively engaging two components of the exocyst complex, EXO84 and SEC5."	RALB|5899	20|24	SEC5|55770	171|175	Association
24056301	S3	"RALB employs SEC5 to trigger innate immunity signalling, whereas RALB-EXO84 interaction induces autophagocytosis."	RALB|5899	65|69	EXO84|149371	70|75	Association
24056301	S3	"RALB employs SEC5 to trigger innate immunity signalling, whereas RALB-EXO84 interaction induces autophagocytosis."	SEC5|55770	13|17	RALB|5899	0|4	Association
24056301	S6	"Specifically, ubiquitylation at Lys47 sterically inhibits RALB binding to EXO84, while facilitating its interaction with SEC5."	RALB|5899	59|63	EXO84|149371	75|80	Binding
24056301	S6	"Specifically, ubiquitylation at Lys47 sterically inhibits RALB binding to EXO84, while facilitating its interaction with SEC5."	SEC5|55770	122|126	RALB|5899	59|63	Association
24056301	S7	Double-stranded RNA promotes RALB ubiquitylation and SEC5-TBK1 complex formation.	SEC5|55770	53|57	TBK1|29110	58|62	Complex
24056301	S9	Deubiquitylated RALB promotes the assembly of the RALB-EXO84-beclin-1 complexes driving autophagosome formation.	RALB|5899	50|54	EXO84|149371	55|60	Complex
24056301	S9	Deubiquitylated RALB promotes the assembly of the RALB-EXO84-beclin-1 complexes driving autophagosome formation.	RALB|5899	50|54	beclin-1|8678	61|69	Complex
24056301	S9	Deubiquitylated RALB promotes the assembly of the RALB-EXO84-beclin-1 complexes driving autophagosome formation.	EXO84|149371	55|60	beclin-1|8678	61|69	Complex
24056301	S9	Deubiquitylated RALB promotes the assembly of the RALB-EXO84-beclin-1 complexes driving autophagosome formation.	RALB|5899	16|20	RALB|5899	50|54	Transformation
24056301	S9	Deubiquitylated RALB promotes the assembly of the RALB-EXO84-beclin-1 complexes driving autophagosome formation.	RALB|5899	16|20	EXO84|149371	55|60	Transformation
24056301	S9	Deubiquitylated RALB promotes the assembly of the RALB-EXO84-beclin-1 complexes driving autophagosome formation.	RALB|5899	16|20	beclin-1|8678	61|69	Transformation
24058170	S6	"The ESCRT-III subunits Vps20 and Vps24 showed a complementary binding pattern, suggesting a model for the series of events in the ESCRT-III functional cycle."	Vps20|855101	23|28	Vps24|853825	33|38	Binding
24058170	S6	"The ESCRT-III subunits Vps20 and Vps24 showed a complementary binding pattern, suggesting a model for the series of events in the ESCRT-III functional cycle."	Vps20|855101	23|28	Vps24|853825	33|38	Complex
24058170	S7	Vps4 bound to individual Snf7 motifs but not to full-length Snf7.	Vps4|856303	0|4	Snf7|850712	25|29	Binding
24058170	S7	Vps4 bound to individual Snf7 motifs but not to full-length Snf7.	Vps4|856303	0|4	Snf7|850712	60|64	Negation_Binding
24058170	S8	This suggests that Vps4 does not bind to the closed conformation of Snf7.	Vps4|856303	19|23	Snf7|850712	68|72	Negation_Binding
24058170	S9	We also demonstrate for the first time that the ALIX/Bro1 homologue Rim20 binds to the a6 helix of Snf7.	Snf7|850712	99|103	Rim20|854449	68|73	Binding
24058170	S10	Analysis of a Snf7 a6 deletion mutant showed that the a6 helix is crucial for binding of Bro1 and Rim20 in vivo and is indispensable for the multivesicular body (MVB)-sorting and Rim-signaling functions of Snf7.	Bro1|856021	89|93	Rim20|854449	98|103	Binding
24062075	S1	"Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue."	hus1|3364	44|48	per2|8864	123|127	Association
24062075	S1	"Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue."	gadd45a|1647	50|57	per2|8864	123|127	Association
24062075	S1	"Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue."	rb1|5925	59|62	per2|8864	123|127	Association
24062075	S1	"Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue."	cdkn2a|1029	64|70	per2|8864	123|127	Association
24062075	S1	"Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue."	mre11a|4361	75|81	per2|8864	123|127	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	cdc20|991	138|143	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	birc5|332	145|150	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	hus1|3364	49|53	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	gadd45a|1647	55|62	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	rb1|5925	64|67	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	cdkn2a|1029	69|75	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	mre11a|4361	86|92	per2|8864	157|161	Association
24062075	S6	"We identified seven genes positively correlated (hus1, gadd45a, rb1, cdkn2a, cdk5rp1, mre11a, sumo1) and two genes negatively correlated (cdc20, birc5) with per2 expression."	sumo1|7341	94|99	per2|8864	157|161	Association
24085845	S5	"Here, we show HSP90-mediated stabilization of a BRCT domain mutant BRCA1 protein under PARP inhibitor selection pressure."	HSP90|3320	14|19	BRCA1|672	67|72	Neutral_Regulation
24085845	S6	"The stabilized mutant BRCA1 protein interacted with PALB2-BRCA2-RAD51, was essential for RAD51 focus formation, and conferred PARP inhibitor as well as cisplatin resistance."	BRCA1|672	22|27	PALB2|79728	52|57	Association
24085845	S6	"The stabilized mutant BRCA1 protein interacted with PALB2-BRCA2-RAD51, was essential for RAD51 focus formation, and conferred PARP inhibitor as well as cisplatin resistance."	BRCA1|672	22|27	BRCA2|675	58|63	Association
24085845	S6	"The stabilized mutant BRCA1 protein interacted with PALB2-BRCA2-RAD51, was essential for RAD51 focus formation, and conferred PARP inhibitor as well as cisplatin resistance."	BRCA1|672	22|27	RAD51|5888	64|69	Association
24085845	S8	Resistant cells also acquired a TP53BP1 mutation that facilitated DNA end resection in the absence of a BRCA1 protein capable of binding CtIP.	CtIP|5932	137|141	BRCA1|672	104|109	Binding
24113472	S1	"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients."	SF3B1|23451	0|5	NOTCH1|4851	60|66	Association
24113472	S1	"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients."	SF3B1|23451	0|5	FBXW7|55294	68|73	Association
24113472	S1	"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients."	SF3B1|23451	0|5	MYD88|4615	75|80	Association
24113472	S1	"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients."	SF3B1|23451	0|5	XPO1|7514	82|86	Association
24113472	S1	"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients."	SF3B1|23451	0|5	TP53|7157	91|95	Association
24113472	S4	"SF3B1mut, NOTCH1mut, TP53mut and XPO1mut were highly correlated to unmutated, whereas MYD88mut were associated with mutated IGHV status."	MYD88|4615	86|91	IGHV|28402	124|128	Association
24113472	S4	"SF3B1mut, NOTCH1mut, TP53mut and XPO1mut were highly correlated to unmutated, whereas MYD88mut were associated with mutated IGHV status."	IGHV|28402	124|128	SF3B1|23451	0|5	Association
24113472	S4	"SF3B1mut, NOTCH1mut, TP53mut and XPO1mut were highly correlated to unmutated, whereas MYD88mut were associated with mutated IGHV status."	IGHV|28402	124|128	NOTCH1|4851	10|16	Association
24113472	S4	"SF3B1mut, NOTCH1mut, TP53mut and XPO1mut were highly correlated to unmutated, whereas MYD88mut were associated with mutated IGHV status."	IGHV|28402	124|128	TP53|7157	21|25	Association
24113472	S4	"SF3B1mut, NOTCH1mut, TP53mut and XPO1mut were highly correlated to unmutated, whereas MYD88mut were associated with mutated IGHV status."	IGHV|28402	124|128	XPO1|7514	33|37	Association
24121510	S4	shRNA-mediated down-regulation of AKAP5 in HEK-293 cells inhibited the recycling of the b1-AR.	AKAP5|9495	34|39	b1-AR|153	88|93	Translocation
24121510	S5	Recycling of the b1-AR in AKAP5 knockdown cells was rescued by shRNA-resistant AKAP5.	AKAP5|9495	79|84	b1-AR|153	17|22	Translocation
24121510	S6	"However, truncated mutants of AKAP5 with deletions in the domains involved in membrane targeting or in binding to calcineurin or PKA failed to restore the recycling of the b1-AR, indicating that full-length AKAP5 was required."	AKAP5|9495	30|35	b1-AR|153	172|177	Negation_Translocation
24121510	S10	These data indicate that AKAP5 exerted specific and profound effects on b1-AR recycling in mammalian cells.	AKAP5|9495	25|30	b1-AR|153	72|77	Translocation
24124444	S10	"HAM1 is the strongest resistance gene, but it partially depends on YJL055W for its function."	HAM1|853532	0|4	YJL055W|853391	67|74	Association
24124444	S11	This suggests that HAM1 and YJL055W function together in mediating resistance to 5-FU.	HAM1|853532	19|23	YJL055W|853391	28|35	Association
24165940	S6	"In atg38 cells, autophagic activity was significantly reduced and PI3-kinase complex I dissociated into the Vps15-Vps34 and Atg14-Vps30 subcomplexes."	Vps15|852394	109|114	Vps34|850941	115|120	Complex
24165940	S6	"In atg38 cells, autophagic activity was significantly reduced and PI3-kinase complex I dissociated into the Vps15-Vps34 and Atg14-Vps30 subcomplexes."	Atg14|852425	125|130	Vps30|855983	131|136	Complex
24165940	S7	We find that Atg38 physically interacted with Atg14 and Vps34 via its N terminus.	Atg38|850908	13|18	Atg14|852425	46|51	Association
24165940	S7	We find that Atg38 physically interacted with Atg14 and Vps34 via its N terminus.	Atg38|850908	13|18	Vps34|850941	56|61	Association
24165940	S9	These data suggest that the homodimer of Atg38 functions as a physical linkage between the Vps15-Vps34 and Atg14-Vps30 subcomplexes to facilitate complex I formation.	Vps15|852394	91|96	Vps34|850941	97|102	Complex
24165940	S9	These data suggest that the homodimer of Atg38 functions as a physical linkage between the Vps15-Vps34 and Atg14-Vps30 subcomplexes to facilitate complex I formation.	Vps30|855983	113|118	Atg14|852425	107|112	Complex
24165940	S9	These data suggest that the homodimer of Atg38 functions as a physical linkage between the Vps15-Vps34 and Atg14-Vps30 subcomplexes to facilitate complex I formation.	Atg38|850908	41|46	Vps15|852394	91|96	Interaction_Agent
24165940	S9	These data suggest that the homodimer of Atg38 functions as a physical linkage between the Vps15-Vps34 and Atg14-Vps30 subcomplexes to facilitate complex I formation.	Atg38|850908	41|46	Vps34|850941	97|102	Interaction_Agent
24165940	S9	These data suggest that the homodimer of Atg38 functions as a physical linkage between the Vps15-Vps34 and Atg14-Vps30 subcomplexes to facilitate complex I formation.	Atg38|850908	41|46	Atg14|852425	107|112	Interaction_Agent
24165940	S9	These data suggest that the homodimer of Atg38 functions as a physical linkage between the Vps15-Vps34 and Atg14-Vps30 subcomplexes to facilitate complex I formation.	Atg38|850908	41|46	Vps30|855983	113|118	Interaction_Agent
24167073	S1	Pcid2 inactivates developmental genes in human and mouse embryonic stem cells to sustain their pluripotency by modulation of EID1 stability.	EID1|58521	125|129	Pcid2|55795	0|5	Neutral_Regulation
24167073	S7	Pcid2 associates with EID1 and is present in the CBP/p300-EID1 complex in the ESCs.	Pcid2|55795	0|5	EID1|23741	22|26	Association
24167073	S7	Pcid2 associates with EID1 and is present in the CBP/p300-EID1 complex in the ESCs.	CBP|1387	49|52	p300|2033	53|57	Complex
24167073	S7	Pcid2 associates with EID1 and is present in the CBP/p300-EID1 complex in the ESCs.	CBP|1387	49|52	EID1|23741	58|62	Complex
24167073	S7	Pcid2 associates with EID1 and is present in the CBP/p300-EID1 complex in the ESCs.	p300|2033	53|57	EID1|23741	58|62	Complex
24167073	S8	We show that MDM2 is an E3 ligase for K48-linked EID1 ubiquitination for its degradation.	MDM2|4193	13|17	EID1|23741	49|53	Interaction_Agent
24167073	S9	"For the maintenance of self-renewal, Pcid2 binds to EID1 to impede the association with MDM2."	Pcid2|55795	37|42	EID1|23741	52|56	Binding
24167073	S9	"For the maintenance of self-renewal, Pcid2 binds to EID1 to impede the association with MDM2."	MDM2|4193	88|92	EID1|23741	52|56	Association
24167073	S9	"For the maintenance of self-renewal, Pcid2 binds to EID1 to impede the association with MDM2."	MDM2|4193	88|92	Pcid2|55795	37|42	Negative_Regulation
24167073	S9	"For the maintenance of self-renewal, Pcid2 binds to EID1 to impede the association with MDM2."	EID1|23741	52|56	Pcid2|55795	37|42	Negative_Regulation
24167073	S10	"Then EID1 is not degraded to sustain its stability to block the HAT activity of CBP/p300, leading to suppression of the developmental gene expression."	EID1|23741	5|9	CBP|1387	80|83	Negative_Regulation
24167073	S10	"Then EID1 is not degraded to sustain its stability to block the HAT activity of CBP/p300, leading to suppression of the developmental gene expression."	EID1|23741	5|9	p300|2033	84|88	Negative_Regulation
24167073	S11	"Collectively, Pcid2 is present in the CBP/p300-EID1 complex to control the switch balance of mouse and human ESCs through modulation of EID1 degradation."	CBP|1387	38|41	p300|2033	42|46	Complex
24167073	S11	"Collectively, Pcid2 is present in the CBP/p300-EID1 complex to control the switch balance of mouse and human ESCs through modulation of EID1 degradation."	CBP|1387	38|41	EID1|23741	47|51	Complex
24167073	S11	"Collectively, Pcid2 is present in the CBP/p300-EID1 complex to control the switch balance of mouse and human ESCs through modulation of EID1 degradation."	p300|2033	42|46	EID1|23741	47|51	Complex
24167073	S11	"Collectively, Pcid2 is present in the CBP/p300-EID1 complex to control the switch balance of mouse and human ESCs through modulation of EID1 degradation."	Pcid2|55795	14|19	EID1|23741	136|140	Negative_Regulation
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	PABPC1|26986	60|66	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	YBX1|4904	68|72	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	KHSRP|8570	74|79	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	SYNCRIP|10492	81|88	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	DDX39|10212	90|95	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	ELAV1|1994	97|102	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	EIF4A1|1973	104|110	Association
24189637	S6	"The interactions between MAEL and 8 of these SG components (PABPC1, YBX1, KHSRP, SYNCRIP, DDX39, ELAV1, EIF4A1 and EIF3F) were confirmed by anti-tag immunoprecipitation."	MAEL|84944	25|29	EIF3F|8665	115|120	Association
24189637	S7	Immunofluorescence analysis showed that MAEL co-localizes with the SG marker PABPC1 in SGs during oxidative stress.	MAEL|84944	40|44	PABPC1|26986	77|83	Association
24244375	S1	"HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-kB, AP-1, C/EBPa and C/EBPg transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways."	HIV-1 Tat|155871	0|9	CCL5|6352	32|36	Positive_Regulation
24244375	S1	"HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-kB, AP-1, C/EBPa and C/EBPg transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways."	NF-kB|4790	60|65	CCL5|6352	32|36	Association
24244375	S1	"HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-kB, AP-1, C/EBPa and C/EBPg transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways."	AP-1|3727	67|71	CCL5|6352	32|36	Association
24244375	S1	"HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-kB, AP-1, C/EBPa and C/EBPg transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways."	C/EBPa|1050	73|79	CCL5|6352	32|36	Association
24244375	S1	"HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-kB, AP-1, C/EBPa and C/EBPg transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways."	C/EBPg|1054	84|90	CCL5|6352	32|36	Association
24244375	S4	"HIV-1 Tat is known to up-regulate CCL5 expression in mouse astrocytes, but the mechanism of up-regulation is not known."	HIV-1 Tat|155871	0|9	CCL5|6352	34|38	Positive_Regulation
24244375	S5	The present study was undertaken with the objective of determining the mechanism(s) underlying HIV-1 Tat-mediated expression of CCL5 in astrocytes.	HIV-1 Tat|155871	95|104	CCL5|6352	128|132	Neutral_Regulation
24244375	S9	"Pre-treatment with SC514 (NF-kB inhibitor), LY294002 (PI3K inhibitor), AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting involvement of JAK, PI3K/Akt and NF-kB in CCL5 expression."	Tat|155871	155|158	CCL5|6352	181|185	Positive_Regulation
24244375	S9	"Pre-treatment with SC514 (NF-kB inhibitor), LY294002 (PI3K inhibitor), AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting involvement of JAK, PI3K/Akt and NF-kB in CCL5 expression."	CCL5|6352	239|243	PI3K|5293	217|221	Association
24244375	S9	"Pre-treatment with SC514 (NF-kB inhibitor), LY294002 (PI3K inhibitor), AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting involvement of JAK, PI3K/Akt and NF-kB in CCL5 expression."	CCL5|6352	239|243	Akt|207	222|225	Association
24244375	S9	"Pre-treatment with SC514 (NF-kB inhibitor), LY294002 (PI3K inhibitor), AG490 (JAK2 inhibitor) and Janex-1 (JAK3 inhibitor) showed partial reduction of the Tat-mediated induction of CCL5 suggesting involvement of JAK, PI3K/Akt and NF-kB in CCL5 expression."	CCL5|6352	239|243	NF-kB|4790	230|235	Association
24244375	S12	"This was further confirmed at transcriptional level that AP-1, C/EBPa and C/EBPg were involved in CCL5 up-regulation."	CCL5|6352	98|102	AP-1|3727	57|61	Association
24244375	S12	"This was further confirmed at transcriptional level that AP-1, C/EBPa and C/EBPg were involved in CCL5 up-regulation."	CCL5|6352	98|102	C/EBPa|1050	63|69	Association
24244375	S12	"This was further confirmed at transcriptional level that AP-1, C/EBPa and C/EBPg were involved in CCL5 up-regulation."	CCL5|6352	98|102	C/EBPg|1054	74|80	Association
24257755	S1	"Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation."	chymase|17228	10|17	heat shock protein 70|15511	40|61	Negative_Regulation
24257755	S1	"Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation."	chymase|17228	10|17	biglycan|12111	63|71	Negative_Regulation
24257755	S1	"Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation."	chymase|17228	10|17	HMGB1|15289	73|78	Negative_Regulation
24257755	S1	"Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation."	chymase|17228	10|17	interleukin-33 (IL-33)|77125	84|106	Negative_Regulation
24257755	S6	"We found that protein extracts from wild type (WT), carboxypeptidase A3-, and MCPT6-deficient mice and MCs and recombinant human chymase efficiently degrade the Trichinella spiralis virulence factor heat shock protein 70 (Hsp70) as well as endogenous Hsp70."	chymase|1215	129|136	Hsp70|15511	251|256	Negative_Regulation
24257755	S8	"Chymase, but not MC tryptase, also degraded other alarmins, i.e. biglycan, HMGB1, and IL-33, a degradation that was efficiently blocked by the chymase inhibitor chymostatin."	Chymase|17228	0|7	biglycan|12111	65|73	Negative_Regulation
24257755	S8	"Chymase, but not MC tryptase, also degraded other alarmins, i.e. biglycan, HMGB1, and IL-33, a degradation that was efficiently blocked by the chymase inhibitor chymostatin."	Chymase|17228	0|7	HMGB1|15289	75|80	Negative_Regulation
24257755	S8	"Chymase, but not MC tryptase, also degraded other alarmins, i.e. biglycan, HMGB1, and IL-33, a degradation that was efficiently blocked by the chymase inhibitor chymostatin."	Chymase|17228	0|7	IL-33|77125	86|91	Negative_Regulation
24275659	S5	c-FLIP can inhibit death receptor-mediated apoptosis by competing with caspase-8 for recruitment to FADD.	c-FLIP|12633	0|6	FADD|14082	100|104	Binding
24275659	S5	c-FLIP can inhibit death receptor-mediated apoptosis by competing with caspase-8 for recruitment to FADD.	caspase-8|12370	71|80	FADD|14082	100|104	Binding
24275659	S9	We demonstrate that acute deletion of endogenous c-FLIP in murine effector T cells results in loss of caspase-8 activity and cell death.	caspase-8|12370	102|111	c-FLIP|12633	49|55	Negative_Regulation
24275659	S12	"Thus, not only is c-FLIP the initiator of caspase-8 activity during T cell activation, it is also an initial caspase-8 substrate, with cleaved p43FLIP serving to both stabilize caspase-8 activity and promote activation of pathways involved with T cell growth."	c-FLIP|12633	18|24	caspase-8|12370	42|51	Positive_Agent
24275659	S12	"Thus, not only is c-FLIP the initiator of caspase-8 activity during T cell activation, it is also an initial caspase-8 substrate, with cleaved p43FLIP serving to both stabilize caspase-8 activity and promote activation of pathways involved with T cell growth."	caspase-8|12370	109|118	c-FLIP|12633	18|24	Interaction_Agent
24277077	S5	"Knockdown of aggf1 expression decreases expression of endothelial cell-specific markers (cdh5, admr) and disrupts primitive hematopoiesis as shown by a decreased number of erythroid cells and reduced expression of gata1 (marker for erythroid progenitors) and pu.1 (myeloid progenitors)."	aggf1|559905	13|18	cdh5|445471	89|93	Negative_Regulation
24277077	S5	"Knockdown of aggf1 expression decreases expression of endothelial cell-specific markers (cdh5, admr) and disrupts primitive hematopoiesis as shown by a decreased number of erythroid cells and reduced expression of gata1 (marker for erythroid progenitors) and pu.1 (myeloid progenitors)."	aggf1|559905	13|18	admr|323641	95|99	Negative_Regulation
24277077	S5	"Knockdown of aggf1 expression decreases expression of endothelial cell-specific markers (cdh5, admr) and disrupts primitive hematopoiesis as shown by a decreased number of erythroid cells and reduced expression of gata1 (marker for erythroid progenitors) and pu.1 (myeloid progenitors)."	gata1|30481	214|219	aggf1|559905	13|18	Negative_Regulation
24277077	S5	"Knockdown of aggf1 expression decreases expression of endothelial cell-specific markers (cdh5, admr) and disrupts primitive hematopoiesis as shown by a decreased number of erythroid cells and reduced expression of gata1 (marker for erythroid progenitors) and pu.1 (myeloid progenitors)."	pu.1|30117	259|263	aggf1|559905	13|18	Negative_Regulation
24277077	S6	"Aggf1 knockdown also decreases expression of runx1 and c-myb, indicating that it is required for specification of hematopoietic stem cells (definitive hematopoiesis)."	Aggf1|559905	0|5	runx1|58126	45|50	Negative_Regulation
24277077	S6	"Aggf1 knockdown also decreases expression of runx1 and c-myb, indicating that it is required for specification of hematopoietic stem cells (definitive hematopoiesis)."	Aggf1|559905	0|5	c-myb|30519	55|60	Negative_Regulation
24277077	S7	"Aggf1 knockdown led to dramatically reduced expression of hemangioblast markers fli1, etsrp, lmo2, and scl, and hematopoietic/endothelial defects in aggf1 morphants were rescued by messenger RNA for scl, fli-vp16, or etsrp."	Aggf1|559905	0|5	fli1|30619	80|84	Negative_Regulation
24277077	S7	"Aggf1 knockdown led to dramatically reduced expression of hemangioblast markers fli1, etsrp, lmo2, and scl, and hematopoietic/endothelial defects in aggf1 morphants were rescued by messenger RNA for scl, fli-vp16, or etsrp."	Aggf1|559905	0|5	etsrp|555766	86|91	Negative_Regulation
24277077	S7	"Aggf1 knockdown led to dramatically reduced expression of hemangioblast markers fli1, etsrp, lmo2, and scl, and hematopoietic/endothelial defects in aggf1 morphants were rescued by messenger RNA for scl, fli-vp16, or etsrp."	Aggf1|559905	0|5	lmo2|30332	93|97	Negative_Regulation
24277077	S7	"Aggf1 knockdown led to dramatically reduced expression of hemangioblast markers fli1, etsrp, lmo2, and scl, and hematopoietic/endothelial defects in aggf1 morphants were rescued by messenger RNA for scl, fli-vp16, or etsrp."	Aggf1|559905	0|5	scl|30766	103|106	Negative_Regulation
24277077	S8	"Taken together, these data indicate that aggf1 is involved in differentiation of both hematopoietic and endothelial lineages and that aggf1 acts upstream of scl, fli1, and etsrp in specification of hemangioblasts."	aggf1|559905	134|139	scl|30766	157|160	Interaction_Agent
24277077	S8	"Taken together, these data indicate that aggf1 is involved in differentiation of both hematopoietic and endothelial lineages and that aggf1 acts upstream of scl, fli1, and etsrp in specification of hemangioblasts."	aggf1|559905	134|139	fli1|30619	162|166	Interaction_Agent
24277077	S8	"Taken together, these data indicate that aggf1 is involved in differentiation of both hematopoietic and endothelial lineages and that aggf1 acts upstream of scl, fli1, and etsrp in specification of hemangioblasts."	aggf1|559905	134|139	etsrp|555766	172|177	Interaction_Agent
24285179	S1	EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.	MDM4|4194	74|78	AKT|207	38|41	Association
24285179	S1	EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.	MDM4|4194	74|78	mTOR|2475	42|46	Association
24285179	S1	EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.	EEF1A2|1917	0|6	p53|7157	19|22	Negative_Regulation
24285179	S1	EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.	EEF1A2|1917	0|6	MDM4|4194	74|78	Interaction_Agent
24285179	S9	The eukaryotic elongation factor 1A2 (EEF1A2) was identified as an upstream inducer of PI3K supporting MDM4 stabilization.	MDM4|4194	103|107	eukaryotic elongation factor 1A2 (EEF1A2)|1917	4|45	Neutral_Regulation
24285179	S10	"Also, we detected MDM4 protein up-regulation in an AKT mouse model and a strong correlation between the expression of EEF1A2, activated/phosphorylated AKT, and MDM4 in human HCC (each rho > 0.8, P < 0.001)."	EEF1A2|13628	118|124	AKT|11651	151|154	Association
24285179	S10	"Also, we detected MDM4 protein up-regulation in an AKT mouse model and a strong correlation between the expression of EEF1A2, activated/phosphorylated AKT, and MDM4 in human HCC (each rho > 0.8, P < 0.001)."	EEF1A2|13628	118|124	MDM4|17248	160|164	Association
24285179	S10	"Also, we detected MDM4 protein up-regulation in an AKT mouse model and a strong correlation between the expression of EEF1A2, activated/phosphorylated AKT, and MDM4 in human HCC (each rho > 0.8, P < 0.001)."	AKT|11651	151|154	MDM4|17248	160|164	Association
24286242	S1	IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.	IL-29|282618	0|5	IL-6|3569	43|47	Positive_Regulation
24286242	S1	IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.	IL-29|282618	0|5	IL-8|3576	52|56	Positive_Regulation
24286242	S2	"INTRODUCTION: We previously reported that IL-29, a newly described member of interferon (IFN) family, was overexpressed in blood and synovium of rheumatoid arthritis (RA) patients and triggered proinflammatory cytokine IL-6 and IL-8 mRNA expression in RA synovial fibroblasts (RA-FLS)."	IL-6|3569	219|223	IL-29|282618	42|47	Positive_Regulation
24286242	S2	"INTRODUCTION: We previously reported that IL-29, a newly described member of interferon (IFN) family, was overexpressed in blood and synovium of rheumatoid arthritis (RA) patients and triggered proinflammatory cytokine IL-6 and IL-8 mRNA expression in RA synovial fibroblasts (RA-FLS)."	IL-8|3576	228|232	IL-29|282618	42|47	Positive_Regulation
24286242	S7	METHODS: The mRNA level of IL-29 receptors (IL-28Ra and IL-10R2) in RA-FLS was determined by semi-quantitative RT- PCR.	IL-28Ra|163702	44|51	IL-29|282618	27|32	Interaction_Agent
24286242	S7	METHODS: The mRNA level of IL-29 receptors (IL-28Ra and IL-10R2) in RA-FLS was determined by semi-quantitative RT- PCR.	IL-10R2|3588	56|63	IL-29|282618	27|32	Interaction_Agent
24286242	S11	RESULTS: The IL-29 receptor complex (IL-28Ra and IL-10R2) was identified in RA-FLS.	IL-28Ra|163702	37|44	IL-10R2|3588	49|56	Complex
24286242	S11	RESULTS: The IL-29 receptor complex (IL-28Ra and IL-10R2) was identified in RA-FLS.	IL-28Ra|163702	37|44	IL-29|282618	13|18	Interaction_Agent
24286242	S11	RESULTS: The IL-29 receptor complex (IL-28Ra and IL-10R2) was identified in RA-FLS.	IL-10R2|3588	49|56	IL-29|282618	13|18	Interaction_Agent
24286242	S12	IL-29 enhanced TLR-mediated IL-6 and IL-8 expression in RA-FLS.	IL-29|282618	0|5	IL-6|3569	28|32	Positive_Regulation
24286242	S12	IL-29 enhanced TLR-mediated IL-6 and IL-8 expression in RA-FLS.	IL-29|282618	0|5	IL-8|3576	37|41	Positive_Regulation
24286242	S13	"IL-29 upregulated expression of TLR2, 3 and 4 in RA-FLS."	IL-29|282618	0|5	TLR2|7097	32|36	Positive_Regulation
24287595	S1	Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics.	RhoA|387	55|59	Nck1|4690	27|31	Neutral_Regulation
24287595	S1	Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics.	RhoA|387	55|59	Nck2|8440	40|44	Negation_Neutral_Regulation
24287595	S5	"We previously reported that synaptopodin, a proline-rich actin-binding protein, induces stress fibres by blocking the Smurf1-mediated ubiquitination of RhoA."	RhoA|387	152|156	synaptopodin|11346	28|40	Negation_Modification
24287595	S5	"We previously reported that synaptopodin, a proline-rich actin-binding protein, induces stress fibres by blocking the Smurf1-mediated ubiquitination of RhoA."	RhoA|387	152|156	Smurf1|57154	118|124	Modification
24287595	S6	"We now find that synaptopodin competes with c-Cbl for binding to Nck1, which prevents the ubiquitination of Nck1 by c-Cbl."	Nck1|4690	65|69	synaptopodin|11346	17|29	Binding
24287595	S6	"We now find that synaptopodin competes with c-Cbl for binding to Nck1, which prevents the ubiquitination of Nck1 by c-Cbl."	Nck1|4690	65|69	c-Cbl|867	44|49	Binding
24287595	S6	"We now find that synaptopodin competes with c-Cbl for binding to Nck1, which prevents the ubiquitination of Nck1 by c-Cbl."	c-Cbl|867	116|121	Nck1|4690	108|112	Modification
24287595	S6	"We now find that synaptopodin competes with c-Cbl for binding to Nck1, which prevents the ubiquitination of Nck1 by c-Cbl."	Nck1|4690	108|112	synaptopodin|11346	17|29	Negation_Modification
24287595	S7	Gene silencing of c-Cbl restores Nck1 protein abundance and stress fibres in synaptopodin knockdown cells.	Nck1|4690	33|37	c-Cbl|867	18|23	Positive_Regulation
24287595	S8	"Similarly, expression of c-Cbl-resistant Nck1(K178R) or Nck2 containing the SH3 domain 2 of Nck1 restores stress fibres in synaptopodin-depleted podocytes through activation of RhoA signalling."	RhoA|387	177|181	Nck1|4690	41|45	Positive_Regulation
24287595	S8	"Similarly, expression of c-Cbl-resistant Nck1(K178R) or Nck2 containing the SH3 domain 2 of Nck1 restores stress fibres in synaptopodin-depleted podocytes through activation of RhoA signalling."	RhoA|387	177|181	Nck2|8440	56|60	Positive_Regulation
24299456	S1	Interaction of human minichromosome maintenance protein-binding protein with minichromosome maintenance 2-7.	minichromosome maintenance protein-binding protein|79892	21|71	minichromosome maintenance 2|4171	77|105	Association
24299456	S2	"It has been reported that minichromosome maintenance protein-binding protein (MCM-BP) functions in the formation of the pre-replication complex, unloading of minichromosome maintenance (MCM)2-7 from chromatin in late S phase, and formation of the cohesion complex by interacting with MCM3-7 proteins, suggesting that MCM-BP functions in several different reactions during the cell cycle."	MCM3|4172	284|288	minichromosome maintenance protein-binding protein (MCM-BP)|79892	26|85	Association
24299456	S2	"It has been reported that minichromosome maintenance protein-binding protein (MCM-BP) functions in the formation of the pre-replication complex, unloading of minichromosome maintenance (MCM)2-7 from chromatin in late S phase, and formation of the cohesion complex by interacting with MCM3-7 proteins, suggesting that MCM-BP functions in several different reactions during the cell cycle."	minichromosome maintenance protein-binding protein (MCM-BP)|79892	26|85	minichromosome maintenance (MCM)2|4171	158|191	Translocation
24299456	S4	"The results show that MCM-BP mainly interacts with MCM7 in the Triton-soluble fraction from S phase and G(2) phase cells, and it also interacts with structural maintenance of chromosome 3 in the fraction from G(2) phase cells."	MCM-BP|79892	22|28	MCM7|4176	51|55	Association
24299456	S5	"In vitro studies show that MCM-BP disassembles MCM2-7 bound to DNA with a fork-like structure by interacting with MCM3, MCM5, and MCM7."	MCM-BP|79892	27|33	MCM2|4171	47|51	Transformation
24299456	S5	"In vitro studies show that MCM-BP disassembles MCM2-7 bound to DNA with a fork-like structure by interacting with MCM3, MCM5, and MCM7."	MCM3|4172	114|118	MCM-BP|79892	27|33	Association
24299456	S5	"In vitro studies show that MCM-BP disassembles MCM2-7 bound to DNA with a fork-like structure by interacting with MCM3, MCM5, and MCM7."	MCM5|4174	120|124	MCM-BP|79892	27|33	Association
24299456	S5	"In vitro studies show that MCM-BP disassembles MCM2-7 bound to DNA with a fork-like structure by interacting with MCM3, MCM5, and MCM7."	MCM7|4176	130|134	MCM-BP|79892	27|33	Association
24299456	S6	"These results suggest that MCM-BP functions in disassembling MCM2-7 on chromatin during S phase and G2 phase by interacting with MCM3, MCM5, and MCM7."	MCM3|4172	129|133	MCM-BP|79892	27|33	Association
24299456	S6	"These results suggest that MCM-BP functions in disassembling MCM2-7 on chromatin during S phase and G2 phase by interacting with MCM3, MCM5, and MCM7."	MCM5|4174	135|139	MCM-BP|79892	27|33	Association
24299456	S6	"These results suggest that MCM-BP functions in disassembling MCM2-7 on chromatin during S phase and G2 phase by interacting with MCM3, MCM5, and MCM7."	MCM7|4176	145|149	MCM-BP|79892	27|33	Association
24299456	S6	"These results suggest that MCM-BP functions in disassembling MCM2-7 on chromatin during S phase and G2 phase by interacting with MCM3, MCM5, and MCM7."	MCM-BP|79892	27|33	MCM2|4171	61|65	Transformation
24312498	S1	PRICKLE1 interaction with SYNAPSIN I reveals a role in autism spectrum disorders.	PRICKLE1|106042	0|8	SYNAPSIN I|20964	26|36	Association
24312498	S8	Endogenous Prickle1 and Syn1 co-localize in neurons and physically interact via the SYN1 region mutated in ASD and epilepsy.	SYN1|20964	84|88	Prickle1|106042	11|19	Association
24312498	S8	Endogenous Prickle1 and Syn1 co-localize in neurons and physically interact via the SYN1 region mutated in ASD and epilepsy.	Prickle1|106042	11|19	Syn1|20964	24|28	Association
24312498	S10	"Taken together, these findings suggest PRICKLE1 mutations contribute to ASD by disrupting the interaction with SYN1 and regulation of synaptic vesicles."	PRICKLE1|106042	39|47	SYN1|20964	111|115	Negation_Association
24344282	S2	"Retromer is an evolutionarily conserved protein complex composed of the VPS26, VPS29, and VPS35 proteins that selects and packages cargo proteins into transport carriers that export cargo from the endosome."	VPS26|9559	72|77	VPS29|51699	79|84	Complex
24344282	S2	"Retromer is an evolutionarily conserved protein complex composed of the VPS26, VPS29, and VPS35 proteins that selects and packages cargo proteins into transport carriers that export cargo from the endosome."	VPS26|9559	72|77	VPS35|55737	90|95	Complex
24344282	S2	"Retromer is an evolutionarily conserved protein complex composed of the VPS26, VPS29, and VPS35 proteins that selects and packages cargo proteins into transport carriers that export cargo from the endosome."	VPS29|51699	79|84	VPS35|55737	90|95	Complex
24347165	S6	"Tgfbr3 was demonstrated to be a ""switch"" that blunted Tgfbr1/Smad2/3 and potentiated Acvrl1/Smad1 signaling in lung fibroblasts."	Tgfbr1|7046	54|60	Tgfbr3|7049	0|6	Negative_Regulation
24347165	S6	"Tgfbr3 was demonstrated to be a ""switch"" that blunted Tgfbr1/Smad2/3 and potentiated Acvrl1/Smad1 signaling in lung fibroblasts."	Smad2|4087	61|66	Tgfbr3|7049	0|6	Negative_Regulation
24347165	S6	"Tgfbr3 was demonstrated to be a ""switch"" that blunted Tgfbr1/Smad2/3 and potentiated Acvrl1/Smad1 signaling in lung fibroblasts."	Acvrl1|94	85|91	Tgfbr3|7049	0|6	Positive_Regulation
24347165	S6	"Tgfbr3 was demonstrated to be a ""switch"" that blunted Tgfbr1/Smad2/3 and potentiated Acvrl1/Smad1 signaling in lung fibroblasts."	Smad1|4086	92|97	Tgfbr3|7049	0|6	Positive_Regulation
24349530	S6	"RESULTS: Inhibitors of cPLA2a enzyme activity (AVX002, ATK) significantly reduced TNF-induced cellular release of AA, PGE2, IL8 and MMP3."	IL8|3576	124|127	TNF|7124	82|85	Translocation
24349530	S6	"RESULTS: Inhibitors of cPLA2a enzyme activity (AVX002, ATK) significantly reduced TNF-induced cellular release of AA, PGE2, IL8 and MMP3."	MMP3|4314	132|136	TNF|7124	82|85	Translocation
24349530	S8	"Interestingly, cPLA2a inhibition affected several key points of the arachidonyl cascade; AA-release, cyclooxygenase-2 (COX2) expression and PGE2 production."	cPLA2a|5321	15|21	cyclooxygenase-2 (COX2)|5743	101|124	Neutral_Regulation
24349530	S10	"CONCLUSIONS: cPLA2a appears to be an important regulator of central effectors of inflammation and joint destruction, namely MMP3, IL8, COX2, and PGE2."	cPLA2a|5321	13|19	MMP3|4314	124|128	Interaction_Agent
24349530	S10	"CONCLUSIONS: cPLA2a appears to be an important regulator of central effectors of inflammation and joint destruction, namely MMP3, IL8, COX2, and PGE2."	cPLA2a|5321	13|19	IL8|3576	130|133	Interaction_Agent
24349530	S10	"CONCLUSIONS: cPLA2a appears to be an important regulator of central effectors of inflammation and joint destruction, namely MMP3, IL8, COX2, and PGE2."	cPLA2a|5321	13|19	COX2|5743	135|139	Interaction_Agent
24349530	S11	Decreased transcription of the PLA2G4A and COX2 genes in response to cPLA2a enzyme inhibition further suggest a self-reinforcing effect of cPLA2a inhibition in response to TNF.	cPLA2a|5321	69|75	COX2|5743	43|47	Association
24349530	S11	Decreased transcription of the PLA2G4A and COX2 genes in response to cPLA2a enzyme inhibition further suggest a self-reinforcing effect of cPLA2a inhibition in response to TNF.	TNF|7124	172|175	cPLA2a|5321	139|145	Association
24371122	S1	Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARg/PGC-1a pathway and Insig1/2 expression in hepatocytes.	CD36|948	19|23	Insig1|3638	116|122	Positive_Regulation
24371122	S7	"Genes encoding key enzymes involved in cholesterol synthesis and under the control of transcription factor sterol regulatory element-binding protein (SREBP)-2 remained unresponsive to sterol depletion, due to retention of the SREBP-2 escort protein Scap by Insig-1/2."	Insig-1|3638	257|264	Scap|22937	249|253	Neutral_Regulation
24371122	S7	"Genes encoding key enzymes involved in cholesterol synthesis and under the control of transcription factor sterol regulatory element-binding protein (SREBP)-2 remained unresponsive to sterol depletion, due to retention of the SREBP-2 escort protein Scap by Insig-1/2."	SREBP-2|6721	226|233	Scap|22937	249|253	Interaction_Agent
24371122	S8	"Insig1 and Insig2 gene expression was also increased through activation of nuclear receptor peroxisome-proliferator activating receptor g (PPARg) by CD36, which lifted the inhibitory effect of PPARg1 Ser-84 phosphorylation."	Insig1|3638	0|6	peroxisome-proliferator activating receptor g (PPARg)|5468	92|145	Positive_Regulation
24371122	S8	"Insig1 and Insig2 gene expression was also increased through activation of nuclear receptor peroxisome-proliferator activating receptor g (PPARg) by CD36, which lifted the inhibitory effect of PPARg1 Ser-84 phosphorylation."	Insig2|51141	11|17	peroxisome-proliferator activating receptor g (PPARg)|5468	92|145	Positive_Regulation
24371122	S8	"Insig1 and Insig2 gene expression was also increased through activation of nuclear receptor peroxisome-proliferator activating receptor g (PPARg) by CD36, which lifted the inhibitory effect of PPARg1 Ser-84 phosphorylation."	CD36|948	149|153	peroxisome-proliferator activating receptor g (PPARg)|5468	92|145	Positive_Regulation
24371122	S8	"Insig1 and Insig2 gene expression was also increased through activation of nuclear receptor peroxisome-proliferator activating receptor g (PPARg) by CD36, which lifted the inhibitory effect of PPARg1 Ser-84 phosphorylation."	CD36|948	149|153	PPARg1|5468	193|199	Modification
24371122	S9	"Recruitment of coactivator peroxisome proliferator-activated receptor-g coactivator 1a (PGC1a) to activated AMPKa was also promoted, resulting in PGC-1a transcriptional activation through Sirt1-mediated deacetylation, increased recruitment of PPARg, and up-regulation of Insig-1/2, revealing a regulatory role of CD36 on PGC-1a signaling."	CD36|948	313|317	PGC-1a|10891	321|327	Interaction_Agent
24371122	S10	"Our data identify CD36 as a novel regulator of HMG-CoA reductase function and Insig-1/2 expression, 2 critical steps regulating cholesterol synthesis in hepatocytes."	CD36|948	18|22	Insig-1|3638	78|85	Interaction_Agent
24371122	S10	"Our data identify CD36 as a novel regulator of HMG-CoA reductase function and Insig-1/2 expression, 2 critical steps regulating cholesterol synthesis in hepatocytes."	CD36|948	18|22	HMG-CoA reductase|3156	47|64	Interaction_Agent
24374083	S2	The Atg2-Atg18 complex acts in parallel to Atg8 and regulates Atg9 recycling from phagophore assembly site (PAS) during autophagy in yeast.	Atg2|38344	4|8	Atg18|850577	9|14	Complex
24374083	S2	The Atg2-Atg18 complex acts in parallel to Atg8 and regulates Atg9 recycling from phagophore assembly site (PAS) during autophagy in yeast.	Atg9|851406	62|66	Atg2|38344	4|8	Translocation
24374083	S2	The Atg2-Atg18 complex acts in parallel to Atg8 and regulates Atg9 recycling from phagophore assembly site (PAS) during autophagy in yeast.	Atg9|851406	62|66	Atg18|850577	9|14	Translocation
24374083	S3	"Here we show that in Drosophila, both Atg9 and Atg18 are required for Atg8a puncta formation, unlike Atg2."	Atg8a|32001	70|75	Atg9|36821	38|42	Association
24374083	S3	"Here we show that in Drosophila, both Atg9 and Atg18 are required for Atg8a puncta formation, unlike Atg2."	Atg8a|32001	70|75	Atg18|38913	47|52	Association
24374083	S3	"Here we show that in Drosophila, both Atg9 and Atg18 are required for Atg8a puncta formation, unlike Atg2."	Atg2|38344	101|105	Atg8a|32001	70|75	Negation_Association
24374083	S5	"The transmembrane protein Atg9 accumulates on refractory to Sigma P (Ref(2)P) aggregates in Atg7, Atg8a and Atg2 mutants."	Atg9|36821	26|30	refractory to Sigma P (Ref(2)P)|35246	46|77	Association
24374083	S6	"No accumulation of Atg9 is seen on Ref(2)P in cells lacking Atg18 or Vps34 lipid kinase function, while the Atg1 complex subunit FIP200 is recruited."	Atg9|36821	19|23	Ref(2)P|35246	35|42	Negation_Association
24374083	S7	The simultaneous interaction of Atg18 with both Atg9 and Ref(2)P raises the possibility that Atg18 may facilitate selective degradation of ubiquitinated protein aggregates by autophagy.	Atg18|38913	32|37	Atg9|36821	48|52	Association
24374083	S7	The simultaneous interaction of Atg18 with both Atg9 and Ref(2)P raises the possibility that Atg18 may facilitate selective degradation of ubiquitinated protein aggregates by autophagy.	Atg18|38913	32|37	Ref(2)P|35246	57|64	Association
24402281	S1	Structural basis for hijacking CBF-b and CUL5 E3 ligase complex by HIV-1 Vif.	CBF-b|865	31|36	CUL5|8065	41|45	Complex
24402281	S1	Structural basis for hijacking CBF-b and CUL5 E3 ligase complex by HIV-1 Vif.	Vif|155459	73|76	CBF-b|865	31|36	Binding
24402281	S1	Structural basis for hijacking CBF-b and CUL5 E3 ligase complex by HIV-1 Vif.	Vif|155459	73|76	CUL5|8065	41|45	Binding
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	Vif|155459	42|45	CBF-b|865	46|51	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	Vif|155459	42|45	CUL5|8065	52|56	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	Vif|155459	42|45	ELOB|6923	57|61	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	Vif|155459	42|45	ELOC|6921	62|66	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	CBF-b|865	46|51	CUL5|8065	52|56	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	CBF-b|865	46|51	ELOB|6923	57|61	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	CBF-b|865	46|51	ELOC|6921	62|66	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	CUL5|8065	52|56	ELOB|6923	57|61	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	CUL5|8065	52|56	ELOC|6921	62|66	Complex
24402281	S3	Here we report a crystal structure of the Vif-CBF-b-CUL5-ELOB-ELOC complex.	ELOB|6923	57|61	ELOC|6921	62|66	Complex
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	Vif|155459	27|30	CBF-b|865	123|128	Association
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	Vif|155459	27|30	CUL5|8065	130|134	Association
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	Vif|155459	27|30	ELOC|6921	139|143	Association
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	Vif|155459	27|30	CBF-b|865	123|128	Complex
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	Vif|155459	27|30	CUL5|8065	130|134	Complex
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	Vif|155459	27|30	ELOC|6921	139|143	Complex
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	CBF-b|865	123|128	CUL5|8065	130|134	Complex
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	CBF-b|865	123|128	ELOC|6921	139|143	Complex
24402281	S4	"The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-b, CUL5 and ELOC."	CUL5|8065	130|134	ELOC|6921	139|143	Complex
24402281	S5	"The larger domain (a/b domain) of Vif binds to the same side of CBF-b as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-b binding."	Vif|155459	34|37	CBF-b|865	64|69	Binding
24402281	S5	"The larger domain (a/b domain) of Vif binds to the same side of CBF-b as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-b binding."	RUNX1|861	73|78	CBF-b|865	64|69	Binding
24402281	S5	"The larger domain (a/b domain) of Vif binds to the same side of CBF-b as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-b binding."	CBF-b|865	128|133	Vif|155459	96|99	Binding
24402281	S5	"The larger domain (a/b domain) of Vif binds to the same side of CBF-b as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-b binding."	CBF-b|865	128|133	RUNX1|861	104|109	Binding
24402281	S6	Interactions of the smaller domain (a-domain) of Vif with ELOC and CUL5 are cooperative and mimic those of SOCS2 with the latter two proteins.	Vif|155459	49|52	ELOC|6921	58|62	Association
24402281	S6	Interactions of the smaller domain (a-domain) of Vif with ELOC and CUL5 are cooperative and mimic those of SOCS2 with the latter two proteins.	Vif|155459	49|52	CUL5|8065	67|71	Association
24402281	S7	"A unique zinc-finger motif of Vif, which is located between the two Vif domains, makes no contacts with the other proteins but stabilizes the conformation of the a-domain, which may be important for Vif-CUL5 interaction."	Vif|155459	199|202	CUL5|8065	203|207	Association
24402281	S8	"Together, our data reveal the structural basis for Vif hijacking of the CBF-b and CUL5 E3 ligase complex, laying a foundation for rational design of novel anti-HIV drugs."	CBF-b|865	72|77	CUL5|8065	82|86	Complex
24402281	S8	"Together, our data reveal the structural basis for Vif hijacking of the CBF-b and CUL5 E3 ligase complex, laying a foundation for rational design of novel anti-HIV drugs."	Vif|155459	51|54	CBF-b|865	72|77	Binding
24402281	S8	"Together, our data reveal the structural basis for Vif hijacking of the CBF-b and CUL5 E3 ligase complex, laying a foundation for rational design of novel anti-HIV drugs."	Vif|155459	51|54	CUL5|8065	82|86	Binding
24413081	S1	Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.	NEDD4-1|4734	61|68	Mdm2|4193	14|18	Neutral_Regulation
24413081	S1	Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.	NEDD4-1|4734	61|68	p53|7157	45|48	Neutral_Regulation
24413081	S2	Mdm2 is a critical negative regulator of the tumor suppressor protein p53.	Mdm2|4193	0|4	p53|7157	70|73	Negative_Agent
24413081	S3	Mdm2 is an E3 ligase whose overexpression leads to functional inactivation of p53.	Mdm2|4193	0|4	p53|7157	78|81	Negative_Regulation
24413081	S5	Here we report biochemical identification of NEDD4-1 as an E3 ligase for Mdm2 that contributes to the regulation of Mdm2 protein stability in cells.	NEDD4-1|4734	45|52	Mdm2|4193	73|77	Interaction_Agent
24413081	S5	Here we report biochemical identification of NEDD4-1 as an E3 ligase for Mdm2 that contributes to the regulation of Mdm2 protein stability in cells.	Mdm2|4193	116|120	NEDD4-1|4734	45|52	Neutral_Regulation
24413081	S8	Recombinant NEDD4-1 promotes Mdm2 ubiquitination in vitro in a concentration- and time-dependent manner.	NEDD4-1|4734	12|19	Mdm2|4193	29|33	Modification
24413081	S9	"In cells, NEDD4-1 physically interacts with Mdm2 via the RING domain of Mdm2."	NEDD4-1|4734	10|17	Mdm2|4193	44|48	Association
24413081	S9	"In cells, NEDD4-1 physically interacts with Mdm2 via the RING domain of Mdm2."	Mdm2|4193	72|76	NEDD4-1|4734	10|17	Interaction_Agent
24413081	S10	"Overexpression of NEDD4-1, but not an enzyme-dead NEDD4-1CS mutant, increases ubiquitination of Mdm2."	NEDD4-1|4734	18|25	Mdm2|4193	96|100	Modification
24413081	S10	"Overexpression of NEDD4-1, but not an enzyme-dead NEDD4-1CS mutant, increases ubiquitination of Mdm2."	NEDD4-1|4734	50|57	Mdm2|4193	96|100	Negation_Modification
24413081	S11	NEDD4-1 catalyzes the formation of K63-type polyubiquitin chains on Mdm2 that are distinct from K48-type polyubiquitination chains mediated by the Mdm2/MdmX complex.	Mdm2|4193	147|151	MdmX|4194	152|156	Complex
24413081	S11	NEDD4-1 catalyzes the formation of K63-type polyubiquitin chains on Mdm2 that are distinct from K48-type polyubiquitination chains mediated by the Mdm2/MdmX complex.	NEDD4-1|4734	0|7	Mdm2|4193	68|72	Modification
24413081	S14	NEDD4-1 knockdown reduces the t1/2 (half-life) of endogenous Mdm2 from 20 to 12min in U2OS cells.	NEDD4-1|4734	0|7	Mdm2|4193	61|65	Negative_Regulation
24413081	S16	"Similarly, NEDD4-1 knockdown in WT-p53-bearing cells increases basal p53 levels and activity in an Mdm2-dependent manner, causes stronger p53 responses to DNA damage and results in p53-dependent growth inhibition compared with corresponding NEDD4-1-proficient control cells."	p53|7157	69|72	NEDD4-1|4734	11|18	Positive_Regulation
24413081	S17	This study identifies NEDD4-1 as a novel component of the p53/Mdm2 regulatory feedback loop that controls p53 activity during stress responses.	NEDD4-1|4734	22|29	p53|7157	58|61	Interaction_Agent
24413081	S17	This study identifies NEDD4-1 as a novel component of the p53/Mdm2 regulatory feedback loop that controls p53 activity during stress responses.	NEDD4-1|4734	22|29	Mdm2|4193	62|66	Interaction_Agent
24413081	S17	This study identifies NEDD4-1 as a novel component of the p53/Mdm2 regulatory feedback loop that controls p53 activity during stress responses.	NEDD4-1|4734	22|29	p53|7157	106|109	Neutral_Regulation
24419107	S1	Atg17/FIP200 localizes to perilysosomal Ref(2)P aggregates and promotes autophagy by activation of Atg1 in Drosophila.	Atg17/FIP200|40700	0|12	Atg1|39454	99|103	Positive_Regulation
24419107	S1	Atg17/FIP200 localizes to perilysosomal Ref(2)P aggregates and promotes autophagy by activation of Atg1 in Drosophila.	Ref(2)P|35246	40|47	Atg17/FIP200|40700	0|12	Association
24419107	S8	"Drosophila Atg17 is a member of the Atg1 kinase complex as in mammals, and we showed that it binds to the other subunits including Atg1, Atg13, and Atg101 (C12orf44 in humans, 9430023L20Rik in mice and RGD1359310 in rats)."	Atg1|39454	131|135	Atg17|40700	11|16	Binding
24419107	S8	"Drosophila Atg17 is a member of the Atg1 kinase complex as in mammals, and we showed that it binds to the other subunits including Atg1, Atg13, and Atg101 (C12orf44 in humans, 9430023L20Rik in mice and RGD1359310 in rats)."	Atg13|40998	137|142	Atg17|40700	11|16	Binding
24419107	S8	"Drosophila Atg17 is a member of the Atg1 kinase complex as in mammals, and we showed that it binds to the other subunits including Atg1, Atg13, and Atg101 (C12orf44 in humans, 9430023L20Rik in mice and RGD1359310 in rats)."	Atg101|32871	148|154	Atg17|40700	11|16	Binding
24419107	S9	"Atg17 is required for the kinase activity of endogenous Atg1 in vivo, as loss of Atg17 prevents the Atg1-dependent shift of endogenous Atg13 to hyperphosphorylated forms, and also blocks punctate Atg1 localization during starvation."	Atg17|40700	0|5	Atg1|39454	56|60	Association
24419107	S9	"Atg17 is required for the kinase activity of endogenous Atg1 in vivo, as loss of Atg17 prevents the Atg1-dependent shift of endogenous Atg13 to hyperphosphorylated forms, and also blocks punctate Atg1 localization during starvation."	Atg1|39454	196|200	Atg17|40700	81|86	Translocation
24419107	S9	"Atg17 is required for the kinase activity of endogenous Atg1 in vivo, as loss of Atg17 prevents the Atg1-dependent shift of endogenous Atg13 to hyperphosphorylated forms, and also blocks punctate Atg1 localization during starvation."	Atg17|40700	81|86	Atg13|40998	135|140	Negation_Modification
24419107	S9	"Atg17 is required for the kinase activity of endogenous Atg1 in vivo, as loss of Atg17 prevents the Atg1-dependent shift of endogenous Atg13 to hyperphosphorylated forms, and also blocks punctate Atg1 localization during starvation."	Atg1|39454	100|104	Atg13|40998	135|140	Association
24419107	S10	"Finally, we found that Atg1 overexpression induces autophagy and reduces cell size in Atg17-null mutant fat body cells, and that overexpression of Atg17 promotes endogenous Atg13 phosphorylation and enhances autophagy in an Atg1-dependent manner in the fat body."	Atg17|40700	147|152	Atg13|40998	173|178	Modification
24440154	S6	The Six2-GFP::Cre(tg/+) mediated inactivation of Mdm2 in the NPC (NPC(Mdm)2(-/-)) results in perinatal lethality.	Six2|20472	4|8	Mdm2|17246	49|53	Negative_Regulation
24445282	S1	Zebrafish eaf1 suppresses foxo3b expression to modulate transcriptional activity of gata1 and spi1 in primitive hematopoiesis.	eaf1|415205	10|14	foxo3b|30296	26|32	Negative_Regulation
24445282	S1	Zebrafish eaf1 suppresses foxo3b expression to modulate transcriptional activity of gata1 and spi1 in primitive hematopoiesis.	gata1|30481	84|89	eaf1|415205	10|14	Neutral_Regulation
24445282	S1	Zebrafish eaf1 suppresses foxo3b expression to modulate transcriptional activity of gata1 and spi1 in primitive hematopoiesis.	spi1|30117	94|98	eaf1|415205	10|14	Neutral_Regulation
24445282	S4	"Using microarray analysis, we identified foxo3b as a target gene suppressed by eaf1."	eaf1|415205	79|83	foxo3b|30296	41|47	Negative_Regulation
24445282	S4	"Using microarray analysis, we identified foxo3b as a target gene suppressed by eaf1."	foxo3b|30296	41|47	eaf1|415205	79|83	Interaction_Agent
24445282	S5	"Ectopic expression of foxo3b in embryos mimicked the phenotypes exhibited in eaf1 morphants, except that foxo3b had no effect on runx1 and c-myb expression while eaf1 morphants did not express these markers in the ventral wall of dorsal aorta."	foxo3b|30296	105|111	runx1|58126	129|134	Negation_Association
24445282	S5	"Ectopic expression of foxo3b in embryos mimicked the phenotypes exhibited in eaf1 morphants, except that foxo3b had no effect on runx1 and c-myb expression while eaf1 morphants did not express these markers in the ventral wall of dorsal aorta."	foxo3b|30296	105|111	c-myb|30519	139|144	Negation_Association
24445282	S7	"Furthermore, we observed that foxo3b inhibited the transcriptional activity of gata1 and spi1 through protein-protein interaction."	foxo3b|30296	30|36	gata1|30481	79|84	Negative_Regulation
24445282	S7	"Furthermore, we observed that foxo3b inhibited the transcriptional activity of gata1 and spi1 through protein-protein interaction."	foxo3b|30296	30|36	spi1|30117	89|93	Negative_Regulation
24451387	S5	"We identified a PY motif (L/PPxY), the characteristic binding motif for Nedd4-2 in the C terminus of the HCN1 subunit, and showed that HCN1 and Nedd4-2 interacted both in vivo (rat hippocampus, neocortex, and cerebellum) and in vitro [human embryonic kidney 293 (HEK293) cells], resulting in increased HCN1 ubiquitination."	HCN1|84390	135|139	Nedd4-2|291553	144|151	Association
24451387	S5	"We identified a PY motif (L/PPxY), the characteristic binding motif for Nedd4-2 in the C terminus of the HCN1 subunit, and showed that HCN1 and Nedd4-2 interacted both in vivo (rat hippocampus, neocortex, and cerebellum) and in vitro [human embryonic kidney 293 (HEK293) cells], resulting in increased HCN1 ubiquitination."	Nedd4-2|291553	72|79	HCN1|84390	105|109	Interaction_Agent
24451387	S5	"We identified a PY motif (L/PPxY), the characteristic binding motif for Nedd4-2 in the C terminus of the HCN1 subunit, and showed that HCN1 and Nedd4-2 interacted both in vivo (rat hippocampus, neocortex, and cerebellum) and in vitro [human embryonic kidney 293 (HEK293) cells], resulting in increased HCN1 ubiquitination."	HCN1|348980	302|306	Nedd4-2|291553	144|151	Modification
24451387	S7	"Coexpression of Nedd4-2 and HCN1 drastically reduced the HCN1-mediated h-current amplitude (85-92%) in Xenopus laevis oocytes and reduced surface expression (34%) of HCN1 channels in HEK293 cells, thereby opposing effects of tetratricopeptide repeat-containing Rab8b interacting protein (TRIP8b)-(1a-4), an auxiliary subunit that promotes HCN1 surface expression."	tetratricopeptide repeat-containing Rab8b interacting protein (TRIP8b)|51555	225|295	HCN1|348980	339|343	Positive_Regulation
24451387	S7	"Coexpression of Nedd4-2 and HCN1 drastically reduced the HCN1-mediated h-current amplitude (85-92%) in Xenopus laevis oocytes and reduced surface expression (34%) of HCN1 channels in HEK293 cells, thereby opposing effects of tetratricopeptide repeat-containing Rab8b interacting protein (TRIP8b)-(1a-4), an auxiliary subunit that promotes HCN1 surface expression."	HCN1|348980	166|170	Nedd4-2|399396	16|23	Negative_Regulation
24451387	S8	"Regulation may further include N-glycosylation of HCN1 channels, which is significantly enhanced by TRIP8b(1a-4), but may be reduced by Nedd4-2."	TRIP8b|51555	100|106	HCN1|348980	50|54	Modification
24451387	S9	"Taken together, our data indicate that Nedd4-2 plays an important role in the regulation of HCN1 trafficking and may compete with TRIP8b(1a-4) in this process."	Nedd4-2|23327	39|46	HCN1|348980	92|96	Translocation
24465650	S1	Pch2 prevents Mec1/Tel1-mediated Hop1 phosphorylation occurring independently of Red1 in budding yeast meiosis.	Hop1|854738	33|37	Mec1|852433	14|18	Modification
24465650	S1	Pch2 prevents Mec1/Tel1-mediated Hop1 phosphorylation occurring independently of Red1 in budding yeast meiosis.	Hop1|854738	33|37	Tel1|852190	19|23	Modification
24465650	S1	Pch2 prevents Mec1/Tel1-mediated Hop1 phosphorylation occurring independently of Red1 in budding yeast meiosis.	Hop1|854738	33|37	Pch2|852484	0|4	Negation_Modification
24465650	S1	Pch2 prevents Mec1/Tel1-mediated Hop1 phosphorylation occurring independently of Red1 in budding yeast meiosis.	Red1|850968	81|85	Hop1|854738	33|37	Negation_Association
24465650	S3	Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1.	Hop1|854738	194|198	Mec1|852433	44|48	Modification
24465650	S3	Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1.	Hop1|854738	194|198	Tel1|852190	53|57	Modification
24465650	S3	Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1.	Hop1|854738	194|198	Red1|850968	102|106	Modification
24465650	S3	Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1.	Mec1|852433	44|48	Red1|850968	102|106	Association
24465650	S3	Budding yeast DNA damage checkpoint kinases Mec1 and Tel1 act together with the axial element protein Red1 to promote interhomolog recombination by phosphorylating another axial element protein Hop1.	Tel1|852190	53|57	Red1|850968	102|106	Association
24465650	S4	"Mec1 and Tel1 also phosphorylate gH2A and the synaptonemal complex protein Zip1 independently of Red1 to facilitate premeiotic DNA replication and to destabilize homology-independent centromere pairing, respectively."	Zip1|851879	75|79	Mec1|852433	0|4	Modification
24465650	S4	"Mec1 and Tel1 also phosphorylate gH2A and the synaptonemal complex protein Zip1 independently of Red1 to facilitate premeiotic DNA replication and to destabilize homology-independent centromere pairing, respectively."	Zip1|851879	75|79	Tel1|852190	9|13	Modification
24465650	S4	"Mec1 and Tel1 also phosphorylate gH2A and the synaptonemal complex protein Zip1 independently of Red1 to facilitate premeiotic DNA replication and to destabilize homology-independent centromere pairing, respectively."	Red1|850968	97|101	Mec1|852433	0|4	Negation_Association
24465650	S4	"Mec1 and Tel1 also phosphorylate gH2A and the synaptonemal complex protein Zip1 independently of Red1 to facilitate premeiotic DNA replication and to destabilize homology-independent centromere pairing, respectively."	Red1|850968	97|101	Tel1|852190	9|13	Negation_Association
24465650	S5	It has been unclear why Hop1 phosphorylation is Red1-dependent.	Red1|850968	48|52	Hop1|854738	24|28	Association
24465650	S6	"Here, we report that the pachytene checkpoint protein 2 (Pch2) specifically prevents Red1-independent Hop1 phosphorylation."	pachytene checkpoint protein 2 (Pch2)|852484	25|62	Hop1|854738	102|106	Negation_Modification
24465650	S6	"Here, we report that the pachytene checkpoint protein 2 (Pch2) specifically prevents Red1-independent Hop1 phosphorylation."	Red1|850968	85|89	Hop1|854738	102|106	Negation_Association
24465650	S7	Our findings reveal a new function for Pch2 in linking two axial element proteins Red1 and Hop1 thus coordinating their effects in meiotic recombination and the checkpoint network.	Pch2|852484	39|43	Red1|850968	82|86	Association
24465650	S7	Our findings reveal a new function for Pch2 in linking two axial element proteins Red1 and Hop1 thus coordinating their effects in meiotic recombination and the checkpoint network.	Pch2|852484	39|43	Hop1|854738	91|95	Association
24465706	S6	The results showed that Ang II and ghrelin were both significantly increased in CHF patients and that the ghrelin levels were significantly positively correlated with Ang II.	ghrelin|59301	106|113	Ang II|183	167|173	Association
24465706	S10	"Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression."	ghrelin|59301	52|59	Ang II|183	69|75	Negative_Regulation
24465706	S10	"Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression."	Ang II|183	167|173	AT1|185	191|194	Positive_Regulation
24465706	S10	"Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression."	Ang II|183	167|173	AT2 receptors|186	199|212	Positive_Regulation
24465706	S10	"Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression."	ghrelin|59301	240|247	AT1|185	257|260	Negative_Regulation
24465706	S10	"Lastly, to further elucidate the mechanism by which ghrelin inhibits Ang II action, the expression of the AT1 and AT2 receptors was evaluated; the results showed that Ang II up-regulates the AT1 and AT2 receptors in cardiomyocytes, whereas ghrelin inhibits AT1 receptor up-regulation but does not affect AT2 receptor expression."	AT2|186	304|307	ghrelin|59301	240|247	Negation_Neutral_Regulation
24465706	S11	"CONCLUSIONS: These data suggest that the serum levels of ghrelin are significantly positively correlated with Ang II in CHF patients and that ghrelin can inhibit Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R, thereby playing a role in preventing HF."	ghrelin|59301	57|64	Ang II|183	110|116	Association
24465706	S11	"CONCLUSIONS: These data suggest that the serum levels of ghrelin are significantly positively correlated with Ang II in CHF patients and that ghrelin can inhibit Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R, thereby playing a role in preventing HF."	AT1R|185	220|224	ghrelin|59301	142|149	Negative_Regulation
24479681	S1	"IL-1b-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9."	IL-1b|3553	0|5	p38|1432	28|31	Positive_Regulation
24479681	S1	"IL-1b-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9."	AP-1/c-fos|2353	98|108	p38|1432	28|31	Positive_Regulation
24479681	S1	"IL-1b-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9."	MMP2|4313	110|114	p38|1432	28|31	Positive_Regulation
24479681	S1	"IL-1b-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9."	MMP9|4318	119|123	p38|1432	28|31	Positive_Regulation
24479681	S5	"METHODS: The effects of IL-1b-induced p38 and JNK activation in GA cells were determined using in vitro Transwell migration and invasion assays of MKN-45 and AGS cells, or an in vivo metastasis assay in nude mice."	IL-1b|3553	24|29	p38|1432	38|41	Positive_Regulation
24479681	S5	"METHODS: The effects of IL-1b-induced p38 and JNK activation in GA cells were determined using in vitro Transwell migration and invasion assays of MKN-45 and AGS cells, or an in vivo metastasis assay in nude mice."	IL-1b|3553	24|29	JNK|5599	46|49	Positive_Regulation
24479681	S8	RESULTS: IL-1b-induced activation of p38 increased GA cell migration and invasion in vitro and promoted the metastatic potential of GA cells in vivo; these effects were attenuated by p38 siRNA or the p38 inhibitor SB202190.	IL-1b|3553	9|14	p38|1432	37|40	Positive_Regulation
24479681	S10	IL-1b-induced p38 activation significantly increased MMP2 and MMP9 mRNA and protein expression and activity.	IL-1b|3553	0|5	p38|1432	14|17	Positive_Regulation
24479681	S10	IL-1b-induced p38 activation significantly increased MMP2 and MMP9 mRNA and protein expression and activity.	MMP2|4313	53|57	p38|1432	14|17	Positive_Regulation
24479681	S10	IL-1b-induced p38 activation significantly increased MMP2 and MMP9 mRNA and protein expression and activity.	MMP9|4318	62|66	p38|1432	14|17	Positive_Regulation
24479681	S11	Luciferase reporter assays demonstrated that the activator protein-1 (AP-1) and the AP-1 binding sites of the MMP9 promoter (-670/MMP9) were activated by IL-1b-induced p38 activation.	IL-1b|3553	154|159	p38|1432	168|171	Positive_Regulation
24479681	S11	Luciferase reporter assays demonstrated that the activator protein-1 (AP-1) and the AP-1 binding sites of the MMP9 promoter (-670/MMP9) were activated by IL-1b-induced p38 activation.	AP-1|2353	84|88	MMP9|4318	110|114	Interaction_Agent
24479681	S11	Luciferase reporter assays demonstrated that the activator protein-1 (AP-1) and the AP-1 binding sites of the MMP9 promoter (-670/MMP9) were activated by IL-1b-induced p38 activation.	p38|1432	168|171	activator protein-1 (AP-1)|2353	49|75	Positive_Regulation
24479681	S11	Luciferase reporter assays demonstrated that the activator protein-1 (AP-1) and the AP-1 binding sites of the MMP9 promoter (-670/MMP9) were activated by IL-1b-induced p38 activation.	p38|1432	168|171	MMP9|4318	110|114	Positive_Regulation
24479681	S13	"Expression of phospho-p38 significantly correlated with IL-1b, MMP2, MMP9, and c-fos expression in both human GA tissues and GA cell metastases in the lungs of nude mice."	p38|1432	22|25	IL-1b|3553	56|61	Association
24479681	S13	"Expression of phospho-p38 significantly correlated with IL-1b, MMP2, MMP9, and c-fos expression in both human GA tissues and GA cell metastases in the lungs of nude mice."	p38|1432	22|25	MMP2|4313	63|67	Association
24479681	S13	"Expression of phospho-p38 significantly correlated with IL-1b, MMP2, MMP9, and c-fos expression in both human GA tissues and GA cell metastases in the lungs of nude mice."	p38|1432	22|25	MMP9|4318	69|73	Association
24479681	S13	"Expression of phospho-p38 significantly correlated with IL-1b, MMP2, MMP9, and c-fos expression in both human GA tissues and GA cell metastases in the lungs of nude mice."	p38|1432	22|25	c-fos|2353	79|84	Association
24479681	S14	"IL-1b was also capable of activating JNK in GA cells, but activation of JNK was not associated with GA cell migration and invasion."	IL-1b|3553	0|5	JNK|5599	37|40	Positive_Regulation
24479681	S16	CONCLUSIONS: IL-1b-induced p38 activation and the IL-1b/p38/AP-1(c-fos)/MMP2 & MMP9 pathway play an important role in metastasis in GA; this pathway may provide a novel therapeutic target for GA.	IL-1b|3553	13|18	p38|1432	27|30	Positive_Regulation
24486017	S1	Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.	PDP1|54704	23|27	ACAT1|38	56|61	Neutral_Regulation
24486017	S1	Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.	PDP1|54704	23|27	SIRT3|23410	66|71	Neutral_Regulation
24486017	S3	"The current understanding of PDC regulation involves inhibitory serine phosphorylation of pyruvate dehydrogenase (PDH) by PDH kinase (PDK), whereas dephosphorylation of PDH by PDH phosphatase (PDP) activates PDC."	PDH kinase (PDK)|5163	122|138	pyruvate dehydrogenase (PDH)|54704	90|118	Modification
24486017	S6	"Moreover, we identified mitochondrial ACAT1 and SIRT3 as the upstream acetyltransferase and deacetylase, respectively, of PDHA1 and PDP1, while knockdown of ACAT1 attenuates tumor growth."	PDHA1|5160	122|127	ACAT1|38	38|43	Interaction_Agent
24486017	S6	"Moreover, we identified mitochondrial ACAT1 and SIRT3 as the upstream acetyltransferase and deacetylase, respectively, of PDHA1 and PDP1, while knockdown of ACAT1 attenuates tumor growth."	PDP1|54704	132|136	ACAT1|38	38|43	Interaction_Agent
24486017	S6	"Moreover, we identified mitochondrial ACAT1 and SIRT3 as the upstream acetyltransferase and deacetylase, respectively, of PDHA1 and PDP1, while knockdown of ACAT1 attenuates tumor growth."	PDHA1|5160	122|127	SIRT3|23410	48|53	Interaction_Agent
24486017	S6	"Moreover, we identified mitochondrial ACAT1 and SIRT3 as the upstream acetyltransferase and deacetylase, respectively, of PDHA1 and PDP1, while knockdown of ACAT1 attenuates tumor growth."	PDP1|54704	132|136	SIRT3|23410	48|53	Interaction_Agent
24486017	S7	"Furthermore, Y381 phosphorylation of PDP1 dissociates SIRT3 and recruits ACAT1 to PDC."	SIRT3|23410	54|59	PDP1|54704	37|41	Transformation
24486017	S7	"Furthermore, Y381 phosphorylation of PDP1 dissociates SIRT3 and recruits ACAT1 to PDC."	ACAT1|38	73|78	PDP1|54704	37|41	Translocation
24489105	S6	The decrease in serum CXCL8 levels from PRE to EDT significantly correlated with decreases in markers of melanoma proliferation (Ki-67) and increases in cytotoxic tumor-infiltrating T cells in corresponding tumor biopsies.	Ki-67|4288	129|134	CXCL8|3576	22|27	Association
24489105	S8	"These results suggest that BRAF inhibition causes decreased CXCL8 secretion from melanoma cells and induce an immune response against the tumor associated with increased IFN-g, CCL4, and TNF-a."	CXCL8|3576	60|65	BRAF|673	27|31	Translocation
24489825	S5	"Likewise, Nef induced CXCR4 degradation was critically dependent on the three lysines in the C-terminal -SSLKILSKGK- motif."	Nef|156110	10|13	CXCR4|7852	22|27	Negative_Regulation
24489825	S6	Nef directly recruits the HECT domain E3 ligases AIP4 or NEDD4 to CXCR4 in the resting state.	Nef|156110	0|3	AIP4|83737	49|53	Translocation
24489825	S6	Nef directly recruits the HECT domain E3 ligases AIP4 or NEDD4 to CXCR4 in the resting state.	Nef|156110	0|3	NEDD4|4734	57|62	Translocation
24489825	S7	"This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters."	Nef|156110	56|59	CXCR4|7852	61|66	Association
24489825	S7	"This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters."	Nef|156110	56|59	AIP4|83737	71|75	Association
24489825	S7	"This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters."	Nef|156110	56|59	NEDD4|4734	79|84	Association
24489825	S7	"This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters."	CXCR4|7852	61|66	AIP4|83737	71|75	Association
24489825	S7	"This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters."	CXCR4|7852	61|66	NEDD4|4734	79|84	Association
24489825	S9	Agonist and Nef mediated CXCR2 (and CXCR1) degradation was ubiquitinylation independent.	Nef|156110	12|15	CXCR2|3579	25|30	Negative_Regulation
24489825	S9	Agonist and Nef mediated CXCR2 (and CXCR1) degradation was ubiquitinylation independent.	Nef|156110	12|15	CXCR1|3577	36|41	Negative_Regulation
24489825	S10	Nef also profoundly downregulated the naturally truncated CXCR4 associated with WHIM syndrome and engineered variants of CXCR4 that resist CXCL12 induced internalization via an ubiquitinylation independent mechanism.	Nef|156110	0|3	CXCR4|7852	58|63	Negative_Regulation
24501087	S1	MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.	ERK1|5595	61|65	p70S6K|6198	97|103	Association
24501087	S1	MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.	p70S6K|6198	97|103	MEK1|5604	0|4	Modification
24501087	S6	"Indeed, whereas MEK1 silencing inhibits cell cycle progression, we demonstrate that active mutant form of MEK1 or MEK2 triggers a G1 phase arrest by stimulating an activation of p70S6K by ERK1/2 kinases."	p70S6K|6198	178|184	MEK1|5604	106|110	Positive_Regulation
24501087	S6	"Indeed, whereas MEK1 silencing inhibits cell cycle progression, we demonstrate that active mutant form of MEK1 or MEK2 triggers a G1 phase arrest by stimulating an activation of p70S6K by ERK1/2 kinases."	p70S6K|6198	178|184	MEK2|5605	114|118	Positive_Regulation
24501087	S6	"Indeed, whereas MEK1 silencing inhibits cell cycle progression, we demonstrate that active mutant form of MEK1 or MEK2 triggers a G1 phase arrest by stimulating an activation of p70S6K by ERK1/2 kinases."	ERK1|5595	188|192	p70S6K|6198	178|184	Interaction_Agent
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	p70S6K|6198	61|67	ERK1|5595	13|17	Modification
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK1|5595	13|17	S6|6194	105|107	Modification
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	p21|644914	149|152	ERK1|5595	13|17	Negative_Regulation
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK1|5595	257|261	p70S6K|6198	61|67	Modification
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK1|5595	257|261	S6|6194	105|107	Modification
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK2|5594	265|269	p70S6K|6198	61|67	Modification
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK2|5594	265|269	S6|6194	105|107	Modification
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK1|5595	257|261	p21|644914	149|152	Positive_Regulation
24501087	S7	"Silencing of ERK1/2 activity by shRNA efficiently suppresses p70S6K phosphorylation on Thr421/Ser424 and S6 phosphorylation on Ser240/244 as well as p21 expression, but these effects can be partially reversed by the expression of kinase-dead mutant form of ERK1 or ERK2."	ERK2|5594	265|269	p21|644914	149|152	Positive_Regulation
24501087	S8	"In addition, we demonstrate that the kinase p70S6K modulates neither the p21 gene transcription nor the stability of the protein but enhances the translation of the p21 mRNA."	p70S6K|6198	44|50	p21|644914	73|76	Negation_Neutral_Regulation
24501087	S8	"In addition, we demonstrate that the kinase p70S6K modulates neither the p21 gene transcription nor the stability of the protein but enhances the translation of the p21 mRNA."	p21|644914	165|168	p70S6K|6198	44|50	Positive_Regulation
24503185	S7	"A major representation of the ECM and related proteins in the glioblastoma secretome and their modulation by IL-1 suggested that IL-1 induces its effect in part by altering TGFb expression, activity and signaling."	IL-1|3552	129|133	TGFb|7040	173|177	Neutral_Regulation
24550389	S1	Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.	Mlh1|855203	36|40	Pms1|855642	41|45	Complex
24550389	S1	Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.	Msh2|854063	115|119	Msh3|850454	120|124	Complex
24550389	S2	DNA mismatch repair is initiated by either the Msh2-Msh6 or the Msh2-Msh3 mispair recognition heterodimer.	Msh2|854063	47|51	Msh6|851671	52|56	Complex
24550389	S2	DNA mismatch repair is initiated by either the Msh2-Msh6 or the Msh2-Msh3 mispair recognition heterodimer.	Msh2|854063	64|68	Msh3|850454	69|73	Complex
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh2|854063	0|4	Msh3|850454	5|9	Complex
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh2|854063	144|148	Msh6|851671	149|153	Complex
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh2|854063	0|4	Mlh1|855203	46|50	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh2|854063	0|4	Pms1|855642	51|55	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh3|850454	5|9	Mlh1|855203	46|50	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh3|850454	5|9	Pms1|855642	51|55	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh2|854063	144|148	Mlh1|855203	208|212	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh2|854063	144|148	Pms1|855642	213|217	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh6|851671	149|153	Mlh1|855203	208|212	Translocation
24550389	S4	"Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair."	Msh6|851671	149|153	Pms1|855642	213|217	Translocation
24550389	S6	"Analysis of an Msh2-Msh6/Msh3 chimeric protein and mutant Msh2-Msh3 complexes showed that the nucleotide binding domain and communicating regions but not the mispair binding domain of Msh2-Msh3 are responsible for the extremely rapid dissociation of Msh2-Msh3 sliding clamps from DNA relative to that seen for Msh2-Msh6, and that amino acid residues predicted to stabilize Msh2-Msh3 interactions with bent, strand-separated mispair-containing DNA are more critical for the recognition of small +1 insertion/deletions than larger +4 insertion/deletions."	Msh2|854063	58|62	Msh3|850454	63|67	Complex
24550389	S6	"Analysis of an Msh2-Msh6/Msh3 chimeric protein and mutant Msh2-Msh3 complexes showed that the nucleotide binding domain and communicating regions but not the mispair binding domain of Msh2-Msh3 are responsible for the extremely rapid dissociation of Msh2-Msh3 sliding clamps from DNA relative to that seen for Msh2-Msh6, and that amino acid residues predicted to stabilize Msh2-Msh3 interactions with bent, strand-separated mispair-containing DNA are more critical for the recognition of small +1 insertion/deletions than larger +4 insertion/deletions."	Msh2|854063	250|254	Msh3|850454	255|259	Complex
24556609	S11	"We also identified a novel interaction between SYP22 and VAMP711, which was validated using co-localization analysis with confocal microscopy and IP."	SYP22|834730	47|52	VAMP711|829347	57|64	Association
24573675	S1	The Ddc1-Mec3-Rad17 sliding clamp regulates histone-histone chaperone interactions and DNA replication-coupled nucleosome assembly in budding yeast.	Ddc1|855907	4|8	Mec3|850995	9|13	Complex
24573675	S1	The Ddc1-Mec3-Rad17 sliding clamp regulates histone-histone chaperone interactions and DNA replication-coupled nucleosome assembly in budding yeast.	Ddc1|855907	4|8	Rad17|854550	14|19	Complex
24573675	S1	The Ddc1-Mec3-Rad17 sliding clamp regulates histone-histone chaperone interactions and DNA replication-coupled nucleosome assembly in budding yeast.	Mec3|850995	9|13	Rad17|854550	14|19	Complex
24573675	S5	"Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents."	DDC1|855907	71|75	MEC3|850995	76|80	Complex
24573675	S5	"Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents."	DDC1|855907	71|75	RAD17|854550	81|86	Complex
24573675	S5	"Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents."	MEC3|850995	76|80	RAD17|854550	81|86	Complex
24573675	S5	"Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents."	RTT106|855515	56|62	DDC1|855907	71|75	Association
24573675	S5	"Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents."	RTT106|855515	56|62	MEC3|850995	76|80	Association
24573675	S5	"Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents."	RTT106|855515	56|62	RAD17|854550	81|86	Association
24573675	S9	"Finally, deletion of RAD17 results in increased association of Asf1 with checkpoint kinase Rad53, which may lead to the observed reduction in Asf1-H3 interaction in rad17 mutant cells."	Asf1|853327	63|67	Rad53|855950	91|96	Association
24573675	S9	"Finally, deletion of RAD17 results in increased association of Asf1 with checkpoint kinase Rad53, which may lead to the observed reduction in Asf1-H3 interaction in rad17 mutant cells."	RAD17|854550	21|26	Asf1|853327	63|67	Positive_Regulation
24573675	S9	"Finally, deletion of RAD17 results in increased association of Asf1 with checkpoint kinase Rad53, which may lead to the observed reduction in Asf1-H3 interaction in rad17 mutant cells."	RAD17|854550	21|26	Rad53|855950	91|96	Positive_Regulation
24610532	S8	"Regional upregulation of MCT2 after exercise was associated with increases in brain-derived neurotrophic factor and tyrosine-related kinase B proteins, but not insulin-like growth factor 1."	MCT2|29735	25|29	brain-derived neurotrophic factor|24225	78|111	Association
24610532	S8	"Regional upregulation of MCT2 after exercise was associated with increases in brain-derived neurotrophic factor and tyrosine-related kinase B proteins, but not insulin-like growth factor 1."	MCT2|29735	25|29	insulin-like growth factor 1|24482	160|188	Negation_Association
24610532	S9	"MCT4 increased 5-10 h postexercise only in the hypothalamus, and was associated with increased hypoxia-inducible factor-1a expression."	MCT4|80878	0|4	hypoxia-inducible factor-1a|29560	95|122	Association
24634221	S4	"HGF, in a dose-dependent manner, induced c-Met phosphorylation (Tyr-1234/1235, Tyr-1349, Ser-985, Tyr-1003, and Tyr-1313), activation of PI3k (phospho-Yp85) and Akt (phospho-Thr-308 and phospho-Ser-473) and potentiated lamellipodia formation and HLMVEC migration."	HGF|3082	0|3	c-Met|4233	41|46	Modification
24634221	S4	"HGF, in a dose-dependent manner, induced c-Met phosphorylation (Tyr-1234/1235, Tyr-1349, Ser-985, Tyr-1003, and Tyr-1313), activation of PI3k (phospho-Yp85) and Akt (phospho-Thr-308 and phospho-Ser-473) and potentiated lamellipodia formation and HLMVEC migration."	Akt|207	161|164	HGF|3082	0|3	Positive_Regulation
24634221	S5	"Inhibition of c-Met kinase by SU11274 significantly attenuated c-Met, PI3k, and Akt phosphorylation, suppressed lamellipodia formation and endothelial cell migration."	c-Met|4233	14|19	Akt|207	80|83	Modification
24634221	S6	"LY294002, an inhibitor of PI3k, abolished HGF-induced PI3k (Tyr-458), and Akt (Thr-308 and Ser-473) phosphorylation and suppressed lamellipodia formation."	HGF|3082	42|45	Akt|207	74|77	Positive_Regulation
24634221	S7	"Furthermore, HGF stimulated p47(phox)/Cortactin/Rac1 translocation to lamellipodia and ROS generation."	HGF|3082	13|16	p47(phox)|653361	28|37	Translocation
24634221	S7	"Furthermore, HGF stimulated p47(phox)/Cortactin/Rac1 translocation to lamellipodia and ROS generation."	HGF|3082	13|16	Cortactin|2017	38|47	Translocation
24634221	S7	"Furthermore, HGF stimulated p47(phox)/Cortactin/Rac1 translocation to lamellipodia and ROS generation."	HGF|3082	13|16	Rac1|5879	48|52	Translocation
24634221	S10	"Taken together, these data provide evidence in support of a significant role for HGF-induced c-Met/PI3k/Akt signaling and NADPH oxidase activation in lamellipodia formation and motility of lung endothelial cells."	HGF|3082	81|84	c-Met|4233	93|98	Positive_Regulation
24634221	S10	"Taken together, these data provide evidence in support of a significant role for HGF-induced c-Met/PI3k/Akt signaling and NADPH oxidase activation in lamellipodia formation and motility of lung endothelial cells."	HGF|3082	81|84	Akt|207	104|107	Positive_Regulation
24643012	S1	Pou5f1/Oct4 promotes cell survival via direct activation of mych expression during zebrafish gastrulation.	Pou5f1/Oct4|30333	0|11	mych|560341	60|64	Positive_Regulation
24643012	S5	"We found that the broad blastula and gastrula stage mych expression, as well as late gastrula stage mycl1b expression, both depend on Pou5f1 activity."	Pou5f1|30333	134|140	mych|560341	52|56	Association
24643012	S5	"We found that the broad blastula and gastrula stage mych expression, as well as late gastrula stage mycl1b expression, both depend on Pou5f1 activity."	Pou5f1|30333	134|140	mycl1b|567762	100|106	Association
24643012	S6	We analyzed ChIP-Seq data and found that both Pou5f1 and Sox2 bind to mych and mycl1b control regions.	Pou5f1|30333	46|52	mych|560341	70|74	Binding
24643012	S6	We analyzed ChIP-Seq data and found that both Pou5f1 and Sox2 bind to mych and mycl1b control regions.	Pou5f1|30333	46|52	mycl1b|567762	79|85	Binding
24643012	S6	We analyzed ChIP-Seq data and found that both Pou5f1 and Sox2 bind to mych and mycl1b control regions.	Sox2|378723	57|61	mych|560341	70|74	Binding
24643012	S6	We analyzed ChIP-Seq data and found that both Pou5f1 and Sox2 bind to mych and mycl1b control regions.	Sox2|378723	57|61	mycl1b|567762	79|85	Binding
24643012	S7	"The regulation of mych by Pou5f1 appears to be direct transcriptional activation, as overexpression of a Pou5f1 activator fusion protein in MZspg embryos induced strong mych expression even when translation of zygotically expressed mRNAs was suppressed."	Pou5f1|30333	26|32	mych|560341	18|22	Positive_Regulation
24643012	S7	"The regulation of mych by Pou5f1 appears to be direct transcriptional activation, as overexpression of a Pou5f1 activator fusion protein in MZspg embryos induced strong mych expression even when translation of zygotically expressed mRNAs was suppressed."	mych|560341	169|173	Pou5f1|30333	105|111	Positive_Regulation
24651435	S1	MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis.	MicroRNA-23a|387216	0|12	Apaf-1|11783	43|49	Negative_Regulation
24651435	S1	MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis.	microRNA-27a|387220	19|31	Apaf-1|11783	43|49	Negative_Regulation
24651435	S4	"In the present study, we found that four microRNAs (miR-23a/b and miR-27a/b) of miR-23a-27a-24 and miR-23b-27b-24 clusters play key roles in modulating the expression of Apaf-1."	Apaf-1|11783	170|176	miR-23a|387216	52|59	Neutral_Regulation
24651435	S4	"In the present study, we found that four microRNAs (miR-23a/b and miR-27a/b) of miR-23a-27a-24 and miR-23b-27b-24 clusters play key roles in modulating the expression of Apaf-1."	Apaf-1|11783	170|176	miR-27a|387220	66|73	Neutral_Regulation
24651435	S5	"First, we found that miR-23a/b and miR-27a/b suppressed the expression of Apaf-1 in vitro."	Apaf-1|11783	74|80	miR-23a|387216	21|28	Negative_Regulation
24651435	S5	"First, we found that miR-23a/b and miR-27a/b suppressed the expression of Apaf-1 in vitro."	Apaf-1|11783	74|80	miR-27a|387220	35|42	Negative_Regulation
24651435	S7	"Second, hypoxic injuries during fetal distress caused reduced expression of the miR-23b and miR-27b that was inversely correlated with an elevation of Apaf-1 expression during neuronal apoptosis."	Apaf-1|11783	151|157	miR-23b|387217	80|87	Association
24651435	S7	"Second, hypoxic injuries during fetal distress caused reduced expression of the miR-23b and miR-27b that was inversely correlated with an elevation of Apaf-1 expression during neuronal apoptosis."	Apaf-1|11783	151|157	miR-27b|387221	92|99	Association
24651435	S9	"In conclusion, our results demonstrate, in central neural system, that miR-23a/b and miR-27a/b are endogenous inhibitory factors of Apaf-1 expression and regulate the sensitivity of neurons to apoptosis."	miR-23a|387216	71|78	Apaf-1|11783	132|138	Negative_Agent
24651435	S9	"In conclusion, our results demonstrate, in central neural system, that miR-23a/b and miR-27a/b are endogenous inhibitory factors of Apaf-1 expression and regulate the sensitivity of neurons to apoptosis."	miR-27a|387220	85|92	Apaf-1|11783	132|138	Negative_Agent
24670424	S1	NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.	IRF4|3662	43|47	RICK|8767	104|108	Modification
24670424	S1	NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.	IRF4|3662	43|47	TRAF6|7189	113|118	Modification
24670424	S1	NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.	NOD2|64127	0|4	RICK|8767	104|108	Interaction_Agent
24670424	S1	NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.	NOD2|64127	0|4	TRAF6|7189	113|118	Interaction_Agent
24670424	S2	"It is well established that polymorphisms of the caspase activation and recruitment domain 15 (CARD15) gene, a major risk factor in Crohn's disease (CD), lead to loss of nucleotide-binding oligomerization domain 2 (NOD2) function."	caspase activation and recruitment domain 15 (CARD15)|64127	49|102	nucleotide-binding oligomerization domain 2 (NOD2)|64127	170|220	Negative_Regulation
24670424	S5	Here we show that NOD2 activation results in increased interferon regulatory factor 4 (IRF4) expression and binding to tumor necrosis factor receptor associated factor 6 (TRAF6) and RICK (receptor interacting serine-threonine kinase).	tumor necrosis factor receptor associated factor 6 (TRAF6)|7189	119|177	NOD2|64127	18|22	Binding
24670424	S5	Here we show that NOD2 activation results in increased interferon regulatory factor 4 (IRF4) expression and binding to tumor necrosis factor receptor associated factor 6 (TRAF6) and RICK (receptor interacting serine-threonine kinase).	RICK (receptor interacting serine-threonine kinase)|8767	182|233	NOD2|64127	18|22	Binding
24670424	S5	Here we show that NOD2 activation results in increased interferon regulatory factor 4 (IRF4) expression and binding to tumor necrosis factor receptor associated factor 6 (TRAF6) and RICK (receptor interacting serine-threonine kinase).	interferon regulatory factor 4 (IRF4)|3662	55|92	NOD2|64127	18|22	Positive_Regulation
24670424	S6	We then show that such binding leads to IRF4-mediated inhibition of Lys63-linked polyubiquitination of TRAF6 and RICK and thus to downregulation of nuclear factor (NF)-kB activation.	IRF4|3662	40|44	TRAF6|7189	103|108	Modification
24670424	S6	We then show that such binding leads to IRF4-mediated inhibition of Lys63-linked polyubiquitination of TRAF6 and RICK and thus to downregulation of nuclear factor (NF)-kB activation.	IRF4|3662	40|44	RICK|8767	113|117	Modification
24670424	S7	"Finally, we demonstrate that protection of mice from the development of experimental colitis by MDP or IRF4 administration is accompanied by similar IRF4-mediated effects on polyubiquitination of TRAF6 and RICK in colonic lamina propria mononuclear cells."	IRF4|16364	149|153	TRAF6|22034	196|201	Modification
24670424	S7	"Finally, we demonstrate that protection of mice from the development of experimental colitis by MDP or IRF4 administration is accompanied by similar IRF4-mediated effects on polyubiquitination of TRAF6 and RICK in colonic lamina propria mononuclear cells."	IRF4|16364	149|153	RICK|192656	206|210	Modification
24675460	S5	Further experiments demonstrated that TNFa-stimulated IkBa phosphorylation and degradation as well as p65 nuclear translocation were normal in GSK-3b-deficient MEFs.	TNFa|7124	38|42	IkBa|4792	54|58	Modification
24675460	S5	Further experiments demonstrated that TNFa-stimulated IkBa phosphorylation and degradation as well as p65 nuclear translocation were normal in GSK-3b-deficient MEFs.	TNFa|7124	38|42	p65|5970	102|105	Translocation
24675460	S5	Further experiments demonstrated that TNFa-stimulated IkBa phosphorylation and degradation as well as p65 nuclear translocation were normal in GSK-3b-deficient MEFs.	IkBa|4792	54|58	TNFa|7124	38|42	Negative_Regulation
24675460	S6	"Nonetheless, inhibition of GSK-3b function in MEFs or PDA cell lines impaired the expression of the NF-kB target genes Bcl-xL and cIAP2, but not IkBa."	Bcl-xL|598	119|125	GSK-3b|2932	27|33	Negative_Regulation
24675460	S6	"Nonetheless, inhibition of GSK-3b function in MEFs or PDA cell lines impaired the expression of the NF-kB target genes Bcl-xL and cIAP2, but not IkBa."	cIAP2|330	130|135	GSK-3b|2932	27|33	Negative_Regulation
24675460	S6	"Nonetheless, inhibition of GSK-3b function in MEFs or PDA cell lines impaired the expression of the NF-kB target genes Bcl-xL and cIAP2, but not IkBa."	GSK-3b|2932	27|33	IkBa|4792	145|149	Negation_Negative_Regulation
24675460	S6	"Nonetheless, inhibition of GSK-3b function in MEFs or PDA cell lines impaired the expression of the NF-kB target genes Bcl-xL and cIAP2, but not IkBa."	Bcl-xL|598	119|125	NF-kB|4790	100|105	Interaction_Agent
24675460	S6	"Nonetheless, inhibition of GSK-3b function in MEFs or PDA cell lines impaired the expression of the NF-kB target genes Bcl-xL and cIAP2, but not IkBa."	cIAP2|330	130|135	NF-kB|4790	100|105	Interaction_Agent
24675460	S7	"Significantly, the expression of Bcl-xL and cIAP2 could be reestablished by expression of GSK-3b targeted to the nucleus but not GSK-3b targeted to the cytoplasm, suggesting that GSK-3b regulates NF-kB function within the nucleus."	NF-kB|4790	196|201	GSK-3b|2932	179|185	Neutral_Regulation
24675460	S7	"Significantly, the expression of Bcl-xL and cIAP2 could be reestablished by expression of GSK-3b targeted to the nucleus but not GSK-3b targeted to the cytoplasm, suggesting that GSK-3b regulates NF-kB function within the nucleus."	GSK-3b|2932	90|96	Bcl-xL|598	33|39	Positive_Regulation
24675460	S7	"Significantly, the expression of Bcl-xL and cIAP2 could be reestablished by expression of GSK-3b targeted to the nucleus but not GSK-3b targeted to the cytoplasm, suggesting that GSK-3b regulates NF-kB function within the nucleus."	GSK-3b|2932	90|96	cIAP2|330	44|49	Positive_Regulation
24675460	S7	"Significantly, the expression of Bcl-xL and cIAP2 could be reestablished by expression of GSK-3b targeted to the nucleus but not GSK-3b targeted to the cytoplasm, suggesting that GSK-3b regulates NF-kB function within the nucleus."	GSK-3b|2932	129|135	cIAP2|330	44|49	Negation_Positive_Regulation
24675460	S7	"Significantly, the expression of Bcl-xL and cIAP2 could be reestablished by expression of GSK-3b targeted to the nucleus but not GSK-3b targeted to the cytoplasm, suggesting that GSK-3b regulates NF-kB function within the nucleus."	GSK-3b|2932	129|135	Bcl-xL|598	33|39	Negation_Positive_Regulation
24675460	S8	"Consistent with this notion, chromatin immunoprecipitation demonstrated that GSK-3 inhibition resulted in either decreased p65 binding to the promoter of BIR3, which encodes cIAP2, or increased p50 binding as well as recruitment of SIRT1 and HDAC3 to the promoter of BCL2L1, which encodes Bcl-xL."	SIRT1|23411	232|237	BCL2L1|598	267|273	Binding
24675460	S8	"Consistent with this notion, chromatin immunoprecipitation demonstrated that GSK-3 inhibition resulted in either decreased p65 binding to the promoter of BIR3, which encodes cIAP2, or increased p50 binding as well as recruitment of SIRT1 and HDAC3 to the promoter of BCL2L1, which encodes Bcl-xL."	HDAC3|8841	242|247	BCL2L1|598	267|273	Binding
24675460	S10	"These results not only suggest that GSK-3b overexpression and nuclear localization contribute to TNFa and TRAIL resistance via anti-apoptotic NF-kB genes such as Bcl-xL, but also provide a rationale for further exploration of GSK-3 inhibitors combined with TRAIL for the treatment of PDA."	Bcl-xL|598	162|168	GSK-3b|2932	36|42	Interaction_Agent
24675471	S4	"Though studies indicate a conspicuous association between Akt and Nrf2, a confirmatory link between the two is unaddressed."	Akt|24185	58|61	Nrf2|83619	66|70	Association
24675471	S7	"Moreover, Akt inhibition enhanced nuclear translocation as well as phosphorylation of Fyn kinase, an enzyme linked to Nrf2 degradation, by relieving GSK3b from phosphorylation-mediated repression."	Akt|24185	10|13	Fyn|25150	86|89	Modification
24675471	S7	"Moreover, Akt inhibition enhanced nuclear translocation as well as phosphorylation of Fyn kinase, an enzyme linked to Nrf2 degradation, by relieving GSK3b from phosphorylation-mediated repression."	Nrf2|83619	118|122	Fyn|25150	86|89	Association
24675471	S7	"Moreover, Akt inhibition enhanced nuclear translocation as well as phosphorylation of Fyn kinase, an enzyme linked to Nrf2 degradation, by relieving GSK3b from phosphorylation-mediated repression."	GSK3b|84027	149|154	Akt|24185	10|13	Modification
24675471	S7	"Moreover, Akt inhibition enhanced nuclear translocation as well as phosphorylation of Fyn kinase, an enzyme linked to Nrf2 degradation, by relieving GSK3b from phosphorylation-mediated repression."	Akt|24185	10|13	Fyn|25150	86|89	Translocation
24675471	S7	"Moreover, Akt inhibition enhanced nuclear translocation as well as phosphorylation of Fyn kinase, an enzyme linked to Nrf2 degradation, by relieving GSK3b from phosphorylation-mediated repression."	Fyn|25150	86|89	Nrf2|83619	118|122	Interaction_Agent
24675471	S8	The involvement of Akt and Fyn kinase in influencing Nrf2 signaling was further confirmed in oxidatively stressed hepatocytes by using tert-butyl hydroperoxide (tBHP).	Akt|24185	19|22	Nrf2|83619	53|57	Neutral_Regulation
24675471	S8	The involvement of Akt and Fyn kinase in influencing Nrf2 signaling was further confirmed in oxidatively stressed hepatocytes by using tert-butyl hydroperoxide (tBHP).	Fyn|25150	27|30	Nrf2|83619	53|57	Neutral_Regulation
24675471	S9	"tBHP-induced decrease in Nrf2 levels was associated with enhanced Fyn kinase phosphorylation, Fyn kinase nuclear translocation and decreased levels of phosphorylated GSK3b(Ser9) in a time-dependent manner."	Fyn|25150	66|69	Nrf2|83619	25|29	Association
24675471	S9	"tBHP-induced decrease in Nrf2 levels was associated with enhanced Fyn kinase phosphorylation, Fyn kinase nuclear translocation and decreased levels of phosphorylated GSK3b(Ser9) in a time-dependent manner."	GSK3b|84027	166|171	Nrf2|83619	25|29	Association
24675471	S11	"Further, protein expression as well as nuclear localization of PHLPP2, a phosphatase specific for Akt(Ser473), was found to be significantly enhanced in tBHP-stressed hepatocytes."	PHLPP2|498949	63|69	Akt|24185	98|101	Interaction_Agent
24675471	S12	"Silencing of PHLPP2 not only resulted in considerable restoration of Nrf2 signaling, enhanced Nrf2-ARE binding and reduced Nrf2 ubiquitination but also significantly suppressed tBHP-induced ROS generation and alterations in mitochondrial permeability."	PHLPP2|498949	13|19	Nrf2|83619	69|73	Positive_Regulation
24675471	S12	"Silencing of PHLPP2 not only resulted in considerable restoration of Nrf2 signaling, enhanced Nrf2-ARE binding and reduced Nrf2 ubiquitination but also significantly suppressed tBHP-induced ROS generation and alterations in mitochondrial permeability."	Nrf2|83619	123|127	PHLPP2|498949	13|19	Modification
24675471	S13	We infer that cellular PHLPP2 levels may aggravate oxidative toxicity by suppressing Nrf2/ARE transcriptional regulation via Akt(Se473)/GSK3b/Fyn kinase axis.	Nrf2|83619	85|89	PHLPP2|498949	23|29	Negative_Regulation
24681783	S6	"Consistent with this, we observe genetic interaction of BBS1 and BBS4 with the endosomal sorting complexes required for transport (ESCRT) gene TSG101 and accumulation of receptor in late endosomes, reduced endosomal recycling and reduced receptor degradation in lysosomes."	BBS1|582	56|60	TSG101|7251	143|149	Association
24681783	S6	"Consistent with this, we observe genetic interaction of BBS1 and BBS4 with the endosomal sorting complexes required for transport (ESCRT) gene TSG101 and accumulation of receptor in late endosomes, reduced endosomal recycling and reduced receptor degradation in lysosomes."	BBS4|585	65|69	TSG101|7251	143|149	Association
24691443	S7	"We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-kB activity and concomitant IkBb accumulation and that these defects were ameliorated with SFN treatment."	NF-kB|4790	59|64	BBS1|582	22|26	Negative_Regulation
24691443	S7	"We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-kB activity and concomitant IkBb accumulation and that these defects were ameliorated with SFN treatment."	NF-kB|4790	59|64	BBS4|585	28|32	Negative_Regulation
24691443	S7	"We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-kB activity and concomitant IkBb accumulation and that these defects were ameliorated with SFN treatment."	NF-kB|4790	59|64	OFD1|8481	37|41	Negative_Regulation
24691443	S7	"We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-kB activity and concomitant IkBb accumulation and that these defects were ameliorated with SFN treatment."	IkBb|4793	90|94	BBS1|582	22|26	Positive_Regulation
24691443	S7	"We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-kB activity and concomitant IkBb accumulation and that these defects were ameliorated with SFN treatment."	IkBb|4793	90|94	BBS4|585	28|32	Positive_Regulation
24691443	S7	"We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-kB activity and concomitant IkBb accumulation and that these defects were ameliorated with SFN treatment."	IkBb|4793	90|94	OFD1|8481	37|41	Positive_Regulation
24702707	S1	Amino acid residues required for Gtr1p-Gtr2p complex formation and its interactions with the Ego1p-Ego3p complex and TORC1 components in yeast.	Gtr1p|854918	33|38	Gtr2p|853072	39|44	Complex
24702707	S1	Amino acid residues required for Gtr1p-Gtr2p complex formation and its interactions with the Ego1p-Ego3p complex and TORC1 components in yeast.	Ego1p|853876	93|98	Ego3p|852369	99|104	Complex
24702707	S2	"The yeast Ras-like GTPases Gtr1p and Gtr2p form a heterodimer, are implicated in the regulation of TOR complex 1 (TORC1) and play pivotal roles in cell growth."	Gtr1p|854918	27|32	Gtr2p|853072	37|42	Complex
24702707	S3	"Gtr1p and Gtr2p bind Ego1p and Ego3p, which are tethered to the endosomal and vacuolar membranes where TORC1 functions are regulated through a relay of amino acid signaling interactions."	Gtr1p|854918	0|5	Ego1p|853876	21|26	Binding
24702707	S3	"Gtr1p and Gtr2p bind Ego1p and Ego3p, which are tethered to the endosomal and vacuolar membranes where TORC1 functions are regulated through a relay of amino acid signaling interactions."	Gtr1p|854918	0|5	Ego3p|852369	31|36	Binding
24702707	S3	"Gtr1p and Gtr2p bind Ego1p and Ego3p, which are tethered to the endosomal and vacuolar membranes where TORC1 functions are regulated through a relay of amino acid signaling interactions."	Gtr2p|853072	10|15	Ego1p|853876	21|26	Binding
24702707	S3	"Gtr1p and Gtr2p bind Ego1p and Ego3p, which are tethered to the endosomal and vacuolar membranes where TORC1 functions are regulated through a relay of amino acid signaling interactions."	Gtr2p|853072	10|15	Ego3p|852369	31|36	Binding
24702707	S5	We probed the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 subunits.	Gtr1p|854918	34|39	Gtr2p|853072	40|45	Complex
24702707	S5	We probed the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 subunits.	Ego1p|853876	63|68	Ego3p|852369	69|74	Complex
24702707	S6	"Mutations in the region (179-220 a.a.) following the nucleotide-binding region of Gtr1p and Gtr2p abrogated their mutual interaction and resulted in a loss in function, suggesting that complex formation between Gtr1p and Gtr2p was indispensable for TORC1 function."	Gtr1p|854918	211|216	Gtr2p|853072	221|226	Complex
24702707	S7	A modified yeast two-hybrid assay showed that Gtr1p-Gtr2p complex formation is important for its interaction with the Ego1p-Ego3p complex.	Gtr1p|854918	46|51	Gtr2p|853072	52|57	Complex
24702707	S7	A modified yeast two-hybrid assay showed that Gtr1p-Gtr2p complex formation is important for its interaction with the Ego1p-Ego3p complex.	Ego1p|853876	118|123	Ego3p|852369	124|129	Complex
24702707	S7	A modified yeast two-hybrid assay showed that Gtr1p-Gtr2p complex formation is important for its interaction with the Ego1p-Ego3p complex.	Gtr1p|854918	46|51	Ego1p|853876	118|123	Association
24702707	S7	A modified yeast two-hybrid assay showed that Gtr1p-Gtr2p complex formation is important for its interaction with the Ego1p-Ego3p complex.	Gtr1p|854918	46|51	Ego3p|852369	124|129	Association
24702707	S7	A modified yeast two-hybrid assay showed that Gtr1p-Gtr2p complex formation is important for its interaction with the Ego1p-Ego3p complex.	Gtr2p|853072	52|57	Ego1p|853876	118|123	Association
24702707	S7	A modified yeast two-hybrid assay showed that Gtr1p-Gtr2p complex formation is important for its interaction with the Ego1p-Ego3p complex.	Gtr2p|853072	52|57	Ego3p|852369	124|129	Association
24702707	S8	GTP-bound Gtr1p interacted with the region containing the HEAT repeats of Kog1p and the C-terminal region of Tco89p.	Gtr1p|854918	10|15	Kog1p|856593	74|79	Association
24702707	S8	GTP-bound Gtr1p interacted with the region containing the HEAT repeats of Kog1p and the C-terminal region of Tco89p.	Gtr1p|854918	10|15	Tco89p|855922	109|115	Association
24702707	S9	The GTP-bound Gtr2p suppressed a Kog1p mutation.	Gtr2p|853072	14|19	Kog1p|856593	33|38	Negative_Regulation
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Ego1p|853876	80|85	Ego3p|852369	86|91	Complex
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Gtr1p|854918	51|56	Gtr2p|853072	57|62	Complex
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Gtr1p|854918	51|56	Ego1p|853876	80|85	Association
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Gtr1p|854918	51|56	Ego3p|852369	86|91	Association
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Gtr2p|853072	57|62	Ego1p|853876	80|85	Association
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Gtr2p|853072	57|62	Ego3p|852369	86|91	Association
24702707	S10	Our findings indicate that the interactions of the Gtr1p-Gtr2p complex with the Ego1p-Ego3p complex and TORC1 components Kog1p and Tco89p play a role in TORC1 function.	Kog1p|856593	121|126	Tco89p|855922	131|137	Complex
24705354	S2	"HIP14 is the most highly conserved of 23 human palmitoyl acyltransferases (PATs) that catalyze the post-translational addition of palmitate to proteins, including huntingtin (HTT)."	HIP14|23390	0|5	huntingtin (HTT)|3064	163|179	Modification
24705354	S8	"We confirmed that three of them, GPM6A, and the Sprouty domain-containing proteins SPRED1 and SPRED3, are indeed palmitoylated by HIP14; the first enzyme known to palmitoylate these proteins."	HIP14|23390	130|135	GPM6A|2823	33|38	Modification
24705354	S8	"We confirmed that three of them, GPM6A, and the Sprouty domain-containing proteins SPRED1 and SPRED3, are indeed palmitoylated by HIP14; the first enzyme known to palmitoylate these proteins."	HIP14|23390	130|135	SPRED1|161742	83|89	Modification
24705354	S8	"We confirmed that three of them, GPM6A, and the Sprouty domain-containing proteins SPRED1 and SPRED3, are indeed palmitoylated by HIP14; the first enzyme known to palmitoylate these proteins."	HIP14|23390	130|135	SPRED3|399473	94|100	Modification
24705354	S10	"We also show that the vesicular cargo adapter optineurin, an established HTT-binding protein, co-immunoprecipitates with HIP14 but is not palmitoylated."	HTT|3064	73|76	optineurin|10133	46|56	Interaction_Agent
24705354	S10	"We also show that the vesicular cargo adapter optineurin, an established HTT-binding protein, co-immunoprecipitates with HIP14 but is not palmitoylated."	HIP14|23390	121|126	optineurin|10133	46|56	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	KMT2D|8085	115|120	WDR5|11091	177|181	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	KMT2D|8085	115|120	ASH2L|9070	183|188	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	KMT2D|8085	115|120	RbBP5|5929	193|198	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	CHD7|55636	122|126	WDR5|11091	177|181	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	CHD7|55636	122|126	ASH2L|9070	183|188	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	CHD7|55636	122|126	RbBP5|5929	193|198	Association
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	WDR5|11091	177|181	ASH2L|9070	183|188	Complex
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	WDR5|11091	177|181	RbBP5|5929	193|198	Complex
24705355	S8	"By using co-immunoprecipitation, immunohistochemistry and direct yeast two hybrid assays, we could show that, like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5."	ASH2L|9070	183|188	RbBP5|5929	193|198	Complex
24711622	S1	"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells."	STAT3|20848	0|5	PD-1|18566	40|44	Neutral_Regulation
24711622	S1	"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells."	STAT4|20849	7|12	PD-1|18566	40|44	Neutral_Regulation
24711622	S1	"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells."	NFATc1|18018	14|20	PD-1|18566	40|44	Neutral_Regulation
24711622	S1	"STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells."	CTCF|13018	26|30	PD-1|18566	40|44	Neutral_Regulation
24711622	S7	"In splenic CD8 T cells, TCR-induced PD-1 expression was augmented by IL-6 and IL-12, inducers of STAT3 and STAT4 activity, respectively."	IL-6|16193	69|73	PD-1|18566	36|40	Positive_Regulation
24711622	S7	"In splenic CD8 T cells, TCR-induced PD-1 expression was augmented by IL-6 and IL-12, inducers of STAT3 and STAT4 activity, respectively."	STAT3|20848	97|102	IL-6|16193	69|73	Positive_Agent
24711622	S7	"In splenic CD8 T cells, TCR-induced PD-1 expression was augmented by IL-6 and IL-12, inducers of STAT3 and STAT4 activity, respectively."	STAT4|20849	107|112	IL-6|16193	69|73	Positive_Agent
24711622	S8	IL-6 or IL-12 on its own did not induce PD-1.	IL-6|16193	0|4	PD-1|18566	40|44	Negation_Positive_Regulation
24711622	S10	"The NFATc1/STAT regulatory regions were found to interact with the promoter region of the Pdcd1 gene, providing a mechanism for their action."	NFATc1|18018	4|10	Pdcd1|18566	90|95	Association
24711622	S11	"Together these data add multiple novel distal regulatory regions and pathways to the control of PD-1 expression and provide a molecular mechanism by which proinflammatory cytokines, such as IL-6 or IL-12, can augment PD-1 expression."	PD-1|18566	217|221	IL-6|16193	190|194	Positive_Regulation
24727027	S3	"The interaction between Gbs-70E and all catalytic subunits of protein phosphatase 1 (Pp1-87B, Pp1-9C, Pp1-96A and Pp1-13C) of Drosophila melanogaster was confirmed by pairwise yeast two-hybrid tests, co-immunoprecipitation and pull down experiments."	Gbs-70E|39588	24|31	Pp1-87B|49260	85|92	Association
24727027	S3	"The interaction between Gbs-70E and all catalytic subunits of protein phosphatase 1 (Pp1-87B, Pp1-9C, Pp1-96A and Pp1-13C) of Drosophila melanogaster was confirmed by pairwise yeast two-hybrid tests, co-immunoprecipitation and pull down experiments."	Gbs-70E|39588	24|31	Pp1-9C|44289	94|100	Association
24727027	S3	"The interaction between Gbs-70E and all catalytic subunits of protein phosphatase 1 (Pp1-87B, Pp1-9C, Pp1-96A and Pp1-13C) of Drosophila melanogaster was confirmed by pairwise yeast two-hybrid tests, co-immunoprecipitation and pull down experiments."	Gbs-70E|39588	24|31	Pp1-96A|42922	102|109	Association
24727027	S3	"The interaction between Gbs-70E and all catalytic subunits of protein phosphatase 1 (Pp1-87B, Pp1-9C, Pp1-96A and Pp1-13C) of Drosophila melanogaster was confirmed by pairwise yeast two-hybrid tests, co-immunoprecipitation and pull down experiments."	Gbs-70E|39588	24|31	Pp1-13C|48531	114|121	Association
24727614	S1	Protein tyrosine phosphatase PTPN9 regulates erythroid cell development through STAT3 dephosphorylation in zebrafish.	STAT3|30767	80|85	PTPN9|100526653	29|34	Modification
24727614	S7	"Mechanistically, depletion of ptpn9 in zebrafish embryos in vivo or in K562 cells in vitro increased phosphorylated STAT3, and the hyper-phosphorylated STAT3 entrapped and prevented the transcription factors GATA1 and ZBP-89 (also known as ZNF148) from regulating erythroid gene expression."	STAT3|30767	116|121	ptpn9|100526653	30|35	Modification
24727614	S7	"Mechanistically, depletion of ptpn9 in zebrafish embryos in vivo or in K562 cells in vitro increased phosphorylated STAT3, and the hyper-phosphorylated STAT3 entrapped and prevented the transcription factors GATA1 and ZBP-89 (also known as ZNF148) from regulating erythroid gene expression."	STAT3|30767	152|157	GATA1|2623	208|213	Negative_Regulation
24727614	S7	"Mechanistically, depletion of ptpn9 in zebrafish embryos in vivo or in K562 cells in vitro increased phosphorylated STAT3, and the hyper-phosphorylated STAT3 entrapped and prevented the transcription factors GATA1 and ZBP-89 (also known as ZNF148) from regulating erythroid gene expression."	STAT3|30767	152|157	ZBP-89|7707	218|224	Negative_Regulation
24727614	S7	"Mechanistically, depletion of ptpn9 in zebrafish embryos in vivo or in K562 cells in vitro increased phosphorylated STAT3, and the hyper-phosphorylated STAT3 entrapped and prevented the transcription factors GATA1 and ZBP-89 (also known as ZNF148) from regulating erythroid gene expression."	STAT3|30767	152|157	ZNF148|7707	240|246	Negative_Regulation
24727614	S8	"These findings imply that PTPN9 plays an important role in erythropoiesis by disrupting an inhibitory complex of phosphorylated STAT3, GATA1 and ZBP-89, providing new cellular and molecular insights into the role of ptpn9a in developmental hematopoiesis."	STAT3|30767	128|133	GATA1|30481	135|140	Complex
24727614	S8	"These findings imply that PTPN9 plays an important role in erythropoiesis by disrupting an inhibitory complex of phosphorylated STAT3, GATA1 and ZBP-89, providing new cellular and molecular insights into the role of ptpn9a in developmental hematopoiesis."	STAT3|30767	128|133	ZBP-89|560300	145|151	Complex
24727614	S8	"These findings imply that PTPN9 plays an important role in erythropoiesis by disrupting an inhibitory complex of phosphorylated STAT3, GATA1 and ZBP-89, providing new cellular and molecular insights into the role of ptpn9a in developmental hematopoiesis."	GATA1|30481	135|140	ZBP-89|560300	145|151	Complex
24727614	S8	"These findings imply that PTPN9 plays an important role in erythropoiesis by disrupting an inhibitory complex of phosphorylated STAT3, GATA1 and ZBP-89, providing new cellular and molecular insights into the role of ptpn9a in developmental hematopoiesis."	PTPN9|100526653	26|31	STAT3|30767	128|133	Transformation
24727614	S8	"These findings imply that PTPN9 plays an important role in erythropoiesis by disrupting an inhibitory complex of phosphorylated STAT3, GATA1 and ZBP-89, providing new cellular and molecular insights into the role of ptpn9a in developmental hematopoiesis."	PTPN9|100526653	26|31	GATA1|30481	135|140	Transformation
24727614	S8	"These findings imply that PTPN9 plays an important role in erythropoiesis by disrupting an inhibitory complex of phosphorylated STAT3, GATA1 and ZBP-89, providing new cellular and molecular insights into the role of ptpn9a in developmental hematopoiesis."	PTPN9|100526653	26|31	ZBP-89|560300	145|151	Transformation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	heme oxygenase-1|3162	228|244	Brd2|6046	82|86	Positive_Regulation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	heme oxygenase-1|3162	228|244	Brd4|23476	91|95	Positive_Regulation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	NADPH quinone oxidoreductase 1|1728	246|276	Brd2|6046	82|86	Positive_Regulation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	NADPH quinone oxidoreductase 1|1728	246|276	Brd4|23476	91|95	Positive_Regulation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	Brd2|6046	82|86	glutamate-cysteine ligase catalytic subunit|2729	282|325	Positive_Regulation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	Brd4|23476	91|95	glutamate-cysteine ligase catalytic subunit|2729	282|325	Positive_Regulation
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	Nrf2|4780	156|160	heme oxygenase-1|3162	228|244	Association
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	Nrf2|4780	156|160	NADPH quinone oxidoreductase 1|1728	246|276	Association
24733848	S6	"Inhibition of BET protein bromodomains using the inhibitor JQ1+ or attenuation of Brd2 and Brd4 expression using small interfering RNA led to activation of Nrf2-dependent transcription and expression of the antioxidant proteins heme oxygenase-1, NADPH quinone oxidoreductase 1, and glutamate-cysteine ligase catalytic subunit."	Nrf2|4780	156|160	glutamate-cysteine ligase catalytic subunit|2729	282|325	Association
24733848	S8	"By coimmunoprecipitation, BET proteins were found to be complexed with Nrf2, whereas chromatin-immunoprecipitation studies indicated recruitment of Brd2 and Brd4 to Nrf2-binding sites on the promoters of heme oxygenase-1 and NADPH quinone oxidoreductase 1."	Brd2|6046	148|152	heme oxygenase-1|3162	204|220	Binding
24733848	S8	"By coimmunoprecipitation, BET proteins were found to be complexed with Nrf2, whereas chromatin-immunoprecipitation studies indicated recruitment of Brd2 and Brd4 to Nrf2-binding sites on the promoters of heme oxygenase-1 and NADPH quinone oxidoreductase 1."	Brd2|6046	148|152	NADPH quinone oxidoreductase 1|1728	225|255	Binding
24733848	S8	"By coimmunoprecipitation, BET proteins were found to be complexed with Nrf2, whereas chromatin-immunoprecipitation studies indicated recruitment of Brd2 and Brd4 to Nrf2-binding sites on the promoters of heme oxygenase-1 and NADPH quinone oxidoreductase 1."	Brd4|23476	157|161	heme oxygenase-1|3162	204|220	Binding
24733848	S8	"By coimmunoprecipitation, BET proteins were found to be complexed with Nrf2, whereas chromatin-immunoprecipitation studies indicated recruitment of Brd2 and Brd4 to Nrf2-binding sites on the promoters of heme oxygenase-1 and NADPH quinone oxidoreductase 1."	Brd4|23476	157|161	NADPH quinone oxidoreductase 1|1728	225|255	Binding
24735611	S7	Analysis of upstream signaling events revealed that brazilin markedly abolished the IL-1b-induced polyubiquitination of IRAK1 and its interaction with IKK-g counterpart.	IL-1b|3553	84|89	IRAK1|3654	120|125	Modification
24735611	S7	Analysis of upstream signaling events revealed that brazilin markedly abolished the IL-1b-induced polyubiquitination of IRAK1 and its interaction with IKK-g counterpart.	IKK-g|8517	151|156	IRAK1|3654	120|125	Association
24735611	S8	"Notably, pretreatment of brazilin drastically interfered the recruitment of the receptor-proximal signaling components including IRAK1/4 and TRAF6 onto MyD88 in IL-1R-triggerd NF-kB activation."	IL-1R|3554	161|166	NF-kB|4790	176|181	Positive_Regulation
24735611	S8	"Notably, pretreatment of brazilin drastically interfered the recruitment of the receptor-proximal signaling components including IRAK1/4 and TRAF6 onto MyD88 in IL-1R-triggerd NF-kB activation."	IRAK1|3654	129|134	MyD88|4615	152|157	Binding
24735611	S8	"Notably, pretreatment of brazilin drastically interfered the recruitment of the receptor-proximal signaling components including IRAK1/4 and TRAF6 onto MyD88 in IL-1R-triggerd NF-kB activation."	TRAF6|7189	141|146	MyD88|4615	152|157	Binding
24735611	S9	"Interestingly, brazilin did not affect the TNF-induced RIP1 ubiquitination and the recruitment of RIP1 and TRAF2 to TNFR1, suggesting that brazilin is effective in selectively suppressing the proximal signaling complex formation of IL-1R, but not that of TNFR1."	RIP1|8737	55|59	TNF|7124	43|46	Modification
24735611	S9	"Interestingly, brazilin did not affect the TNF-induced RIP1 ubiquitination and the recruitment of RIP1 and TRAF2 to TNFR1, suggesting that brazilin is effective in selectively suppressing the proximal signaling complex formation of IL-1R, but not that of TNFR1."	RIP1|8737	98|102	TNFR1|7132	116|121	Binding
24735611	S9	"Interestingly, brazilin did not affect the TNF-induced RIP1 ubiquitination and the recruitment of RIP1 and TRAF2 to TNFR1, suggesting that brazilin is effective in selectively suppressing the proximal signaling complex formation of IL-1R, but not that of TNFR1."	TRAF2|7186	107|112	TNFR1|7132	116|121	Binding
24735611	S10	"Moreover, our findings suggest that such a disruption of IL-1R-proximal complex formation by brazilin is not mediated by affecting the heterodimerization of IL-1R and IL-1RAcP."	IL-1R|3554	157|162	IL-1RAcP|3556	167|175	Complex
24763515	S1	HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1.	OTUB1|55611	139|144	HSCARG|57407	0|6	Translocation
24763515	S1	HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1.	TRAF3|7187	103|108	HSCARG|57407	0|6	Modification
24763515	S4	HSCARG is a newly reported negative regulator of NF-kB.	HSCARG|57407	0|6	NF-kB|4790	49|54	Negative_Agent
24763515	S7	"After viral infection, HSCARG interacted with tumor necrosis receptor-associated factor 3 (TRAF3) and inhibited its ubiquitination by promoting the recruitment of OTUB1 to TRAF3."	HSCARG|57407	23|29	tumor necrosis receptor-associated factor 3 (TRAF3)|7187	46|97	Association
24763515	S7	"After viral infection, HSCARG interacted with tumor necrosis receptor-associated factor 3 (TRAF3) and inhibited its ubiquitination by promoting the recruitment of OTUB1 to TRAF3."	OTUB1|55611	163|168	TRAF3|7187	172|177	Binding
24763515	S7	"After viral infection, HSCARG interacted with tumor necrosis receptor-associated factor 3 (TRAF3) and inhibited its ubiquitination by promoting the recruitment of OTUB1 to TRAF3."	HSCARG|57407	23|29	OTUB1|55611	163|168	Translocation
24763515	S8	"Knockout of HSCARG attenuated the de-ubiquitination of TRAF3 by OTUB1, and knockdown of OTUB1 abolished the effect of HSCARG."	HSCARG|57407	12|18	OTUB1|55611	64|69	Modification
24763515	S8	"Knockout of HSCARG attenuated the de-ubiquitination of TRAF3 by OTUB1, and knockdown of OTUB1 abolished the effect of HSCARG."	HSCARG|57407	12|18	TRAF3|7187	55|60	Modification
24763515	S8	"Knockout of HSCARG attenuated the de-ubiquitination of TRAF3 by OTUB1, and knockdown of OTUB1 abolished the effect of HSCARG."	OTUB1|55611	88|93	HSCARG|57407	118|124	Modification
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	HSCARG|57407	0|6	Ikappa-B kinase epsilon (IKKe)|9641	28|58	Association
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	TRAF3|7187	118|123	IKKe|9641	128|132	Association
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	HSCARG|57407	0|6	TRAF3|7187	118|123	Negative_Regulation
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	HSCARG|57407	0|6	IKKe|9641	128|132	Negative_Regulation
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	IRF3|3661	289|293	HSCARG|57407	0|6	Translocation
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	HSCARG|57407	0|6	IKKe|9641	181|185	Modification
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	HSCARG|57407	0|6	interferon response factor 3 (IRF3)|3661	190|225	Modification
24763515	S9	"HSCARG also interacted with Ikappa-B kinase epsilon (IKKe) after viral infection and impaired the association between TRAF3 and IKKe, which further decreased the phosphorylation of IKKe and interferon response factor 3 (IRF3), thus suppressed the dimerization and nuclear translocation of IRF3."	IRF3|3661	289|293	HSCARG|57407	0|6	Transformation
24763515	S10	"Moreover, knockdown of TRAF3 dampened the inhibitory effect of IFN-b transcription by HSCARG, suggesting that TRAF3 is necessary for HSCARG to down-regulate RLR pathway."	HSCARG|57407	86|92	TRAF3|7187	23|28	Interaction_Agent
24763515	S10	"Moreover, knockdown of TRAF3 dampened the inhibitory effect of IFN-b transcription by HSCARG, suggesting that TRAF3 is necessary for HSCARG to down-regulate RLR pathway."	TRAF3|7187	23|28	IFN-b|3456	63|68	Negative_Regulation
24771066	S1	ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-b1/ALK5/Smad2 pathway.	ZNF580|51157	0|6	eNOS|4846	16|20	Neutral_Regulation
24771066	S3	Emerging evidence suggests that TGF-b1 can regulate endothelial nitric oxide synthase (eNOS) expression in endothelial cells.	TGF-b1|7040	32|38	endothelial nitric oxide synthase (eNOS)|4846	52|92	Neutral_Regulation
24771066	S5	Overexpression/downexpression of ZNF580 in EAhy926 cells leads to the enhancement/decrease of eNOS expression.	ZNF580|51157	33|39	eNOS|4846	94|98	Neutral_Regulation
24771066	S6	TGF-b1 downregulated both ZNF580 and eNOS at the mRNA and protein levels in concentration- and time-dependent manners.	TGF-b1|7040	0|6	ZNF580|51157	26|32	Negative_Regulation
24771066	S6	TGF-b1 downregulated both ZNF580 and eNOS at the mRNA and protein levels in concentration- and time-dependent manners.	TGF-b1|7040	0|6	eNOS|4846	37|41	Negative_Regulation
24771066	S7	"ZNF580 and eNOS downregulation induced by TGF-b1 was blocked by the specific TGF-b1 type I receptor ALK5 inhibitor, SB431542."	TGF-b1|7040	42|48	ZNF580|51157	0|6	Negative_Regulation
24771066	S7	"ZNF580 and eNOS downregulation induced by TGF-b1 was blocked by the specific TGF-b1 type I receptor ALK5 inhibitor, SB431542."	TGF-b1|7040	42|48	eNOS|4846	11|15	Negative_Regulation
24771066	S7	"ZNF580 and eNOS downregulation induced by TGF-b1 was blocked by the specific TGF-b1 type I receptor ALK5 inhibitor, SB431542."	ALK5|7046	100|104	TGF-b1|7040	77|83	Interaction_Agent
24771066	S9	"These results suggest that ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-b1/ALK5/Smad2 pathway, and thus plays a crucial role in vascular endothelial cells."	ZNF580|51157	27|33	eNOS|4846	43|47	Neutral_Regulation
24778176	S6	"Nuclear galectin-3 increased and mediated increased binding of Sp1 to the Sp1 consensus sequence in the Wnt9A promoter, shown by oligonucleotide-binding assay and by chromatin immunoprecipitation assay."	Sp1|6667	63|66	Wnt9A|7483	104|109	Binding
24778176	S6	"Nuclear galectin-3 increased and mediated increased binding of Sp1 to the Sp1 consensus sequence in the Wnt9A promoter, shown by oligonucleotide-binding assay and by chromatin immunoprecipitation assay."	galectin-3|3958	8|18	Sp1|6667	63|66	Positive_Regulation
24778176	S7	"When galectin-3 was silenced, the increases in Sp1 binding to the Wnt9A promoter and in Wnt9A expression, which followed carrageenan or ARSB silencing, were inhibited."	Sp1|6667	47|50	Wnt9A|7483	66|71	Binding
24780862	S6	"We demonstrate that, Rpb4 interacts functionally with Paf1 to affect the transcription elongation of the FKS1 gene."	Rpb4|853301	21|25	Paf1|852582	54|58	Association
24780862	S6	"We demonstrate that, Rpb4 interacts functionally with Paf1 to affect the transcription elongation of the FKS1 gene."	FKS1|851055	105|109	Paf1|852582	54|58	Neutral_Regulation
24780862	S6	"We demonstrate that, Rpb4 interacts functionally with Paf1 to affect the transcription elongation of the FKS1 gene."	FKS1|851055	105|109	Rpb4|853301	21|25	Neutral_Regulation
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps15|30849	85|90	Beclin-1|8678	92|100	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps15|30849	85|90	Atg14L (autophagy-related 14-like protein)|22863	105|147	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Beclin-1|8678	92|100	Atg14L (autophagy-related 14-like protein)|22863	105|147	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps34|5289	28|33	Vps15|30849	85|90	Binding
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps34|5289	28|33	Beclin-1|8678	92|100	Binding
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps34|5289	28|33	Atg14L (autophagy-related 14-like protein)|22863	105|147	Binding
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps34|5289	28|33	Vps15|30849	85|90	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps34|5289	28|33	Beclin-1|8678	92|100	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps34|5289	28|33	Atg14L (autophagy-related 14-like protein)|22863	105|147	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps15|30849	85|90	Beclin-1|8678	92|100	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Vps15|30849	85|90	Atg14L (autophagy-related 14-like protein)|22863	105|147	Complex
24785657	S5	"The autophagic functions of Vps34 require its recruitment to a complex that includes Vps15, Beclin-1 and Atg14L (autophagy-related 14-like protein) and is known as Vps34 Complex I."	Beclin-1|8678	92|100	Atg14L (autophagy-related 14-like protein)|22863	105|147	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	Vps34|5289	38|43	Vps15|30849	45|50	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	Vps34|5289	38|43	Beclin-1|8678	52|60	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	Vps34|5289	38|43	ATG-14L|22863	65|72	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	Vps15|30849	45|50	Beclin-1|8678	52|60	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	Vps15|30849	45|50	ATG-14L|22863	65|72	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	Beclin-1|8678	52|60	ATG-14L|22863	65|72	Complex
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	NRBF2|29982	0|5	Vps34|5289	38|43	Binding
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	NRBF2|29982	0|5	Vps15|30849	45|50	Binding
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	NRBF2|29982	0|5	Beclin-1|8678	52|60	Binding
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	NRBF2|29982	0|5	ATG-14L|22863	65|72	Binding
24785657	S7	"NRBF2 binds to complexes that include Vps34, Vps15, Beclin-1 and ATG-14L, but not the Vps34 Complex II component UVRAG (UV radiation resistance-associated gene)."	NRBF2|29982	0|5	UVRAG (UV radiation resistance-associated gene)|7405	113|160	Negation_Binding
24785657	S8	NRBF2 directly interacts with Vps15 via the Vps15 WD40 domain as well as other regions of Vps15.	NRBF2|29982	0|5	Vps15|30849	30|35	Association
24785657	S9	"The formation of GFP-LC3 (light chain 3) punctae and PE (phosphatidylethanolamine)-conjugated LC3 (LC3-II) in serum-starved cells was inhibited by NRBF2 knockdown in the absence and presence of lysosomal inhibitors, and p62 levels were increased."	NRBF2|29982	147|152	LC3-II|84557	99|105	Negative_Regulation
24789910	S5	"Additionally, we identified dedicator of cytokinesis 3 (DOCK3) as a miR-486 target in skeletal muscle and determined that DOCK3 expression is induced in dystrophic muscles."	dedicator of cytokinesis 3 (DOCK3)|208869	28|62	miR-486|723876	68|75	Interaction_Agent
24789910	S6	"DOCK3 overexpression in human myotubes modulated PTEN/AKT signaling, which regulates muscle hypertrophy and growth, and induced apoptosis."	PTEN|5728	49|53	DOCK3|1795	0|5	Neutral_Regulation
24789910	S6	"DOCK3 overexpression in human myotubes modulated PTEN/AKT signaling, which regulates muscle hypertrophy and growth, and induced apoptosis."	AKT|207	54|57	DOCK3|1795	0|5	Neutral_Regulation
24789910	S8	"Skeletal muscle-specific miR-486 overexpression in Dmdmdx-5Cv animals decreased levels of DOCK3, reduced PTEN expression, and subsequently increased levels of phosphorylated AKT, which resulted in an overall beneficial effect."	miR-486|723876	25|32	DOCK3|208869	90|95	Negative_Regulation
24789910	S8	"Skeletal muscle-specific miR-486 overexpression in Dmdmdx-5Cv animals decreased levels of DOCK3, reduced PTEN expression, and subsequently increased levels of phosphorylated AKT, which resulted in an overall beneficial effect."	miR-486|723876	25|32	PTEN|19211	105|109	Negative_Regulation
24789910	S8	"Skeletal muscle-specific miR-486 overexpression in Dmdmdx-5Cv animals decreased levels of DOCK3, reduced PTEN expression, and subsequently increased levels of phosphorylated AKT, which resulted in an overall beneficial effect."	AKT|11651	174|177	miR-486|723876	25|32	Modification
24818983	S1	Zebrafish Adar2 Edits the Q/R site of AMPA receptor Subunit gria2a transcript to ensure normal development of nervous system and cranial neural crest cells.	Adar2|58134	10|15	gria2a|170450	60|66	Transformation
24818983	S3	"Although the functions of mouse Adar2 and its biologically most important substrate gria2, encoding the GluA2 subunit of AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor, have been extensively studied, the substrates and functions of zebrafish Adar2 remain elusive."	gria2|14800	84|89	Adar2|110532	32|37	Interaction_Agent
24818983	S5	"The Q/R editing of gria2a was reduced in the adar2MO and was enhanced by overexpression of Adar2, demonstrating an evolutionarily conserved activity between zebrafish and mammalian Adar2 in editing the Q/R site of gria2."	Adar2|58134	91|96	gria2a|170450	19|25	Transformation
24818983	S5	"The Q/R editing of gria2a was reduced in the adar2MO and was enhanced by overexpression of Adar2, demonstrating an evolutionarily conserved activity between zebrafish and mammalian Adar2 in editing the Q/R site of gria2."	Adar2|104	181|186	gria2|2891	214|219	Transformation
24820415	S3	"In yeast, occupancy of GPCR Ste2 by peptide pheromone a-factor initiates signaling by releasing a stimulatory Gbg complex (Ste4-Ste18) from its inhibitory Ga subunit (Gpa1)."	Ste4|854387	123|127	Ste18|853548	128|133	Complex
24820415	S4	"Prolonged pathway stimulation is detrimental, and feedback mechanisms have evolved that act at the receptor level to limit the duration of signaling and stimulate recovery from pheromone-induced G1 arrest, including upregulation of the expression of an a-factor-degrading protease (Bar1), a regulator of G-protein signaling protein (Sst2) that stimulates Gpa1-GTP hydrolysis, and Gpa1 itself."	Sst2|851173	333|337	Gpa1|856394	355|359	Positive_Regulation
24820415	S6	Ste2 internalization requires its phosphorylation and subsequent ubiquitinylation by membrane-localized protein kinases (Yck1 and Yck2) and a ubiquitin ligase (Rsp5).	Yck1|856537	121|125	Ste2|850518	0|4	Modification
24820415	S6	Ste2 internalization requires its phosphorylation and subsequent ubiquitinylation by membrane-localized protein kinases (Yck1 and Yck2) and a ubiquitin ligase (Rsp5).	Yck2|855568	130|134	Ste2|850518	0|4	Modification
24820415	S6	Ste2 internalization requires its phosphorylation and subsequent ubiquitinylation by membrane-localized protein kinases (Yck1 and Yck2) and a ubiquitin ligase (Rsp5).	Ste2|850518	0|4	Rsp5|856862	160|164	Modification
24820415	S7	"Here, we demonstrate that three different members of the a-arrestin family (Ldb19/Art1, Rod1/Art4, and Rog3/Art7) contribute to Ste2 desensitization and internalization, and they do so by discrete mechanisms."	Ste2|850518	128|132	Ldb19/Art1|854500	76|86	Neutral_Regulation
24820415	S7	"Here, we demonstrate that three different members of the a-arrestin family (Ldb19/Art1, Rod1/Art4, and Rog3/Art7) contribute to Ste2 desensitization and internalization, and they do so by discrete mechanisms."	Ste2|850518	128|132	Rod1/Art4|854183	88|97	Neutral_Regulation
24820415	S7	"Here, we demonstrate that three different members of the a-arrestin family (Ldb19/Art1, Rod1/Art4, and Rog3/Art7) contribute to Ste2 desensitization and internalization, and they do so by discrete mechanisms."	Ste2|850518	128|132	Rog3/Art7|850578	103|112	Neutral_Regulation
24820415	S7	"Here, we demonstrate that three different members of the a-arrestin family (Ldb19/Art1, Rod1/Art4, and Rog3/Art7) contribute to Ste2 desensitization and internalization, and they do so by discrete mechanisms."	Ste2|850518	128|132	Ldb19/Art1|854500	76|86	Translocation
24820415	S7	"Here, we demonstrate that three different members of the a-arrestin family (Ldb19/Art1, Rod1/Art4, and Rog3/Art7) contribute to Ste2 desensitization and internalization, and they do so by discrete mechanisms."	Ste2|850518	128|132	Rod1/Art4|854183	88|97	Translocation
24820415	S7	"Here, we demonstrate that three different members of the a-arrestin family (Ldb19/Art1, Rod1/Art4, and Rog3/Art7) contribute to Ste2 desensitization and internalization, and they do so by discrete mechanisms."	Ste2|850518	128|132	Rog3/Art7|850578	103|112	Translocation
24820415	S8	"We provide genetic and biochemical evidence that Ldb19 and Rod1 recruit Rsp5 to Ste2 via PPXY motifs in their C-terminal regions; in contrast, the arrestin fold domain at the N terminus of Rog3 is sufficient to promote adaptation."	Ldb19|854500	49|54	Rsp5|856862	72|76	Translocation
24820415	S8	"We provide genetic and biochemical evidence that Ldb19 and Rod1 recruit Rsp5 to Ste2 via PPXY motifs in their C-terminal regions; in contrast, the arrestin fold domain at the N terminus of Rog3 is sufficient to promote adaptation."	Rod1|854183	59|63	Rsp5|856862	72|76	Translocation
24820415	S8	"We provide genetic and biochemical evidence that Ldb19 and Rod1 recruit Rsp5 to Ste2 via PPXY motifs in their C-terminal regions; in contrast, the arrestin fold domain at the N terminus of Rog3 is sufficient to promote adaptation."	Rsp5|856862	72|76	Ste2|850518	80|84	Binding
24841128	S8	"RESULTS: Tat favors the secretion of interleukin-2, interferon-g and granzyme B in CD8 T cells."	interleukin-2|3558	37|50	Tat|155871	9|12	Translocation
24841128	S8	"RESULTS: Tat favors the secretion of interleukin-2, interferon-g and granzyme B in CD8 T cells."	interferon-g|3458	52|64	Tat|155871	9|12	Translocation
24841128	S8	"RESULTS: Tat favors the secretion of interleukin-2, interferon-g and granzyme B in CD8 T cells."	granzyme B|3002	69|79	Tat|155871	9|12	Translocation
24841128	S9	"Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8 T lymphocytes."	Tat|155871	51|54	T-bet|30009	83|88	Positive_Regulation
24841128	S9	"Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8 T lymphocytes."	Tat|155871	51|54	Eomesdermin|8320	90|101	Positive_Regulation
24841128	S9	"Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8 T lymphocytes."	Tat|155871	51|54	Blimp-1|639	103|110	Positive_Regulation
24841128	S9	"Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8 T lymphocytes."	Tat|155871	51|54	Bcl-6|604	112|117	Positive_Regulation
24841128	S9	"Behind this functional modulation we observed that Tat increases the expression of T-bet, Eomesdermin, Blimp-1, Bcl-6 and Bcl-2 in activated but not in unstimulated CD8 T lymphocytes."	Tat|155871	51|54	Bcl-2|596	122|127	Positive_Regulation
24858471	S7	"Using morpholino-mediated knock down, we demonstrate that disrupted dlx5a/6a function results in pectoral fin agenesis associated with misexpression of bmp4, fgf8a, and1 and msx genes."	bmp4|30612	152|156	dlx5a|30569	68|73	Association
24858471	S7	"Using morpholino-mediated knock down, we demonstrate that disrupted dlx5a/6a function results in pectoral fin agenesis associated with misexpression of bmp4, fgf8a, and1 and msx genes."	fgf8a|30538	158|163	dlx5a|30569	68|73	Association
24858471	S7	"Using morpholino-mediated knock down, we demonstrate that disrupted dlx5a/6a function results in pectoral fin agenesis associated with misexpression of bmp4, fgf8a, and1 and msx genes."	and1|794315	165|169	dlx5a|30569	68|73	Association
24858471	S10	The dlx5a/6a knock down also causes a failure of cleithrum formation associated with a drastic loss of runx2b and col10a1 expression.	runx2b|405788	103|109	dlx5a|30569	4|9	Association
24858471	S10	The dlx5a/6a knock down also causes a failure of cleithrum formation associated with a drastic loss of runx2b and col10a1 expression.	col10a1|558919	114|121	dlx5a|30569	4|9	Association
24875904	S6	"Moreover, treatment of WL-2 cells with TNFa led to repression of DNMT1 and re-expression of RANKL in association with upregulation of miR-140-3p and miR-126, which are partially offset by addition of anti-TNFa antibody to transwell-coculture of WL2 with BMSC."	TNFa|7124	39|43	RANKL|8600	92|97	Positive_Regulation
24875904	S6	"Moreover, treatment of WL-2 cells with TNFa led to repression of DNMT1 and re-expression of RANKL in association with upregulation of miR-140-3p and miR-126, which are partially offset by addition of anti-TNFa antibody to transwell-coculture of WL2 with BMSC."	DNMT1|1786	65|70	TNFa|7124	39|43	Negative_Regulation
24875904	S6	"Moreover, treatment of WL-2 cells with TNFa led to repression of DNMT1 and re-expression of RANKL in association with upregulation of miR-140-3p and miR-126, which are partially offset by addition of anti-TNFa antibody to transwell-coculture of WL2 with BMSC."	miR-140|406932	134|141	TNFa|7124	39|43	Association
24875904	S6	"Moreover, treatment of WL-2 cells with TNFa led to repression of DNMT1 and re-expression of RANKL in association with upregulation of miR-140-3p and miR-126, which are partially offset by addition of anti-TNFa antibody to transwell-coculture of WL2 with BMSC."	miR-126|406913	149|156	TNFa|7124	39|43	Association
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	DNMT1|1786	229|234	miR-126-3p|100302148	183|193	Negative_Regulation
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	DNMT1|1786	229|234	miR-140|406932	198|205	Negative_Regulation
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	DNMT1|1786	146|151	TNFa|7124	40|44	Negative_Regulation
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	miR-126-3p|100302148	183|193	TNFa|7124	40|44	Positive_Regulation
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	miR-140|406932	198|205	TNFa|7124	40|44	Positive_Regulation
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	TNFa|7124	40|44	RANKL|8600	83|88	Positive_Regulation
24875904	S7	"Taken together, our results showed that TNFa in the marrow microenvironment led to RANKL demethylation and re-expression in myeloma cells through DNMT1 repression and upregulation of miR-126-3p and miR-140, both known to repress DNMT1 translation."	TNFa|7124	40|44	RANKL|8600	83|88	Modification
24885147	S1	VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.	VAPB/ALS8|9217	0|9	FAF1|11124	71|75	Association
24885147	S1	VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.	VAPB/ALS8|9217	0|9	ASNA1|439	84|89	Association
24885147	S1	VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.	FAF1|11124	71|75	p97|7415	58|61	Interaction_Agent
24885147	S2	BACKGROUND: FAF1 is a ubiquitin-binding adaptor for the p97 ATPase and belongs to the UBA-UBX family of p97 cofactors.	FAF1|11124	12|16	p97|7415	56|59	Interaction_Agent
24885147	S4	VAPB and the related protein VAPA form homo- and heterodimers that are anchored in the endoplasmic reticulum membrane and can interact with protein partners carrying a FFAT motif.	VAPB|9217	0|4	VAPA|9218	29|33	Complex
24885147	S6	"RESULTS: We show that FAF1 contains a non-canonical FFAT motif that allows it to interact directly with the MSP domain of VAPB and, thereby, to mediate VAPB interaction with p97."	VAPB|9217	122|126	FAF1|11124	22|26	Association
24885147	S6	"RESULTS: We show that FAF1 contains a non-canonical FFAT motif that allows it to interact directly with the MSP domain of VAPB and, thereby, to mediate VAPB interaction with p97."	VAPB|9217	152|156	p97|7415	174|177	Association
24885147	S6	"RESULTS: We show that FAF1 contains a non-canonical FFAT motif that allows it to interact directly with the MSP domain of VAPB and, thereby, to mediate VAPB interaction with p97."	VAPB|9217	152|156	FAF1|11124	22|26	Neutral_Regulation
24885147	S6	"RESULTS: We show that FAF1 contains a non-canonical FFAT motif that allows it to interact directly with the MSP domain of VAPB and, thereby, to mediate VAPB interaction with p97."	FAF1|11124	22|26	p97|7415	174|177	Neutral_Regulation
24885147	S8	"Subsequently, we identified a similar FFAT-like motif in the ASNA1 subunit of the transmembrane-domain recognition complex (TRC), which in turn mediates ASNA1 interaction with the MSP domain of VAPB."	ASNA1|439	153|158	VAPB|9217	194|198	Association
24885147	S9	Proteasome inhibition leads to the accumulation of ubiquitinated species in VAPB immunoprecipitates and this correlates with an increase in FAF1 and p97 binding.	FAF1|11124	140|144	p97|7415	149|152	Binding
24885147	S13	Our findings indicate that the repertoire of VAPB interactors is more diverse than previously anticipated and link VAPB to the function of ATPase complexes such as p97/FAF1 and ASNA1/TRC.	p97|7415	164|167	FAF1|11124	168|172	Complex
24886842	S10	CpG (TLR9) stimulation caused release of IL-8 in the nasal mucosa and in FaDu.	TLR9|54106	5|9	IL-8|3576	41|45	Translocation
24905690	S8	"Moreover, enhanced mRNA level of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in As2O3 exposed zebrafish indicates a protective role of Nrf2. kelch-like ECH-associated protein 1 (Keap1), a negative regulator of Nrf2, inversely correlates with the mRNA expression of Nrf2."	Nrf2|360149	272|276	kelch-like ECH-associated protein 1 (Keap1)|321837	148|191	Association
24905690	S8	"Moreover, enhanced mRNA level of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in As2O3 exposed zebrafish indicates a protective role of Nrf2. kelch-like ECH-associated protein 1 (Keap1), a negative regulator of Nrf2, inversely correlates with the mRNA expression of Nrf2."	kelch-like ECH-associated protein 1 (Keap1)|321837	148|191	Nrf2|360149	217|221	Negative_Agent
24905690	S9	As2O3 induced toxicity was also validated by the alteration in NRF2 and NRF2 dependent expression of proteins such as heme oxygenase1 (HO1) and NAD(P)H dehydrogenase quinone1 (NQO1).	NRF2|360149	72|76	heme oxygenase1 (HO1)|791518	118|139	Association
24905690	S9	As2O3 induced toxicity was also validated by the alteration in NRF2 and NRF2 dependent expression of proteins such as heme oxygenase1 (HO1) and NAD(P)H dehydrogenase quinone1 (NQO1).	NRF2|360149	72|76	NAD(P)H dehydrogenase quinone1 (NQO1)|322506	144|181	Association
24912918	S3	DAB2IP is epigenetically down-regulated in a variety of tumors through the action of the histone methyltransferase EZH2.	EZH2|2146	115|119	DAB2IP|153090	0|6	Negative_Regulation
24912918	S6	"First, we identified that Akt1 can phosphorylate DAB2IP on S847, which regulates the interaction between DAB2IP and its effector molecules H-Ras and TRAF2."	DAB2IP|153090	105|111	H-Ras|3265	139|144	Association
24912918	S6	"First, we identified that Akt1 can phosphorylate DAB2IP on S847, which regulates the interaction between DAB2IP and its effector molecules H-Ras and TRAF2."	DAB2IP|153090	105|111	TRAF2|7186	149|154	Association
24912918	S6	"First, we identified that Akt1 can phosphorylate DAB2IP on S847, which regulates the interaction between DAB2IP and its effector molecules H-Ras and TRAF2."	Akt1|207	26|30	DAB2IP|153090	49|55	Modification
24912918	S6	"First, we identified that Akt1 can phosphorylate DAB2IP on S847, which regulates the interaction between DAB2IP and its effector molecules H-Ras and TRAF2."	DAB2IP|153090	105|111	Akt1|207	26|30	Neutral_Regulation
24912918	S6	"First, we identified that Akt1 can phosphorylate DAB2IP on S847, which regulates the interaction between DAB2IP and its effector molecules H-Ras and TRAF2."	Akt1|207	26|30	H-Ras|3265	139|144	Neutral_Regulation
24912918	S6	"First, we identified that Akt1 can phosphorylate DAB2IP on S847, which regulates the interaction between DAB2IP and its effector molecules H-Ras and TRAF2."	Akt1|207	26|30	TRAF2|7186	149|154	Neutral_Regulation
24912918	S7	"Second, we demonstrated that DAB2IP can be degraded in part through ubiquitin-proteasome pathway by SCF(Fbw7)."	Fbw7|55294	104|108	DAB2IP|153090	29|35	Negative_Regulation
24912918	S8	"DAB2IP harbors two Fbw7 phosho-degron motifs, which can be regulated by the kinase, CK1."	CK1|1453	84|88	DAB2IP|153090	0|6	Neutral_Regulation
24912918	S8	"DAB2IP harbors two Fbw7 phosho-degron motifs, which can be regulated by the kinase, CK1."	CK1|1453	84|88	Fbw7|55294	19|23	Neutral_Regulation
24912918	S8	"DAB2IP harbors two Fbw7 phosho-degron motifs, which can be regulated by the kinase, CK1."	DAB2IP|153090	0|6	Fbw7|55294	19|23	Binding
24920846	S1	Cellular stress amplifies TLR3/4-induced CXCL1/2 gene transcription in mononuclear phagocytes via RIPK1.	TLR3|142980	26|30	CXCL1|14825	41|46	Positive_Regulation
24920846	S6	"IFN regulatory factor 3, a transcription factor that is downstream of TLR4/TRIF signaling, was not required for sensitivity to stress-induced chemokine amplification."	IFN regulatory factor 3|54131	0|23	TLR4|21898	70|74	Interaction_Agent
24920846	S6	"IFN regulatory factor 3, a transcription factor that is downstream of TLR4/TRIF signaling, was not required for sensitivity to stress-induced chemokine amplification."	IFN regulatory factor 3|54131	0|23	TRIF|106759	75|79	Interaction_Agent
24920846	S7	c/EBP homologous protein and X box binding protein 1 have been reported to enhance inflammatory cytokine responses but are not required for amplification of TLR3/4-induced CXCL1 expression.	TLR3|142980	157|161	CXCL1|14825	172|177	Positive_Regulation
24920846	S7	c/EBP homologous protein and X box binding protein 1 have been reported to enhance inflammatory cytokine responses but are not required for amplification of TLR3/4-induced CXCL1 expression.	X box binding protein 1|22433	29|52	CXCL1|14825	172|177	Negation_Association
24920846	S8	"Rather, receptor-interacting protein kinase 1, a kinase also linked with TLR3/4/TRIF signaling, is required and involves a stress-dependent increase in its abundance and ubiquitination."	receptor-interacting protein kinase 1|19766	8|45	TLR3|142980	73|77	Association
24920846	S8	"Rather, receptor-interacting protein kinase 1, a kinase also linked with TLR3/4/TRIF signaling, is required and involves a stress-dependent increase in its abundance and ubiquitination."	receptor-interacting protein kinase 1|19766	8|45	TRIF|106759	80|84	Association
24944064	S1	Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration.	Snail|20613	0|5	Kras|16653	22|26	Association
24944064	S1	Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration.	stem cell factor|17311	52|68	Snail|20613	0|5	Positive_Regulation
24944064	S1	Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration.	stem cell factor|17311	52|68	Kras|16653	22|26	Positive_Regulation
24944064	S7	"In addition, it was revealed that human primary PDAC tumors with increased Snail expression are associated with increased mast cell infiltration, and that Snail expression in these clinical specimens positively correlated with the expression of stem cell factor (SCF/KITLG), a cytokine known to regulate mast cell migration."	stem cell factor (SCF/KITLG)|4254	245|273	Snail|6615	155|160	Association
24944064	S9	"Moreover, overexpression of Snail in PDAC cells increased SCF levels, and the media conditioned by Snail-expressing PDAC cells promoted mast cell migration."	SCF|17311	58|61	Snail|20613	28|33	Positive_Regulation
24948837	S3	AGL15 and AGL18 were previously shown to act redundantly as floral repressors and upstream of FLOWERING LOCUS T (FT) in Arabidopsis (Arabidopsis thaliana).	FLOWERING LOCUS T (FT)|842859	94|116	AGL18|824906	10|15	Interaction_Agent
24948837	S3	AGL15 and AGL18 were previously shown to act redundantly as floral repressors and upstream of FLOWERING LOCUS T (FT) in Arabidopsis (Arabidopsis thaliana).	FLOWERING LOCUS T (FT)|842859	94|116	AGL15|831224	0|5	Interaction_Agent
24948837	S3	AGL15 and AGL18 were previously shown to act redundantly as floral repressors and upstream of FLOWERING LOCUS T (FT) in Arabidopsis (Arabidopsis thaliana).	FLOWERING LOCUS T (FT)|842859	94|116	AGL15|831224	0|5	Negative_Agent
24948837	S3	AGL15 and AGL18 were previously shown to act redundantly as floral repressors and upstream of FLOWERING LOCUS T (FT) in Arabidopsis (Arabidopsis thaliana).	FLOWERING LOCUS T (FT)|842859	94|116	AGL18|824906	10|15	Negative_Agent
24948837	S5	agl15 agl18 mutations fail to suppress ft mutations but show additive interactions with short vegetative phase (svp) mutations in ft and suppressor of constans1 (soc1) backgrounds.	ft|842859	39|41	agl15|831224	0|5	Negation_Negative_Regulation
24948837	S5	agl15 agl18 mutations fail to suppress ft mutations but show additive interactions with short vegetative phase (svp) mutations in ft and suppressor of constans1 (soc1) backgrounds.	ft|842859	39|41	agl18|824906	6|11	Negation_Negative_Regulation
24948837	S5	agl15 agl18 mutations fail to suppress ft mutations but show additive interactions with short vegetative phase (svp) mutations in ft and suppressor of constans1 (soc1) backgrounds.	short vegetative phase (svp)|816787	88|116	agl15|831224	0|5	Association
24948837	S5	agl15 agl18 mutations fail to suppress ft mutations but show additive interactions with short vegetative phase (svp) mutations in ft and suppressor of constans1 (soc1) backgrounds.	short vegetative phase (svp)|816787	88|116	agl18|824906	6|11	Association
24948837	S6	Chromatin immunoprecipitation analyses with AGL15-specific antibodies indicate that AGL15 binds directly to the FT locus at sites that partially overlap those bound by SVP and FLOWERING LOCUS C.	AGL15|831224	84|89	FT|842859	112|114	Binding
24960647	S13	"DISCUSSION: Since Bcl-xl and Bak1, members of the Bcl-2 family, are the targets of hsa-miR-326, our findings suggest that hsa-miR-326 may be involved in platelet apoptosis during storage."	hsa-miR-326|442900	83|94	Bcl-xl|598	18|24	Interaction_Agent
24960647	S13	"DISCUSSION: Since Bcl-xl and Bak1, members of the Bcl-2 family, are the targets of hsa-miR-326, our findings suggest that hsa-miR-326 may be involved in platelet apoptosis during storage."	hsa-miR-326|442900	83|94	Bak1|578	29|33	Interaction_Agent
24970262	S8	"In univariate analysis, GNA11 (odds ratio [OR] 2.5, 95% confidence interval [CI] 1.1-5.5) and BAP1 (OR 6.3, 95% CI 2.7-14.4) mutations were positively associated and EIF1AX mutation (OR 0.13, 95% CI 0.034-0.47) was inversely associated with metastatic status at 48 months after UM treatment."	GNA11|2767	24|29	BAP1|8314	94|98	Association
24982172	S10	"IL-33 blockade specifically attenuated this survival advantage, confirming IL-33 as the relevant ST2 ligand mediating MC survival in vivo."	IL-33|77125	75|80	ST2|17082	97|100	Interaction_Agent
24992036	S3	"We examined three conserved host RNA-binding proteins (RBPs) G3BP1, G3BP2 and CAPRIN1 in dengue virus (DENV-2) infection and found them to be novel regulators of the interferon (IFN) response against DENV-2."	G3BP1|10146	61|66	interferon (IFN)|3439	166|182	Interaction_Agent
24992036	S3	"We examined three conserved host RNA-binding proteins (RBPs) G3BP1, G3BP2 and CAPRIN1 in dengue virus (DENV-2) infection and found them to be novel regulators of the interferon (IFN) response against DENV-2."	G3BP2|9908	68|73	interferon (IFN)|3439	166|182	Interaction_Agent
24992036	S3	"We examined three conserved host RNA-binding proteins (RBPs) G3BP1, G3BP2 and CAPRIN1 in dengue virus (DENV-2) infection and found them to be novel regulators of the interferon (IFN) response against DENV-2."	CAPRIN1|4076	78|85	interferon (IFN)|3439	166|182	Interaction_Agent
25030699	S1	A cell cycle-regulated Slx4-Dpb11 complex promotes the resolution of DNA repair intermediates linked to stalled replication.	Slx4|850826	23|27	Dpb11|853355	28|33	Complex
25030699	S5	"Here, we identify a regulatory mechanism in yeast that critically controls JM resolution by the Mus81-Mms4 endonuclease."	Mus81|851994	96|101	Mms4|852395	102|106	Complex
25030699	S6	Central to this regulation is a conserved complex comprising the scaffold proteins Dpb11 and Slx4 that is under stringent control.	Dpb11|853355	83|88	Slx4|850826	93|97	Complex
25030699	S7	"Cell cycle-dependent phosphorylation of Slx4 by Cdk1 promotes the Dpb11-Slx4 interaction, while in mitosis, phosphorylation of Mms4 by Polo-like kinase Cdc5 promotes the additional association of Mus81-Mms4 with the complex, thereby promoting JM resolution."	Dpb11|853355	66|71	Slx4|850826	72|76	Association
25030699	S7	"Cell cycle-dependent phosphorylation of Slx4 by Cdk1 promotes the Dpb11-Slx4 interaction, while in mitosis, phosphorylation of Mms4 by Polo-like kinase Cdc5 promotes the additional association of Mus81-Mms4 with the complex, thereby promoting JM resolution."	Mms4|852395	127|131	Cdc5|855013	152|156	Modification
25030699	S7	"Cell cycle-dependent phosphorylation of Slx4 by Cdk1 promotes the Dpb11-Slx4 interaction, while in mitosis, phosphorylation of Mms4 by Polo-like kinase Cdc5 promotes the additional association of Mus81-Mms4 with the complex, thereby promoting JM resolution."	Cdk1|852457	48|52	Slx4|850826	40|44	Modification
25030699	S7	"Cell cycle-dependent phosphorylation of Slx4 by Cdk1 promotes the Dpb11-Slx4 interaction, while in mitosis, phosphorylation of Mms4 by Polo-like kinase Cdc5 promotes the additional association of Mus81-Mms4 with the complex, thereby promoting JM resolution."	Dpb11|853355	66|71	Slx4|850826	40|44	Positive_Regulation
25030699	S7	"Cell cycle-dependent phosphorylation of Slx4 by Cdk1 promotes the Dpb11-Slx4 interaction, while in mitosis, phosphorylation of Mms4 by Polo-like kinase Cdc5 promotes the additional association of Mus81-Mms4 with the complex, thereby promoting JM resolution."	Slx4|850826	72|76	Slx4|850826	40|44	Positive_Regulation
25030699	S8	"Finally, the DNA damage checkpoint counteracts Mus81-Mms4 binding to the Dpb11-Slx4 complex."	Dpb11|853355	73|78	Slx4|850826	79|83	Complex
25030699	S8	"Finally, the DNA damage checkpoint counteracts Mus81-Mms4 binding to the Dpb11-Slx4 complex."	Mus81|851994	47|52	Dpb11|853355	73|78	Binding
25030699	S8	"Finally, the DNA damage checkpoint counteracts Mus81-Mms4 binding to the Dpb11-Slx4 complex."	Mus81|851994	47|52	Slx4|850826	79|83	Binding
25030699	S8	"Finally, the DNA damage checkpoint counteracts Mus81-Mms4 binding to the Dpb11-Slx4 complex."	Mms4|852395	53|57	Dpb11|853355	73|78	Binding
25030699	S8	"Finally, the DNA damage checkpoint counteracts Mus81-Mms4 binding to the Dpb11-Slx4 complex."	Mms4|852395	53|57	Slx4|850826	79|83	Binding
25030699	S9	"Thus, Dpb11-Slx4 integrates several cellular inputs and participates in the temporal program for activation of the JM-resolving nuclease Mus81."	Mus81|851994	137|142	Dpb11|853355	6|11	Positive_Regulation
25030699	S9	"Thus, Dpb11-Slx4 integrates several cellular inputs and participates in the temporal program for activation of the JM-resolving nuclease Mus81."	Mus81|851994	137|142	Slx4|850826	12|16	Positive_Regulation
25035869	S1	Regulation of Saccharomyces cerevisiae MEF1 by Hda1p affects salt resistance of bdf1 mutant.	MEF1|850758	39|43	Hda1p|855710	47|52	Neutral_Regulation
25035869	S5	Hda1p overexpression inhibited the relieving effects of low-copy overexpression of MEF1.	Hda1p|855710	0|5	MEF1|850758	83|87	Negative_Regulation
25035869	S6	"Further analysis showed that Bdf1p regulated HDA1 transcription positively by binding to its promoter at 201 to +6 bp, whereas Hda1p modulated MEF1 expression negatively by binding to its promoter at 201 to +6 bp."	Bdf1p|851115	29|34	HDA1|855710	45|49	Positive_Regulation
25035869	S6	"Further analysis showed that Bdf1p regulated HDA1 transcription positively by binding to its promoter at 201 to +6 bp, whereas Hda1p modulated MEF1 expression negatively by binding to its promoter at 201 to +6 bp."	Hda1p|855710	128|133	MEF1|850758	144|148	Negative_Regulation
25035869	S7	These results suggested that Bdf1p likely regulated MEF1 expression negatively by regulating HDA1 positively.	MEF1|850758	52|56	Bdf1p|851115	29|34	Negative_Regulation
25035869	S7	These results suggested that Bdf1p likely regulated MEF1 expression negatively by regulating HDA1 positively.	HDA1|855710	93|97	Bdf1p|851115	29|34	Positive_Regulation
25048004	S7	"Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome."	HIST1H1E|3008	196|204	MAPK3|5595	209|214	Association
25065758	S4	"Here, we show that the +TIP Navigator 1 (NAV1) is important for neurite outgrowth and interacts and colocalizes with TRIO, a Rho guanine nucleotide exchange factor that enables neurite outgrowth by activating the Rho GTPases Rac1 and RhoG."	TRIO|7204	117|121	Navigator 1 (NAV1)|89796	28|46	Association
25065758	S4	"Here, we show that the +TIP Navigator 1 (NAV1) is important for neurite outgrowth and interacts and colocalizes with TRIO, a Rho guanine nucleotide exchange factor that enables neurite outgrowth by activating the Rho GTPases Rac1 and RhoG."	Rac1|5879	225|229	TRIO|7204	117|121	Positive_Regulation
25065758	S4	"Here, we show that the +TIP Navigator 1 (NAV1) is important for neurite outgrowth and interacts and colocalizes with TRIO, a Rho guanine nucleotide exchange factor that enables neurite outgrowth by activating the Rho GTPases Rac1 and RhoG."	RhoG|391	234|238	TRIO|7204	117|121	Positive_Regulation
25065758	S5	"We find that binding of NAV1 enhances the affinity of TRIO for Rac1 and RhoG, and that NAV1 regulates TRIO-mediated Rac1 activation and neurite outgrowth."	Rac1|5879	116|120	TRIO|7204	102|106	Positive_Regulation
25065758	S5	"We find that binding of NAV1 enhances the affinity of TRIO for Rac1 and RhoG, and that NAV1 regulates TRIO-mediated Rac1 activation and neurite outgrowth."	Rac1|5879	116|120	NAV1|89796	87|91	Positive_Regulation
25065758	S5	"We find that binding of NAV1 enhances the affinity of TRIO for Rac1 and RhoG, and that NAV1 regulates TRIO-mediated Rac1 activation and neurite outgrowth."	TRIO|7204	54|58	Rac1|5879	63|67	Binding
25065758	S5	"We find that binding of NAV1 enhances the affinity of TRIO for Rac1 and RhoG, and that NAV1 regulates TRIO-mediated Rac1 activation and neurite outgrowth."	TRIO|7204	54|58	RhoG|391	72|76	Binding
25065758	S5	"We find that binding of NAV1 enhances the affinity of TRIO for Rac1 and RhoG, and that NAV1 regulates TRIO-mediated Rac1 activation and neurite outgrowth."	TRIO|7204	54|58	NAV1|89796	24|28	Positive_Regulation
25065758	S6	"TRIO is also a +TIP, as it interacts with the core +TIP EB1 and tracks microtubule plus ends via EB1 and NAV1."	EB1|22919	56|59	TRIO|7204	0|4	Association
25065758	S6	"TRIO is also a +TIP, as it interacts with the core +TIP EB1 and tracks microtubule plus ends via EB1 and NAV1."	EB1|22919	97|100	TRIO|7204	0|4	Interaction_Agent
25065758	S6	"TRIO is also a +TIP, as it interacts with the core +TIP EB1 and tracks microtubule plus ends via EB1 and NAV1."	NAV1|89796	105|109	TRIO|7204	0|4	Interaction_Agent
25065758	S7	"Strikingly, the EB1-mediated recruitment of TRIO to microtubule ends is required for proper neurite outgrowth, and stabilization of the microtubule network by paclitaxel affects both the TRIO-NAV1 interaction and the accumulation of these proteins in neurite extensions."	TRIO|7204	187|191	NAV1|89796	192|196	Association
25065758	S7	"Strikingly, the EB1-mediated recruitment of TRIO to microtubule ends is required for proper neurite outgrowth, and stabilization of the microtubule network by paclitaxel affects both the TRIO-NAV1 interaction and the accumulation of these proteins in neurite extensions."	EB1|22919	16|19	TRIO|7204	44|48	Translocation
25065758	S8	"We propose that EB1-labeled ends of dynamic microtubules facilitate the formation and localization of functional NAV1-TRIO complexes, which in turn regulate neurite outgrowth by selectively activating Rac1."	NAV1|89796	113|117	TRIO|7204	118|122	Complex
25065758	S8	"We propose that EB1-labeled ends of dynamic microtubules facilitate the formation and localization of functional NAV1-TRIO complexes, which in turn regulate neurite outgrowth by selectively activating Rac1."	Rac1|5879	201|205	NAV1|89796	113|117	Positive_Regulation
25065758	S8	"We propose that EB1-labeled ends of dynamic microtubules facilitate the formation and localization of functional NAV1-TRIO complexes, which in turn regulate neurite outgrowth by selectively activating Rac1."	Rac1|5879	201|205	TRIO|7204	118|122	Positive_Regulation
25066235	S2	The Nrd1-Nab3-Sen1 (NNS) complex is essential for controlling pervasive transcription and generating sn/snoRNAs in S.cerevisiae.	Nrd1|855470	4|8	Nab3|855911	9|13	Complex
25066235	S2	The Nrd1-Nab3-Sen1 (NNS) complex is essential for controlling pervasive transcription and generating sn/snoRNAs in S.cerevisiae.	Nrd1|855470	4|8	Sen1|851150	14|18	Complex
25066235	S2	The Nrd1-Nab3-Sen1 (NNS) complex is essential for controlling pervasive transcription and generating sn/snoRNAs in S.cerevisiae.	Nab3|855911	9|13	Sen1|851150	14|18	Complex
25066235	S4	The Trf4-Air2-Mtr4 (TRAMP) complex polyadenylates NNS target RNAs and favors their degradation.	Trf4|854034	4|8	Air2|851379	9|13	Complex
25066235	S4	The Trf4-Air2-Mtr4 (TRAMP) complex polyadenylates NNS target RNAs and favors their degradation.	Trf4|854034	4|8	Mtr4|853397	14|18	Complex
25066235	S4	The Trf4-Air2-Mtr4 (TRAMP) complex polyadenylates NNS target RNAs and favors their degradation.	Air2|851379	9|13	Mtr4|853397	14|18	Complex
25066235	S6	"Here we provide structural and functional evidence demonstrating that the same domain of Nrd1p interacts with RNA polymerase II and Trf4p in a mutually exclusive manner, thus defining two alternative forms of the NNS complex, one involved in termination and the other in degradation."	Nrd1p|855470	89|94	Trf4p|854034	132|137	Association
25066235	S7	We show that the Nrd1-Trf4 interaction is required for optimal exosome activity invivo and for the stimulation of polyadenylation of NNS targets by TRAMP invitro.	Nrd1|855470	17|21	Trf4|854034	22|26	Association
25091157	S4	"Uls1 works together with Sgs1 and we demonstrate that the attenuation of replication stress-related defects in sgs1 by deletion of ULS1 depends on a functional of Rad51 recombinase and post-replication repair pathway mediated by Rad18 and Rad5, but not on the translesion polymerase, Rev3."	Uls1|854363	0|4	Sgs1|855228	25|29	Association
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	Cyc8|852410	10|14	Tup1|850445	15|19	Complex
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	Cyc8|852410	10|14	Hda1p|855710	44|49	Association
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	Cyc8|852410	10|14	Rpd3p|855386	54|59	Association
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	Tup1|850445	15|19	Hda1p|855710	44|49	Association
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	Tup1|850445	15|19	Rpd3p|855386	54|59	Association
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	FLO1|851289	135|139	Cyc8|852410	10|14	Negative_Regulation
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	FLO1|851289	135|139	Tup1|850445	15|19	Negative_Regulation
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	FLO1|851289	135|139	Hda1p|855710	44|49	Negative_Regulation
25106892	S1	The yeast Cyc8-Tup1 complex cooperates with Hda1p and Rpd3p histone deacetylases to robustly repress transcription of the subtelomeric FLO1 gene.	FLO1|851289	135|139	Rpd3p|855386	54|59	Negative_Regulation
25106892	S2	"We demonstrate that the yeast flocculation gene, FLO1, is representative of a distinct subset of subtelomeric genes that are robustly repressed by the Cyc8-Tup1 complex."	Cyc8|852410	151|155	Tup1|850445	156|160	Complex
25106892	S2	"We demonstrate that the yeast flocculation gene, FLO1, is representative of a distinct subset of subtelomeric genes that are robustly repressed by the Cyc8-Tup1 complex."	Cyc8|852410	151|155	FLO1|851289	49|53	Negative_Regulation
25106892	S2	"We demonstrate that the yeast flocculation gene, FLO1, is representative of a distinct subset of subtelomeric genes that are robustly repressed by the Cyc8-Tup1 complex."	Tup1|850445	156|160	FLO1|851289	49|53	Negative_Regulation
25106892	S7	"The yeast histone deacetylases, Hda1p and Rpd3p, occupy the repressed FLO1 promoter region in a Cyc8-Tup1 dependent manner and coordinate histone deacetylation, nucleosome stabilisation and gene repression."	Hda1p|855710	32|37	FLO1|851289	70|74	Binding
25106892	S7	"The yeast histone deacetylases, Hda1p and Rpd3p, occupy the repressed FLO1 promoter region in a Cyc8-Tup1 dependent manner and coordinate histone deacetylation, nucleosome stabilisation and gene repression."	Rpd3p|855386	42|47	FLO1|851289	70|74	Binding
25106892	S9	"These data suggest that distinctly bound Cyc8-Tup1 cooperates with Hda1p and Rpd3p to establish or maintain an extensive array of strongly positioned, deacetylated nucleosomes over the FLO1 promoter and upstream region which inhibit histone acetylation, block Swi-Snf binding and prevent transcription."	Cyc8|852410	41|45	Hda1p|855710	67|72	Association
25106892	S9	"These data suggest that distinctly bound Cyc8-Tup1 cooperates with Hda1p and Rpd3p to establish or maintain an extensive array of strongly positioned, deacetylated nucleosomes over the FLO1 promoter and upstream region which inhibit histone acetylation, block Swi-Snf binding and prevent transcription."	Cyc8|852410	41|45	Rpd3p|855386	77|82	Association
25106892	S9	"These data suggest that distinctly bound Cyc8-Tup1 cooperates with Hda1p and Rpd3p to establish or maintain an extensive array of strongly positioned, deacetylated nucleosomes over the FLO1 promoter and upstream region which inhibit histone acetylation, block Swi-Snf binding and prevent transcription."	Tup1|850445	46|50	Hda1p|855710	67|72	Association
25106892	S9	"These data suggest that distinctly bound Cyc8-Tup1 cooperates with Hda1p and Rpd3p to establish or maintain an extensive array of strongly positioned, deacetylated nucleosomes over the FLO1 promoter and upstream region which inhibit histone acetylation, block Swi-Snf binding and prevent transcription."	Tup1|850445	46|50	Rpd3p|855386	77|82	Association
25114259	S1	Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2.	protocadherin 15|503521	17|33	TMC1|567237	85|89	Association
25114259	S1	Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2.	protocadherin 15|503521	17|33	TMC2|192140	94|98	Association
25114259	S5	"Using a membrane-based two-hybrid screen to identify proteins that bind to PCDH15, we detected an interaction between zebrafish Pcdh15a and an N-terminal fragment of transmembrane channel-like 2a (Tmc2a)."	Pcdh15a|368476	128|135	transmembrane channel-like 2a (Tmc2a)|571240	166|203	Association
25114259	S7	"Using the above-mentioned two-hybrid assay, we found that zebrafish Tmc1 and Tmc2a can interact with the CD1 or CD3 cytoplasmic domain isoforms of Pcdh15a, and this interaction depends on the common region shared between the two Pcdh15 isoforms."	Tmc1|567237	68|72	Pcdh15a|368476	147|154	Association
25114259	S7	"Using the above-mentioned two-hybrid assay, we found that zebrafish Tmc1 and Tmc2a can interact with the CD1 or CD3 cytoplasmic domain isoforms of Pcdh15a, and this interaction depends on the common region shared between the two Pcdh15 isoforms."	Tmc2a|571240	77|82	Pcdh15a|368476	147|154	Association
25114259	S8	"Moreover, an interaction between mouse PCDH15-CD3 and TMC1 or TMC2 was observed in both yeast two-hybrid assays and coimmunoprecipitation experiments."	TMC1|13409	54|58	PCDH15|11994	39|45	Association
25114259	S8	"Moreover, an interaction between mouse PCDH15-CD3 and TMC1 or TMC2 was observed in both yeast two-hybrid assays and coimmunoprecipitation experiments."	TMC2|192140	62|66	PCDH15|11994	39|45	Association
25114259	S10	"Overexpression of the Tmc2a N terminus results in mislocalization of Pcdh15a within hair bundles, together with a significant decrease in mechanosensitive responses, suggesting that a Pcdh15a-Tmc complex is critical for mechanotransduction."	Tmc2a|571240	22|27	Pcdh15a|368476	69|76	Translocation
25130429	S4	"mRNA and protein expression levels of CNC b-zip transcription factors nuclear factor erythroid 2-related factor 1 (Nrf1), nuclear factor erythroid 2 related factor 2 (Nrf2), nuclear factor erythroid 2 related factor 3 (Nrf3), and Nrf2-regulated antioxidant enzymes superoxide dismutase 3 (SOD3) and NAD(P)H: quinone oxidoreductase 1 (NQO1) were quantified."	Nrf2|4780	230|234	superoxide dismutase 3 (SOD3)|6649	265|294	Neutral_Regulation
25130429	S4	"mRNA and protein expression levels of CNC b-zip transcription factors nuclear factor erythroid 2-related factor 1 (Nrf1), nuclear factor erythroid 2 related factor 2 (Nrf2), nuclear factor erythroid 2 related factor 3 (Nrf3), and Nrf2-regulated antioxidant enzymes superoxide dismutase 3 (SOD3) and NAD(P)H: quinone oxidoreductase 1 (NQO1) were quantified."	Nrf2|4780	230|234	NAD(P)H: quinone oxidoreductase 1 (NQO1)|1728	299|339	Neutral_Regulation
25138157	S1	Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCa-p38-SP-1 pathway.	CD44|960	88|92	E-selectin|6401	110|120	Association
25138157	S8	"Protein kinase Ca (PKC-a) activation was found to be the downstream target of the CD44/selectin-initiated signaling, as ICAM-1 elevation was inhibited by siRNA targeting PKCa or a dominant negative form of PKCa (PKCa DN)."	PKCa|5578	212|216	ICAM-1|3383	120|126	Negative_Regulation
25138157	S8	"Protein kinase Ca (PKC-a) activation was found to be the downstream target of the CD44/selectin-initiated signaling, as ICAM-1 elevation was inhibited by siRNA targeting PKCa or a dominant negative form of PKCa (PKCa DN)."	PKCa|5578	206|210	ICAM-1|3383	120|126	Negative_Regulation
25138157	S8	"Protein kinase Ca (PKC-a) activation was found to be the downstream target of the CD44/selectin-initiated signaling, as ICAM-1 elevation was inhibited by siRNA targeting PKCa or a dominant negative form of PKCa (PKCa DN)."	PKCa|5578	170|174	ICAM-1|3383	120|126	Negative_Regulation
25159185	S4	"The goals of this study were twofold: first, to investigate the complexity of neurotrophin-induced FRS2 interactions in primary cortical neurons and to determine which pathway(s) are important in regulating neuronal growth and, second, to determine whether the related signaling adapter, FRS3, stimulates neuron growth comparable to FRS2."	neurotrophin|627	78|90	FRS2|10818	99|103	Positive_Regulation
25159185	S5	"We find that neurotrophin treatment of primary cortical neurons stimulates the tyrosine phosphorylation of FRS2 and the subsequent recruitment of Shp2, Grb2, and Gab2."	FRS2|10818	107|111	neurotrophin|627	13|25	Modification
25159185	S5	"We find that neurotrophin treatment of primary cortical neurons stimulates the tyrosine phosphorylation of FRS2 and the subsequent recruitment of Shp2, Grb2, and Gab2."	neurotrophin|627	13|25	Shp2|5781	146|150	Translocation
25159185	S5	"We find that neurotrophin treatment of primary cortical neurons stimulates the tyrosine phosphorylation of FRS2 and the subsequent recruitment of Shp2, Grb2, and Gab2."	neurotrophin|627	13|25	Grb2|2885	152|156	Translocation
25159185	S5	"We find that neurotrophin treatment of primary cortical neurons stimulates the tyrosine phosphorylation of FRS2 and the subsequent recruitment of Shp2, Grb2, and Gab2."	neurotrophin|627	13|25	Gab2|9846	162|166	Translocation
25159185	S6	"With FRS2 mutants deficient in Grb2 or Shp2 binding, we demonstrate that FRS2 binds Gab1 and Gab2 through Grb2, providing an alternative route to activate PI3 kinase and Shp2."	FRS2|10818	73|77	Gab1|2549	84|88	Binding
25159185	S6	"With FRS2 mutants deficient in Grb2 or Shp2 binding, we demonstrate that FRS2 binds Gab1 and Gab2 through Grb2, providing an alternative route to activate PI3 kinase and Shp2."	FRS2|10818	73|77	Gab2|9846	93|97	Binding
25159185	S6	"With FRS2 mutants deficient in Grb2 or Shp2 binding, we demonstrate that FRS2 binds Gab1 and Gab2 through Grb2, providing an alternative route to activate PI3 kinase and Shp2."	Grb2|2885	106|110	FRS2|10818	73|77	Interaction_Agent
25170085	S1	"Protein Hit1, a novel box C/D snoRNP assembly factor, controls cellular concentration of the scaffolding protein Rsa1 by direct interaction."	Rsa1|855908	113|117	Hit1|853516	8|12	Neutral_Regulation
25170085	S2	"Biogenesis of eukaryotic box C/D small nucleolar ribonucleoprotein particles (C/D snoRNPs) involves conserved trans-acting factors, which are proposed to facilitate the assembly of the core proteins Snu13p/15.5K, Nop58p/NOP58, Nop56p/NOP56 and Nop1p/Fibrillarin on box C/D small nucleolar RNAs (C/D snoRNAs)."	Snu13p/15.5K|4809	199|211	Nop58p/NOP58|51602	213|225	Complex
25170085	S2	"Biogenesis of eukaryotic box C/D small nucleolar ribonucleoprotein particles (C/D snoRNPs) involves conserved trans-acting factors, which are proposed to facilitate the assembly of the core proteins Snu13p/15.5K, Nop58p/NOP58, Nop56p/NOP56 and Nop1p/Fibrillarin on box C/D small nucleolar RNAs (C/D snoRNAs)."	Snu13p/15.5K|4809	199|211	Nop56p/NOP56|10528	227|239	Complex
25170085	S2	"Biogenesis of eukaryotic box C/D small nucleolar ribonucleoprotein particles (C/D snoRNPs) involves conserved trans-acting factors, which are proposed to facilitate the assembly of the core proteins Snu13p/15.5K, Nop58p/NOP58, Nop56p/NOP56 and Nop1p/Fibrillarin on box C/D small nucleolar RNAs (C/D snoRNAs)."	Snu13p/15.5K|4809	199|211	Nop1p/Fibrillarin|2091	244|261	Complex
25170085	S2	"Biogenesis of eukaryotic box C/D small nucleolar ribonucleoprotein particles (C/D snoRNPs) involves conserved trans-acting factors, which are proposed to facilitate the assembly of the core proteins Snu13p/15.5K, Nop58p/NOP58, Nop56p/NOP56 and Nop1p/Fibrillarin on box C/D small nucleolar RNAs (C/D snoRNAs)."	Nop58p/NOP58|51602	213|225	Nop56p/NOP56|10528	227|239	Complex
25170085	S2	"Biogenesis of eukaryotic box C/D small nucleolar ribonucleoprotein particles (C/D snoRNPs) involves conserved trans-acting factors, which are proposed to facilitate the assembly of the core proteins Snu13p/15.5K, Nop58p/NOP58, Nop56p/NOP56 and Nop1p/Fibrillarin on box C/D small nucleolar RNAs (C/D snoRNAs)."	Nop58p/NOP58|51602	213|225	Nop1p/Fibrillarin|2091	244|261	Complex
25170085	S2	"Biogenesis of eukaryotic box C/D small nucleolar ribonucleoprotein particles (C/D snoRNPs) involves conserved trans-acting factors, which are proposed to facilitate the assembly of the core proteins Snu13p/15.5K, Nop58p/NOP58, Nop56p/NOP56 and Nop1p/Fibrillarin on box C/D small nucleolar RNAs (C/D snoRNAs)."	Nop56p/NOP56|10528	227|239	Nop1p/Fibrillarin|2091	244|261	Complex
25170085	S3	"In yeast, protein Rsa1 acts as a platform, interacting with both the RNA-binding core protein Snu13 and protein Pih1 of the Hsp82-R2TP chaperone complex."	Snu13|856687	94|99	Rsa1|855908	18|22	Association
25170085	S3	"In yeast, protein Rsa1 acts as a platform, interacting with both the RNA-binding core protein Snu13 and protein Pih1 of the Hsp82-R2TP chaperone complex."	Pih1|856429	112|116	Rsa1|855908	18|22	Association
25170085	S4	"In this work, a proteomic approach coupled with functional and structural studies identifies protein Hit1 as a novel Rsa1p-interacting partner involved in C/D snoRNP assembly."	Hit1|853516	101|105	Rsa1p|855908	117|122	Interaction_Agent
25170085	S7	"Remarkably, Hit1p is required to maintain steady-state levels of Rsa1p."	Hit1p|853516	12|17	Rsa1p|855908	65|70	Association
25170085	S8	"This stabilizing activity is likely to be general across eukaryotic species, as the human protein ZNHIT3(TRIP3) showing sequence homology with Hit1p regulates the abundance of NUFIP1, the Rsa1p functional homolog."	ZNHIT3(TRIP3)|9326	98|111	NUFIP1|26747	176|182	Neutral_Regulation
25170085	S9	The nuclear magnetic resonance solution structure of the Rsa1p317-352-Hit1p70-164 complex reveals a novel mode of protein-protein association explaining the strong stability of the Rsa1p-Hit1p complex.	Rsa1p|855908	181|186	Hit1p|853516	187|192	Complex
25170085	S9	The nuclear magnetic resonance solution structure of the Rsa1p317-352-Hit1p70-164 complex reveals a novel mode of protein-protein association explaining the strong stability of the Rsa1p-Hit1p complex.	Rsa1p|855908	57|62	Hit1p|853516	70|75	Complex
25170085	S10	Our biochemical data show that C/D snoRNAs and the core protein Nop58 can interact with the purified Snu13p-Rsa1p-Hit1p heterotrimer.	Nop58|854487	64|69	Snu13p|856687	101|107	Association
25170085	S10	Our biochemical data show that C/D snoRNAs and the core protein Nop58 can interact with the purified Snu13p-Rsa1p-Hit1p heterotrimer.	Nop58|854487	64|69	Rsa1p|855908	108|113	Association
25170085	S10	Our biochemical data show that C/D snoRNAs and the core protein Nop58 can interact with the purified Snu13p-Rsa1p-Hit1p heterotrimer.	Nop58|854487	64|69	Hit1p|853516	114|119	Association
25170085	S10	Our biochemical data show that C/D snoRNAs and the core protein Nop58 can interact with the purified Snu13p-Rsa1p-Hit1p heterotrimer.	Snu13p|856687	101|107	Rsa1p|855908	108|113	Complex
25170085	S10	Our biochemical data show that C/D snoRNAs and the core protein Nop58 can interact with the purified Snu13p-Rsa1p-Hit1p heterotrimer.	Snu13p|856687	101|107	Hit1p|853516	114|119	Complex
25170085	S10	Our biochemical data show that C/D snoRNAs and the core protein Nop58 can interact with the purified Snu13p-Rsa1p-Hit1p heterotrimer.	Rsa1p|855908	108|113	Hit1p|853516	114|119	Complex
25170834	S7	"In addition, at the post-translational level, HIV-1 Vpr induced the phosphorylation of STAT1 at tyrosine 701 in human MDMs."	Vpr|155807	52|55	STAT1|6772	87|92	Modification
25172512	S1	The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7.	TPP1|1200	24|28	USP7|7874	96|100	Interaction_Agent
25172512	S3	"Here we identify USP7 as a novel interacting protein of the oligonucleotide/oligosaccharide-binding fold of TPP1, which was previously known to recruit telomerase to telomeres."	USP7|7874	17|21	TPP1|1200	108|112	Interaction_Agent
25172512	S4	We identify amino acids in TPP1 and USP7 that are critical for their interaction and multiple lysines within TPP1 that are oligo-ubiquitinated and deubiquitinated by USP7.	USP7|7874	166|170	TPP1|1200	109|113	Modification
25172512	S4	We identify amino acids in TPP1 and USP7 that are critical for their interaction and multiple lysines within TPP1 that are oligo-ubiquitinated and deubiquitinated by USP7.	TPP1|1200	27|31	USP7|7874	36|40	Association
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	CTC1|80169	119|123	STN1|79991	124|128	Complex
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	CTC1|80169	119|123	TEN1|100134934	129|133	Complex
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	STN1|79991	124|128	TEN1|100134934	129|133	Complex
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	TPP1|1200	93|97	TIN2|26277	103|107	Association
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	TPP1|1200	93|97	POT1|25913	109|113	Association
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	TPP1|1200	93|97	CTC1|80169	119|123	Association
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	TPP1|1200	93|97	STN1|79991	124|128	Association
25172512	S6	"Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase."	TPP1|1200	93|97	TEN1|100134934	129|133	Association
25184681	S5	"Among the new interacting proteins identified, genetic interactions were detected between BRCA1 and four of the interactors: TONSL, SETX, TCEANC, and TCEA2."	BRCA1|672	90|95	TONSL|4796	125|130	Association
25184681	S5	"Among the new interacting proteins identified, genetic interactions were detected between BRCA1 and four of the interactors: TONSL, SETX, TCEANC, and TCEA2."	BRCA1|672	90|95	SETX|23064	132|136	Association
25184681	S5	"Among the new interacting proteins identified, genetic interactions were detected between BRCA1 and four of the interactors: TONSL, SETX, TCEANC, and TCEA2."	BRCA1|672	90|95	TCEANC|170082	138|144	Association
25184681	S5	"Among the new interacting proteins identified, genetic interactions were detected between BRCA1 and four of the interactors: TONSL, SETX, TCEANC, and TCEA2."	BRCA1|672	90|95	TCEA2|6919	150|155	Association
25201876	S7	We show that the products of these genes along with the Bip1-interacting protein RpS8 (Ribosomal protein S8) are required for the proper expression of Pvr.	RpS8 (Ribosomal protein S8)|43532	81|108	Bip1|38891	56|60	Interaction_Agent
25201876	S7	We show that the products of these genes along with the Bip1-interacting protein RpS8 (Ribosomal protein S8) are required for the proper expression of Pvr.	Pvr|34127	151|154	RpS8 (Ribosomal protein S8)|43532	81|108	Association
25202022	S1	"C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-kB activation."	dectin-3|338339	23|31	Mincle|56619	81|87	Neutral_Regulation
25202022	S1	"C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-kB activation."	nuclear factor (NF)-kB|4790	135|157	CARD9|332579	107|112	Association
25202022	S1	"C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-kB activation."	nuclear factor (NF)-kB|4790	135|157	Bcl10|12042	113|118	Association
25202022	S1	"C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-kB activation."	nuclear factor (NF)-kB|4790	135|157	MALT1|240354	119|124	Association
25202022	S1	"C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-kB activation."	dectin-3|338339	23|31	nuclear factor (NF)-kB|4790	135|157	Interaction_Agent
25202022	S3	"Interestingly, stimulation of Dectin-3 by TDM can also induce Mincle expression, which may enhance the host innate immune system to sense Mycobacterium infection."	Mincle|56619	62|68	Dectin-3|338339	30|38	Positive_Regulation
25202022	S4	"However, the mechanism by which Dectin-3 induces Mincle expression is not fully defined."	Mincle|56619	49|55	Dectin-3|338339	32|40	Positive_Regulation
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	CARD9|332579	204|209	BCL10|12042	210|215	Complex
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	CARD9|332579	204|209	MALT1|240354	216|221	Complex
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	BCL10|12042	210|215	MALT1|240354	216|221	Complex
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	NF-kB|4790	83|88	Mincle|56619	31|37	Association
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	Dectin-3|338339	65|73	NF-kB|4790	83|88	Neutral_Regulation
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	NF-kB|4790	175|180	Dectin-3|338339	158|166	Positive_Regulation
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	CARD9|332579	204|209	Dectin-3|338339	158|166	Interaction_Agent
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	BCL10|12042	210|215	Dectin-3|338339	158|166	Interaction_Agent
25202022	S5	"Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-kB, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-kB activation through the CARD9-BCL10-MALT1 complex."	MALT1|240354	216|221	Dectin-3|338339	158|166	Interaction_Agent
25202022	S8	"Consistently, inhibition of NF-kB, but not NFAT, impaired TDM-induced Mincle expression, whereas NF-kB, but not NFAT, binds to the Mincle promoter."	NF-kB|4790	28|33	Mincle|56619	70|76	Negative_Regulation
25202022	S8	"Consistently, inhibition of NF-kB, but not NFAT, impaired TDM-induced Mincle expression, whereas NF-kB, but not NFAT, binds to the Mincle promoter."	NF-kB|4790	97|102	Mincle|56619	131|137	Binding
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	CARD9|332579	55|60	Bcl10|12042	61|66	Complex
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	CARD9|332579	55|60	MALT1|240354	67|72	Complex
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	Bcl10|12042	61|66	MALT1|240354	67|72	Complex
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	CARD9|332579	55|60	NF-kB|4790	18|23	Association
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	Bcl10|12042	61|66	NF-kB|4790	18|23	Association
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	MALT1|240354	67|72	NF-kB|4790	18|23	Association
25202022	S9	Dectin-3-mediated NF-kB activation is dependent on the CARD9-Bcl10-MALT1 complex.	Dectin-3|338339	0|8	NF-kB|4790	18|23	Neutral_Regulation
25202022	S11	"Overall, this study provides the mechanism by which Dectin-3 induces Mincle expression in response to Mycobacterium infection, which will have significant impact to improve adjuvant and design vaccine for antimicrobial infection."	Dectin-3|338339	52|60	Mincle|56619	69|75	Positive_Regulation
25216524	S3	We have recently reported that AR is deubiquitinated and stabilised by Usp12 resulting in increased transcriptional activity.	AR|367	31|33	Usp12|219333	71|76	Modification
25216524	S3	We have recently reported that AR is deubiquitinated and stabilised by Usp12 resulting in increased transcriptional activity.	Usp12|219333	71|76	AR|367	31|33	Neutral_Regulation
25216524	S5	PHLPP and PHLPPL are pro-apoptotic phosphatases that dephosphorylate and subsequently deactivate Akt.	Akt|207	97|100	PHLPP|23239	0|5	Modification
25216524	S5	PHLPP and PHLPPL are pro-apoptotic phosphatases that dephosphorylate and subsequently deactivate Akt.	Akt|207	97|100	PHLPPL|23035	10|16	Modification
25216524	S5	PHLPP and PHLPPL are pro-apoptotic phosphatases that dephosphorylate and subsequently deactivate Akt.	Akt|207	97|100	PHLPP|23239	0|5	Negative_Regulation
25216524	S5	PHLPP and PHLPPL are pro-apoptotic phosphatases that dephosphorylate and subsequently deactivate Akt.	Akt|207	97|100	PHLPPL|23035	10|16	Negative_Regulation
25216524	S6	Phosphorylated Akt is reported to deactivate AR in PC by phosphorylation at Ser213 and Ser791 leading to ligand dissociation and AR degradation.	AR|367	45|47	Akt|207	15|18	Negative_Regulation
25216524	S6	Phosphorylated Akt is reported to deactivate AR in PC by phosphorylation at Ser213 and Ser791 leading to ligand dissociation and AR degradation.	AR|367	129|131	Akt|207	15|18	Negative_Regulation
25216524	S7	"In contrast, PHLPP- and PHLPPL-mediated dephosphorylation and inactivation of Akt elevates the levels of active AR."	AR|367	112|114	Akt|207	78|81	Positive_Regulation
25216524	S7	"In contrast, PHLPP- and PHLPPL-mediated dephosphorylation and inactivation of Akt elevates the levels of active AR."	Akt|207	78|81	PHLPP|23239	13|18	Negative_Regulation
25216524	S7	"In contrast, PHLPP- and PHLPPL-mediated dephosphorylation and inactivation of Akt elevates the levels of active AR."	Akt|207	78|81	PHLPPL|23035	24|30	Negative_Regulation
25216524	S7	"In contrast, PHLPP- and PHLPPL-mediated dephosphorylation and inactivation of Akt elevates the levels of active AR."	PHLPPL|23035	24|30	Akt|207	78|81	Modification
25216524	S7	"In contrast, PHLPP- and PHLPPL-mediated dephosphorylation and inactivation of Akt elevates the levels of active AR."	PHLPP|23239	13|18	Akt|207	78|81	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Usp12|219333	35|40	Uaf-1|57599	58|63	Complex
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Usp12|219333	35|40	WDR20|91833	68|73	Complex
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Uaf-1|57599	58|63	WDR20|91833	68|73	Complex
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	Usp12|219333	35|40	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	Uaf-1|57599	58|63	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	WDR20|91833	68|73	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPPL|23035	146|152	Usp12|219333	35|40	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPPL|23035	146|152	Uaf-1|57599	58|63	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPPL|23035	146|152	WDR20|91833	68|73	Modification
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	Usp12|219333	35|40	Neutral_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	Uaf-1|57599	58|63	Neutral_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	WDR20|91833	68|73	Neutral_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPPL|23035	146|152	Usp12|219333	35|40	Neutral_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPPL|23035	146|152	Uaf-1|57599	58|63	Neutral_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPPL|23035	146|152	WDR20|91833	68|73	Neutral_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	PHLPP|23239	136|141	Akt|207	119|122	Interaction_Agent
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Akt|207	119|122	PHLPPL|23035	146|152	Interaction_Agent
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Akt|207	194|197	Usp12|219333	35|40	Negative_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Akt|207	194|197	Uaf-1|57599	58|63	Negative_Regulation
25216524	S8	"In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, directly deubiquitinates and stabilises the Akt phosphatases PHLPP and PHLPPL resulting in decreased levels of active pAkt."	Akt|207	194|197	WDR20|91833	68|73	Negative_Regulation
25216524	S9	Decreased pAkt in turn down-regulates AR Ser213 phosphorylation resulting in enhanced receptor stability and transcriptional activity.	AR|367	38|40	Akt|207	11|14	Modification
25224329	S1	Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP.	GABARAP|11337	117|124	Mulan|79594	0|5	Translocation
25224329	S6	"Our studies identified four different E2 conjugating enzymes (Ube2E2, Ube2E3, Ube2G2 and Ube2L3) as specific interactors of Mulan."	Mulan|79594	124|129	Ube2E2|7325	62|68	Interaction_Agent
25224329	S6	"Our studies identified four different E2 conjugating enzymes (Ube2E2, Ube2E3, Ube2G2 and Ube2L3) as specific interactors of Mulan."	Mulan|79594	124|129	Ube2E3|10477	70|76	Interaction_Agent
25224329	S6	"Our studies identified four different E2 conjugating enzymes (Ube2E2, Ube2E3, Ube2G2 and Ube2L3) as specific interactors of Mulan."	Mulan|79594	124|129	Ube2G2|7327	78|84	Interaction_Agent
25224329	S6	"Our studies identified four different E2 conjugating enzymes (Ube2E2, Ube2E3, Ube2G2 and Ube2L3) as specific interactors of Mulan."	Mulan|79594	124|129	Ube2L3|7332	89|95	Interaction_Agent
25224329	S9	One such specific interactor of Mulan-Ube2E3 was the GABARAP (GABAA receptor-associated protein).	GABARAP (GABAA receptor-associated protein)|11337	53|96	Mulan|79594	32|37	Interaction_Agent
25224329	S9	One such specific interactor of Mulan-Ube2E3 was the GABARAP (GABAA receptor-associated protein).	GABARAP (GABAA receptor-associated protein)|11337	53|96	Ube2E3|10477	38|44	Interaction_Agent
25224329	S11	The interaction of GABARAP with Mulan-Ube2E3 required an LC3-interacting region (LIR) located in the RING finger domain of Mulan as well as the presence of Ube2E3.	GABARAP|11337	19|26	Mulan|79594	32|37	Association
25224329	S11	The interaction of GABARAP with Mulan-Ube2E3 required an LC3-interacting region (LIR) located in the RING finger domain of Mulan as well as the presence of Ube2E3.	GABARAP|11337	19|26	Ube2E3|10477	38|44	Association
25224329	S13	"In addition, the interaction of GABARAP with Mulan-Ube2E3 supports the role of Mulan as an important regulator of mitophagy and provides a plausible mechanism for its function in this process."	GABARAP|11337	32|39	Mulan|79594	45|50	Association
25224329	S13	"In addition, the interaction of GABARAP with Mulan-Ube2E3 supports the role of Mulan as an important regulator of mitophagy and provides a plausible mechanism for its function in this process."	GABARAP|11337	32|39	Ube2E3|10477	51|57	Association
25225333	S1	Plakophilins 1 and 3 bind to FXR1 and thereby influence the mRNA stability of desmosomal proteins.	Plakophilins 1|5317	0|14	FXR1|8087	29|33	Binding
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PKP1|5317	26|30	FXR1|8087	78|82	Association
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PKP1|5317	26|30	G3BP|10146	84|88	Association
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PKP1|5317	26|30	PABPC1|26986	90|96	Association
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PKP1|5317	26|30	UPF1|5976	102|106	Association
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	FXR1|8087	78|82	G3BP|10146	84|88	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	FXR1|8087	78|82	PABPC1|26986	90|96	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	FXR1|8087	78|82	UPF1|5976	102|106	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	FXR1|8087	78|82	PKP1|5317	118|122	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	FXR1|8087	78|82	desmoplakin|1832	150|161	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	FXR1|8087	78|82	PKP2|5318	166|170	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	G3BP|10146	84|88	PABPC1|26986	90|96	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	G3BP|10146	84|88	UPF1|5976	102|106	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	G3BP|10146	84|88	PKP1|5317	118|122	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	G3BP|10146	84|88	desmoplakin|1832	150|161	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	G3BP|10146	84|88	PKP2|5318	166|170	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PABPC1|26986	90|96	UPF1|5976	102|106	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PABPC1|26986	90|96	PKP1|5317	118|122	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PABPC1|26986	90|96	desmoplakin|1832	150|161	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PABPC1|26986	90|96	PKP2|5318	166|170	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	UPF1|5976	102|106	PKP1|5317	118|122	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	UPF1|5976	102|106	desmoplakin|1832	150|161	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	UPF1|5976	102|106	PKP2|5318	166|170	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PKP1|5317	118|122	desmoplakin|1832	150|161	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	PKP1|5317	118|122	PKP2|5318	166|170	Complex
25225333	S4	"We found that cytoplasmic PKP1/3 coprecipitated with the RNA-binding proteins FXR1, G3BP, PABPC1, and UPF1, and these PKP1/3 complexes also comprised desmoplakin and PKP2 mRNAs."	desmoplakin|1832	150|161	PKP2|5318	166|170	Complex
25225333	S5	"Moreover, we showed that the interaction of PKP1/3 with G3BP, PABPC1, and UPF1 but not with FXR1 was RNase sensitive."	PKP1|5317	44|48	G3BP|10146	56|60	Association
25225333	S5	"Moreover, we showed that the interaction of PKP1/3 with G3BP, PABPC1, and UPF1 but not with FXR1 was RNase sensitive."	PKP1|5317	44|48	PABPC1|26986	62|68	Association
25225333	S5	"Moreover, we showed that the interaction of PKP1/3 with G3BP, PABPC1, and UPF1 but not with FXR1 was RNase sensitive."	PKP1|5317	44|48	UPF1|5976	74|78	Association
25225333	S5	"Moreover, we showed that the interaction of PKP1/3 with G3BP, PABPC1, and UPF1 but not with FXR1 was RNase sensitive."	PKP1|5317	44|48	FXR1|8087	92|96	Negation_Association
25225333	S9	"Furthermore, binding of PKP1/3 to FXR1 was RNA independent, and both PKP3 and FXR1 stabilized PKP2 mRNA."	PKP1|5317	24|28	FXR1|8087	34|38	Binding
25225333	S9	"Furthermore, binding of PKP1/3 to FXR1 was RNA independent, and both PKP3 and FXR1 stabilized PKP2 mRNA."	PKP3|11187	69|73	PKP2|5318	94|98	Neutral_Regulation
25225333	S9	"Furthermore, binding of PKP1/3 to FXR1 was RNA independent, and both PKP3 and FXR1 stabilized PKP2 mRNA."	FXR1|8087	78|82	PKP2|5318	94|98	Neutral_Regulation
25228646	S1	"Drosophila TAP/p32 is a core histone chaperone that cooperates with NAP-1, NLP, and nucleophosmin in sperm chromatin remodeling during fertilization."	TAP/p32|37006	11|18	NAP-1|37798	68|73	Association
25228646	S1	"Drosophila TAP/p32 is a core histone chaperone that cooperates with NAP-1, NLP, and nucleophosmin in sperm chromatin remodeling during fertilization."	TAP/p32|37006	11|18	NLP|43560	75|78	Association
25228646	S1	"Drosophila TAP/p32 is a core histone chaperone that cooperates with NAP-1, NLP, and nucleophosmin in sperm chromatin remodeling during fertilization."	TAP/p32|37006	11|18	nucleophosmin|43559	84|97	Association
25228646	S6	"We show that TAP/p32 is required for the removal of Drosophila protamine B in vitro, whereas NAP-1, NLP, and Nph share roles in the removal of protamine A."	TAP/p32|37006	13|20	protamine B|34867	63|74	Association
25231745	S1	SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.	JAK2|3717	71|75	SRSF2|6427	0|5	Association
25231745	S1	SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.	JAK2|3717	71|75	U2AF1|7307	10|15	Association
25231745	S1	SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.	MPL|4352	80|83	SRSF2|6427	0|5	Association
25231745	S1	SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.	MPL|4352	80|83	U2AF1|7307	10|15	Association
25231745	S1	SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.	calreticulin|811	92|104	SRSF2|6427	0|5	Negation_Association
25231745	S1	SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation.	calreticulin|811	92|104	U2AF1|7307	10|15	Negation_Association
25236186	S1	"miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs."	RhoC|389	117|121	miR-10b|406903	0|7	Interaction_Agent
25236186	S1	"miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs."	uPAR|5329	123|127	miR-10b|406903	0|7	Interaction_Agent
25236186	S10	"We also showed that HOXD10 was negatively regulated by miR-10b at the posttranscriptional level, via a specific target site within the 3'UTR by luciferase reporter assay."	miR-10b|406903	55|62	HOXD10|3236	20|26	Negative_Regulation
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	miR-10b|406903	27|34	RhoC|389	112|116	Neutral_Regulation
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	miR-10b|406903	27|34	uPAR|5329	118|122	Neutral_Regulation
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	miR-10b|406903	27|34	MMP-2|4313	124|129	Neutral_Regulation
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	miR-10b|406903	27|34	MMP-9|4318	134|139	Neutral_Regulation
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	RhoC|389	112|116	HOXD10|3236	93|99	Interaction_Agent
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	uPAR|5329	118|122	HOXD10|3236	93|99	Interaction_Agent
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	MMP-2|4313	124|129	HOXD10|3236	93|99	Interaction_Agent
25236186	S11	"Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression."	MMP-9|4318	134|139	HOXD10|3236	93|99	Interaction_Agent
25241761	S9	"The top 2 connected cross-talk PPIs are MAPK3-DAPK1 and FAS-PRKCA interactions, which link 9 and 8 pathways, respectively."	MAPK3|5595	40|45	DAPK1|1612	46|51	Association
25241761	S9	"The top 2 connected cross-talk PPIs are MAPK3-DAPK1 and FAS-PRKCA interactions, which link 9 and 8 pathways, respectively."	FAS|355	56|59	PRKCA|5578	60|65	Association
25247923	S8	"Loss of Trr1 induced Yap1 nuclear accumulation and over-expression of a set of Yap1-regulated oxido-reductases with antioxidant properties that ultimately re-equilibrate intracellular redox environment, reducing substantially ROS-associated DNA damages."	Yap1|855005	21|25	Trr1|851955	8|12	Translocation
25313037	S1	XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.	HIPK2|28996	69|74	XAF1|54739	0|4	Positive_Regulation
25313037	S1	XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.	ZNF313|55905	79|85	XAF1|54739	0|4	Positive_Regulation
25313037	S1	XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.	XAF1|54739	0|4	p53|7157	33|36	Neutral_Regulation
25313037	S5	XAF1 binds directly to the N-terminal proline-rich domain of p53 and thus interferes with E3 ubiquitin ligase MDM2 binding and ubiquitination of p53.	XAF1|54739	0|4	p53|7157	61|64	Binding
25313037	S5	XAF1 binds directly to the N-terminal proline-rich domain of p53 and thus interferes with E3 ubiquitin ligase MDM2 binding and ubiquitination of p53.	MDM2|4193	110|114	p53|7157	145|148	Binding
25313037	S5	XAF1 binds directly to the N-terminal proline-rich domain of p53 and thus interferes with E3 ubiquitin ligase MDM2 binding and ubiquitination of p53.	MDM2|4193	110|114	p53|7157	145|148	Modification
25313037	S5	XAF1 binds directly to the N-terminal proline-rich domain of p53 and thus interferes with E3 ubiquitin ligase MDM2 binding and ubiquitination of p53.	XAF1|54739	0|4	MDM2|4193	110|114	Negative_Regulation
25313037	S6	XAF1 stimulates homeodomain-interacting protein kinase 2 (HIPK2)-mediated Ser-46 phosphorylation of p53 by blocking E3 ubiquitin ligase Siah2 interaction with and ubiquitination of HIPK2.	p53|7157	100|103	homeodomain-interacting protein kinase 2 (HIPK2)|28996	16|64	Modification
25313037	S6	XAF1 stimulates homeodomain-interacting protein kinase 2 (HIPK2)-mediated Ser-46 phosphorylation of p53 by blocking E3 ubiquitin ligase Siah2 interaction with and ubiquitination of HIPK2.	Siah2|6478	136|141	HIPK2|28996	181|186	Association
25313037	S6	XAF1 stimulates homeodomain-interacting protein kinase 2 (HIPK2)-mediated Ser-46 phosphorylation of p53 by blocking E3 ubiquitin ligase Siah2 interaction with and ubiquitination of HIPK2.	XAF1|54739	0|4	Siah2|6478	136|141	Negative_Regulation
25313037	S6	XAF1 stimulates homeodomain-interacting protein kinase 2 (HIPK2)-mediated Ser-46 phosphorylation of p53 by blocking E3 ubiquitin ligase Siah2 interaction with and ubiquitination of HIPK2.	p53|7157	100|103	XAF1|54739	0|4	Modification
25313037	S6	XAF1 stimulates homeodomain-interacting protein kinase 2 (HIPK2)-mediated Ser-46 phosphorylation of p53 by blocking E3 ubiquitin ligase Siah2 interaction with and ubiquitination of HIPK2.	HIPK2|28996	181|186	Siah2|6478	136|141	Modification
25313037	S6	XAF1 stimulates homeodomain-interacting protein kinase 2 (HIPK2)-mediated Ser-46 phosphorylation of p53 by blocking E3 ubiquitin ligase Siah2 interaction with and ubiquitination of HIPK2.	HIPK2|28996	181|186	XAF1|54739	0|4	Negation_Modification
25313037	S7	"XAF1 also steps up the termination of p53-mediated cell-cycle arrest by activating zinc finger protein 313 (ZNF313), a p21(WAF1)-targeting ubiquitin E3 ligase."	zinc finger protein 313 (ZNF313)|55905	83|115	XAF1|54739	0|4	Positive_Regulation
25313037	S7	"XAF1 also steps up the termination of p53-mediated cell-cycle arrest by activating zinc finger protein 313 (ZNF313), a p21(WAF1)-targeting ubiquitin E3 ligase."	zinc finger protein 313 (ZNF313)|55905	83|115	p21(WAF1)|1026	119|128	Binding
25313037	S8	"XAF1 interacts with p53, Siah2, and ZNF313 through the zinc finger domains 5, 6, and 7, respectively, and truncated XAF1 isoforms preferentially expressed in cancer cells fail to form a feedback loop with p53."	XAF1|54739	0|4	p53|7157	20|23	Association
25313037	S8	"XAF1 interacts with p53, Siah2, and ZNF313 through the zinc finger domains 5, 6, and 7, respectively, and truncated XAF1 isoforms preferentially expressed in cancer cells fail to form a feedback loop with p53."	XAF1|54739	0|4	Siah2|6478	25|30	Association
25313037	S8	"XAF1 interacts with p53, Siah2, and ZNF313 through the zinc finger domains 5, 6, and 7, respectively, and truncated XAF1 isoforms preferentially expressed in cancer cells fail to form a feedback loop with p53."	XAF1|54739	0|4	ZNF313|55905	36|42	Association
25320078	S5	"Here we used affinity chromatography of tumor cell extracts to identify LGALS3BP as a novel sialic acid-dependent ligand for human Siglec-9 and for other immunomodulatory Siglecs, such as Siglec-5 and Siglec-10."	LGALS3BP|3959	72|80	Siglec-9|27180	131|139	Interaction_Agent
25320078	S5	"Here we used affinity chromatography of tumor cell extracts to identify LGALS3BP as a novel sialic acid-dependent ligand for human Siglec-9 and for other immunomodulatory Siglecs, such as Siglec-5 and Siglec-10."	LGALS3BP|3959	72|80	Siglec-5|8778	188|196	Interaction_Agent
25320078	S5	"Here we used affinity chromatography of tumor cell extracts to identify LGALS3BP as a novel sialic acid-dependent ligand for human Siglec-9 and for other immunomodulatory Siglecs, such as Siglec-5 and Siglec-10."	LGALS3BP|3959	72|80	Siglec-10|89790	201|210	Interaction_Agent
25320078	S6	"In contrast, the mouse homolog Siglec-E binds to murine LGALS3BP with lower affinity."	Siglec-E|83382	31|39	LGALS3BP|19039	56|64	Binding
25320329	S3	"We previously showed that the HIV-1 structural protein Gag localizes to the uropod, a rear-end structure of polarized T cells, and that assembling Gag copatches with a subset, but not all, of the uropod-directed proteins, i.e., PSGL-1, CD43, and CD44, in nonpolarized T cells."	Gag|155030	147|150	PSGL-1|6404	228|234	Association
25320329	S3	"We previously showed that the HIV-1 structural protein Gag localizes to the uropod, a rear-end structure of polarized T cells, and that assembling Gag copatches with a subset, but not all, of the uropod-directed proteins, i.e., PSGL-1, CD43, and CD44, in nonpolarized T cells."	Gag|155030	147|150	CD43|6693	236|240	Association
25320329	S3	"We previously showed that the HIV-1 structural protein Gag localizes to the uropod, a rear-end structure of polarized T cells, and that assembling Gag copatches with a subset, but not all, of the uropod-directed proteins, i.e., PSGL-1, CD43, and CD44, in nonpolarized T cells."	Gag|155030	147|150	CD44|960	246|250	Association
25320329	S6	"Consistent with the findings of the T-cell copatching study, we found that basic residues within the matrix domain of Gag are required for Gag-PSGL-1 coclustering."	Gag|155030	139|142	PSGL-1|6404	143|149	Association
25320329	S6	"Consistent with the findings of the T-cell copatching study, we found that basic residues within the matrix domain of Gag are required for Gag-PSGL-1 coclustering."	Gag|155030	118|121	PSGL-1|6404	143|149	Association
25320329	S8	We also found that polybasic motifs present in the cytoplasmic tails of CD43 and CD44 also promote their coclustering with Gag.	CD43|6693	72|76	Gag|155030	123|126	Association
25320329	S8	We also found that polybasic motifs present in the cytoplasmic tails of CD43 and CD44 also promote their coclustering with Gag.	CD44|960	81|85	Gag|155030	123|126	Association
25320329	S9	"ICAM-1 and ICAM-3, uropod-directed proteins that do not copatch with Gag in T cells, and CD46, a non-uropod-directed protein, showed no or little coclustering with Gag."	Gag|155030	69|72	ICAM-1|3383	0|6	Negation_Association
25320329	S9	"ICAM-1 and ICAM-3, uropod-directed proteins that do not copatch with Gag in T cells, and CD46, a non-uropod-directed protein, showed no or little coclustering with Gag."	Gag|155030	69|72	ICAM-3|3385	11|17	Negation_Association
25320329	S9	"ICAM-1 and ICAM-3, uropod-directed proteins that do not copatch with Gag in T cells, and CD46, a non-uropod-directed protein, showed no or little coclustering with Gag."	Gag|155030	164|167	CD46|4179	89|93	Association
25320329	S9	"ICAM-1 and ICAM-3, uropod-directed proteins that do not copatch with Gag in T cells, and CD46, a non-uropod-directed protein, showed no or little coclustering with Gag."	CD46|4179	89|93	Gag|155030	164|167	Negation_Association
25320329	S10	"However, replacing their cytoplasmic tails with the cytoplasmic tail of PSGL-1 significantly enhanced their coclustering with Gag."	Gag|155030	126|129	PSGL-1|6404	72|78	Association
25320329	S14	"Notably, our previous study showed that HIV-1 structural protein Gag colocalizes with a group of uropod-directed transmembrane proteins, PSGL-1, CD43, and CD44, at the plasma membrane of T cells."	Gag|155030	65|68	PSGL-1|6404	137|143	Association
25320329	S14	"Notably, our previous study showed that HIV-1 structural protein Gag colocalizes with a group of uropod-directed transmembrane proteins, PSGL-1, CD43, and CD44, at the plasma membrane of T cells."	Gag|155030	65|68	CD43|6693	145|149	Association
25320329	S14	"Notably, our previous study showed that HIV-1 structural protein Gag colocalizes with a group of uropod-directed transmembrane proteins, PSGL-1, CD43, and CD44, at the plasma membrane of T cells."	Gag|155030	65|68	CD44|960	155|159	Association
25335082	S12	"Further, we found that Gpr22 does not act upstream of the two cilia master regulators, Foxj1a and Rfx2."	Gpr22|504167	23|28	Foxj1a|767737	87|93	Negation_Interaction_Agent
25335082	S12	"Further, we found that Gpr22 does not act upstream of the two cilia master regulators, Foxj1a and Rfx2."	Gpr22|504167	23|28	Rfx2|503590	98|102	Negation_Interaction_Agent
25355947	S1	COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A.	ATP7A|538	99|104	COMMD1|150684	0|6	Translocation
25355947	S3	"Here we report that COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62."	CCDC22|28952	123|129	CCDC93|54520	131|137	Complex
25355947	S3	"Here we report that COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62."	CCDC22|28952	123|129	C16orf62|57020	143|151	Complex
25355947	S3	"Here we report that COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62."	CCDC93|54520	131|137	C16orf62|57020	143|151	Complex
25355947	S3	"Here we report that COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62."	COMMD1|150684	20|26	CCDC22|28952	123|129	Association
25355947	S3	"Here we report that COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62."	COMMD1|150684	20|26	CCDC93|54520	131|137	Association
25355947	S3	"Here we report that COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62."	COMMD1|150684	20|26	C16orf62|57020	143|151	Association
25355947	S4	"This COMMD/CCDC22/CCDC93 (CCC) complex interacts with the multisubunit WASH complex, an evolutionarily conserved system, which is required for endosomal deposition of F-actin and cargo trafficking in conjunction with the retromer."	CCDC22|28952	11|17	CCDC93|54520	18|24	Complex
25361581	S1	A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis.	Tor|47396	28|31	VAPB|31349	52|56	Interaction_Agent
25384973	S1	Cdc42p-interacting protein Bem4p regulates the filamentous-growth mitogen-activated protein kinase pathway.	Bem4p|855942	27|32	Cdc42p|850930	0|6	Interaction_Agent
25384973	S4	We show that the Cdc42p-interacting protein Bem4p regulates the mitogen-activated protein kinase (MAPK) pathway that controls filamentous growth in Saccharomyces cerevisiae.	Cdc42p|850930	17|23	Bem4p|855942	44|49	Interaction_Agent
25384973	S6	"Bem4p associated with the plasma membrane (PM) protein, Sho1p, to regulate MAPK activity and cell polarization under nutrient-limiting conditions that favor filamentous growth."	Bem4p|855942	0|5	Sho1p|856854	56|61	Association
25384973	S7	"Bem4p also interacted with the major activator of Cdc42p, the guanine nucleotide exchange factor (GEF) Cdc24p, which we show also regulates the filamentous-growth pathway."	Bem4p|855942	0|5	Cdc42p|850930	50|56	Association
25384973	S7	"Bem4p also interacted with the major activator of Cdc42p, the guanine nucleotide exchange factor (GEF) Cdc24p, which we show also regulates the filamentous-growth pathway."	Bem4p|855942	0|5	Cdc24p|851190	103|109	Association
25384973	S8	"Bem4p interacted with the pleckstrin homology (PH) domain of Cdc24p, which functions in an autoinhibitory capacity, and was required, along with other pathway regulators, to maintain Cdc24p at polarized sites during filamentous growth."	Bem4p|855942	0|5	Cdc24p|851190	61|67	Association
25384973	S9	Bem4p also interacted with the MAPK kinase kinase (MAPKKK) Ste11p.	Bem4p|855942	0|5	Ste11p|851076	59|65	Association
25384973	S10	"Thus, Bem4p is a new regulator of the filamentous-growth MAPK pathway and binds to general proteins, like Cdc42p and Ste11p, to promote a pathway-specific response."	Bem4p|855942	6|11	Cdc42p|850930	106|112	Binding
25384973	S10	"Thus, Bem4p is a new regulator of the filamentous-growth MAPK pathway and binds to general proteins, like Cdc42p and Ste11p, to promote a pathway-specific response."	Bem4p|855942	6|11	Ste11p|851076	117|123	Binding
25391383	S8	"Gene-based analyses revealed four significant associations in the WT1, ZC3H12C, DLGAP2, and GPR1 genes at p < 0.05."	WT1|7490	66|69	ZC3H12C|85463	71|78	Association
25391383	S8	"Gene-based analyses revealed four significant associations in the WT1, ZC3H12C, DLGAP2, and GPR1 genes at p < 0.05."	WT1|7490	66|69	DLGAP2|9228	80|86	Association
25391383	S8	"Gene-based analyses revealed four significant associations in the WT1, ZC3H12C, DLGAP2, and GPR1 genes at p < 0.05."	WT1|7490	66|69	GPR1|2825	92|96	Association
25391383	S8	"Gene-based analyses revealed four significant associations in the WT1, ZC3H12C, DLGAP2, and GPR1 genes at p < 0.05."	ZC3H12C|85463	71|78	DLGAP2|9228	80|86	Association
25391383	S8	"Gene-based analyses revealed four significant associations in the WT1, ZC3H12C, DLGAP2, and GPR1 genes at p < 0.05."	ZC3H12C|85463	71|78	GPR1|2825	92|96	Association
25391383	S8	"Gene-based analyses revealed four significant associations in the WT1, ZC3H12C, DLGAP2, and GPR1 genes at p < 0.05."	DLGAP2|9228	80|86	GPR1|2825	92|96	Association
25392066	S6	"We used co-immunoprecipitation and bimolecular fluorescence complementation, with signal quantification by flow cytometry, to demonstrate that CSLC4 interacts with MUR3, XLT2 and FUT1."	CSLC4|822444	143|148	MUR3|816556	164|168	Association
25392066	S6	"We used co-immunoprecipitation and bimolecular fluorescence complementation, with signal quantification by flow cytometry, to demonstrate that CSLC4 interacts with MUR3, XLT2 and FUT1."	CSLC4|822444	143|148	XLT2|836343	170|174	Association
25392066	S6	"We used co-immunoprecipitation and bimolecular fluorescence complementation, with signal quantification by flow cytometry, to demonstrate that CSLC4 interacts with MUR3, XLT2 and FUT1."	CSLC4|822444	143|148	FUT1|814851	179|183	Association
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	MUR3|816556	44|48	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	XLT2|836343	50|54	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	XXT2|827940	56|60	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	XXT5|843779	65|69	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	MUR3|816556	44|48	XLT2|836343	50|54	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	MUR3|816556	44|48	XXT2|827940	56|60	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	MUR3|816556	44|48	XXT5|843779	65|69	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	XLT2|836343	50|54	XXT2|827940	56|60	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	XLT2|836343	50|54	XXT5|843779	65|69	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	XXT2|827940	56|60	XXT5|843779	65|69	Complex
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	MUR3|816556	44|48	Association
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	XLT2|836343	50|54	Association
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	XXT2|827940	56|60	Association
25392066	S7	"FUT1 forms homocomplexes and interacts with MUR3, XLT2, XXT2 and XXT5."	FUT1|814851	0|4	XXT5|843779	65|69	Association
25392066	S8	"XLT2 interacts with XXT2 and XXT5, but MUR3 does not."	XLT2|836343	0|4	XXT2|827940	20|24	Association
25392066	S8	"XLT2 interacts with XXT2 and XXT5, but MUR3 does not."	XLT2|836343	0|4	XXT5|843779	29|33	Association
25392066	S8	"XLT2 interacts with XXT2 and XXT5, but MUR3 does not."	MUR3|816556	39|43	XXT2|827940	20|24	Negation_Association
25392066	S8	"XLT2 interacts with XXT2 and XXT5, but MUR3 does not."	MUR3|816556	39|43	XXT5|843779	29|33	Negation_Association
25392066	S10	In vitro pull-down assays indicated that interactions in the FUT1-MUR3 and FUT1-XXT2 complexes occur through the protein catalytic domains.	FUT1|814851	61|65	MUR3|816556	66|70	Complex
25392066	S10	In vitro pull-down assays indicated that interactions in the FUT1-MUR3 and FUT1-XXT2 complexes occur through the protein catalytic domains.	FUT1|814851	75|79	XXT2|827940	80|84	Complex
25392066	S10	In vitro pull-down assays indicated that interactions in the FUT1-MUR3 and FUT1-XXT2 complexes occur through the protein catalytic domains.	FUT1|814851	61|65	FUT1|814851	75|79	Association
25392066	S10	In vitro pull-down assays indicated that interactions in the FUT1-MUR3 and FUT1-XXT2 complexes occur through the protein catalytic domains.	FUT1|814851	61|65	XXT2|827940	80|84	Association
25392066	S10	In vitro pull-down assays indicated that interactions in the FUT1-MUR3 and FUT1-XXT2 complexes occur through the protein catalytic domains.	MUR3|816556	66|70	FUT1|814851	75|79	Association
25392066	S10	In vitro pull-down assays indicated that interactions in the FUT1-MUR3 and FUT1-XXT2 complexes occur through the protein catalytic domains.	MUR3|816556	66|70	XXT2|827940	80|84	Association
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	TRAF4|9618	55|60	p47phox|653361	61|68	Complex
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	TRAF4|9618	55|60	Hic5|7041	69|73	Complex
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	TRAF4|9618	55|60	Pyk2|2185	74|78	Complex
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	p47phox|653361	61|68	Hic5|7041	69|73	Complex
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	p47phox|653361	61|68	Pyk2|2185	74|78	Complex
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	Hic5|7041	69|73	Pyk2|2185	74|78	Complex
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	GPVI|51206	135|139	TRAF4|9618	55|60	Association
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	GPVI|51206	135|139	p47phox|653361	61|68	Association
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	GPVI|51206	135|139	Hic5|7041	69|73	Association
25415317	S2	"BACKGROUND: We have previously shown the presence of a TRAF4/p47phox/Hic5/Pyk2 complex associated with the platelet collagen receptor, GPVI, consistent with a potential role of this complex in GPVI-dependent ROS formation."	GPVI|51206	135|139	Pyk2|2185	74|78	Association
25415317	S7	"Subsequent human platelet studies with PF-228 confirmed FAK is essential for GPVI-mediated phosphatidylserine exposure, a-granule secretion (P-selectin (CD62P) surface expression) and integrin aIIbb3 activation."	GPVI|51206	77|81	P-selectin (CD62P)|6403	141|159	Neutral_Regulation
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	Lyn|4067	234|237	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	Syk|6850	263|266	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	PI3-K|5293	269|274	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	Bruton's tyrosine kinase (Btk)|695	279|309	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	Rac1|5879	326|330	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	PLCg2|5336	332|337	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	Hic-5|7041	358|363	Interaction_Agent
25415317	S8	"To determine the precise location of FAK within the GPVI pathway, we analyzed the effect of PF-228 inhibition in CRP-stimulated platelets in conjunction with immunoprecipitation and pulldown analysis to show that FAK is downstream of Lyn, Spleen tyrosine kinase (Syk), PI3-K and Bruton's tyrosine kinase (Btk) and upstream of Rac1, PLCg2, Ca2+ release, PKC, Hic-5, NOX1 and aIIbb3 activation."	FAK|5747	213|216	NOX1|27035	365|369	Interaction_Agent